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Digital phenotyping through multimodal, unobtrusive sensing
Ignacio Perez-Pozuelo
The growing adoption of multimodal wearable and mobile devices, such as smartphones and
wrist-worn watches has generated an increase in the collection of physiological and behavioural
data at scale. This digital phenotyping data enables researchers to make inferences regarding
users’ physical and mental health at scale, for the first time. However, translating this data
into actionable insights requires computational approaches that turn unlabelled, multimodal
time-series sensor data into validated measures that can be interpreted at scale.
This thesis describes the derivation of novel computational methods that leverage digital
phenotyping data from wearable devices in large-scale populations to infer physical behaviours.
These methods combine insights from signal processing, data mining and machine learning
alongside domain knowledge in physical activity and sleep epidemiology. First, the inference
of sleeping windows in free-living conditions through a heart rate sensing approach is explored.
This algorithm is particularly valuable in the absence of ground truth or sleep diaries given
its simplicity, adaptability and capacity for personalization. I then explore multistage sleep
classification through combined movement and cardiac wearable sensing and machine learning.
Further, I demonstrate that postural changes detected through wrist accelerometers can inform
habitual behaviours and are valuable complements to traditional, intensity-based physical
activity metrics. I then leverage the concomitant responses of heart rate to physical activity
that can be captured through multimodal wearable sensors through a self-supervised training
task. The resulting embeddings from this task are shown to be useful for the downstream
classification of demographic factors, BMI, energy expenditure and cardiorespiratory fitness.
Finally, I describe a deep learning model for the adaptive inference of cardiorespiratory fitness
(VO2max) using wearable data in free living conditions. I demonstrate the robustness of
the model in a large UK population and show the models’ adaptability by evaluating its
performance in a subset of the population with repeated measures 6 years after the original
recordings.
Abstract
Together, this work increases the potential of multimodal wearable and mobile sensors for
physical activity and behavioural inferences in population studies. In particular, this thesis
showcases the potential of using wearable devices to make valuable physical activity, sleep
and fitness inferences in large cohort studies. Given the nature of the data collected and the
fact that most of this data is currently generated by commercial providers and not research
institutes, laying the foundations for responsible data governance and ethical use of these
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CHAPTER 1
INTRODUCTION: WEARABLE AND MOBILE DE-
VICES FOR DIGITAL PHENOTYPING AND HEALTH
Ubiquitous progress in wearable sensing and mobile-computing technologies, alongside grow-
ing diversity in sensor modalities, has created new pathways for the collection of health and
well-being data outside of laboratory settings, in a longitudinal fashion. Traditionally, epidemi-
ologists and clinicians have relied upon self-report measures of physical activity and sleep
which, whilst valuable in the absence of alternatives for large-scale data collection, are subject
to bias and often provide partial, incomplete information [2]. Wearable and mobile devices
now have the potential to provide low-cost, objective measures of physical activity, clinically
relevant data for patient assessment and scalable behaviour monitoring in large populations.
Indeed, today, over 400,000 participants have had their behaviour tracked prospectively using
accelerometers for epidemiological studies across the globe [3–5]. This data can be used in
both interventional and observational studies to derive insights regarding the links between
behaviour, health and disease, as well as to advance the personalization and effectiveness of
commercial wellness applications.
Physical behaviour data extracted from wearable devices is now being used to derive sensor-
assessed, objective measures of physical behaviours, overcoming the limitations of self-report
with the aim of relating these to clinical endpoints and eventually applying the findings to
preventive and predictive medicine. Moreover, the application of artificial intelligence (AI),
sensor fusion and signal processing to wearable sensor data has led to improved human activity
recognition (HAR) and behavioural phenotyping. In this chapter, we first introduce the state of
the art in wearable and mobile sensing technology in epidemiology and clinical medicine and
discuss how AI is changing the field. We then discuss the outstanding challenges in HAR and
the inference of sleep and fitness from wearable sensor data, alongside the contribution of the
original research work presented in this thesis to addressing them.
1
Introduction
1.1 Towards Digital Phenotyping
Physical behaviours, including activity and sleep, have long been thought to have important
health consequences. The earliest records of organised exercise as a formal means of health
promotion date back to 2500 BC [6] and the importance of physical activity and exercise
to health and longevity have long been promulgated. For instance, Hippocrates and Galen
advised that a lack of physical activity, as well as over-exertion, were detrimental to health and
well-being. Whilst the links between physical behaviour and health have long been suspected,
the formal, objective investigation of this relationship began with the Industrial Revolution in
England. The first physical activity studies were small, cross-sectional, observational studies,
including those conducted by Dr WA Guy of King’s College London, who compared mortality
rates between physically active and sedentary workers, favouring the former [7]. Modern-day
physical activity and exercise science research may have originated during the mid-1800s due
to the concern for the well-being and longevity of rowing oarsmen from the Universities of
Oxford and Cambridge [8]. Until then, the common belief, dating back to Galen, suggested
that vigorous exercise had deleterious effects on health. However, these studies showed that
the life expectancy of the athletes exceeded that of the general population, suggesting that even
vigorous exercise might possibly be advantageous to health [9]. Whilst these early studies
were all subject to potential biases and confounding, they sparked interest in understanding the
relationship between activity and health outcomes, which persists to the present day.
The field of physical activity and health research as we now understand it developed during the
1950s with studies of the association between physical activity and health [10, 11]. Seminal
work on coronary heart disease and physical activity amongst London workers by Morris and
colleges was followed by similar studies in the US. During the 1980s, the volume of evidence
suggesting and inverse association between physical activity and coronary heart disease,
supported by reviews of both cross-sectional and longitudinal studies, afforded epidemiologists
more confidence in asserting that the association was causal in nature [12]. The findings had a
strong impact on the promotion of physical activity as a matter of urgent public health interest,
ultimately leading to the physical activity recommendations launched in 1995 by the Centres of
Disease Control and Prevention and the American College of Sports Medicine, alongside other
analogous institutions elsewhere [13]. In the following years, randomised trials of physical
activity interventions were conducted, providing further support for a causal impact of physical
activity on health and the notion that physicians might prescribe physical activity began to
become more prevalent in the literature [14]. By the turn of the millennia, alongside a growing
number of epidemiological studies exploring the association between physical activity and
health, studies had begun to explore the measurement of physical activity [15].
Until recently, the study of physical activity has been hindered by the inability to accurately
quantify its component parts. The first large population-based study with objective monitoring
of physical activity levels was presented in 2008 [16]. Importantly, technological advances
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in wearable devices and smartphones increasingly facilitate the collection of vast amounts
of multimodal data in an unobtrusive, seamless way. In particular, the use of data generated
passively by these devices enables the measurement of free-living human behaviour in a
scalable manner. This data can be used for digital phenotyping. Given evidence of the health
consequences of physical behaviours, being able to distinguish exactly what, when and how
physical activity is linked to health, through more accurate characterization of physical activity,
would be advantageous.
Digital phenotyping can be defined as “movement-by-movement quantification of the in situ
individual-level human phenotype using data from personal digital devices" [17]. This new
field has already generated significant research interest across epidemiology and clinical
medicine. For instance, in psychiatry, objective, multimodal, continuous quantification of
behaviour using individuals’ own devices may result in clinically useful markers which can
then be used to improve diagnostics, tailor treatment or design new intervention models [18].
Similarly, real-time feedback paired with AI models introduces new opportunities for health
and well-being applications. For example, it may become possible to develop personalised
interventional feedback generated automatically based upon physiological, environmental and
social cues from mobile and wearable devices [19].
The decreasing cost and increasing capabilities of sensors embedded in mobile and wearable
devices, coupled with the proliferation of data sources from social media, environmental
sensors and other sources have yielded new ideas and techniques in the study and quantification
of well-being, mobility and social interaction [19]. However, as the data is proliferating, there
remain important limitations to our ability to interpret this data, allowing us to make inferences
about the associations between physical behaviour, health and disease.
Throughout this thesis we leverage multimodal wearable sensor technologies from large
epidemiological cohort studies, with strong parallels to the data captured by wearable devices,
to derive inferences about physical behaviours and characteristics. For instance, we explore
how these signals can be used to determine an individuals’ cardiorespiratory fitness (CRF) by
inferring their VO2max or to determine their sleep timing and quality. Improving our ability to
infer these characteristics from the data, helps to address an important limitation of current
research efforts.
Remark: The remainder of this chapter provides an introduction to how multimodal wearable
and smartphone devices can be used to derive objective measurements of physical activity
and behaviour. In doing so, we provide an introduction to the field of physical activity
epidemiology and the transition from questionnaire based assessments to objective monitoring
through accelerometers. We explore how mobile phones can be used to track physical and
psychological behaviours. Furthermore, the impact of AI in this emerging field of digital




1.2 Objective measures of physical behaviours in epidemiology
1.2.1 Introduction to epidemiological research
The overarching goal of epidemiological research is to inform the development of interven-
tions that reduce mortality and morbidity in populations [20]. In order to achieve this aim,
epidemiologists study the distribution of health-related states or events, such as disease, in
order to understand their burden and identify their determinants 1. To conduct this type of
research, intersecting data regarding both the outcome of interest and the potential determinants
is required. Not only must this data intersect, with the same individuals providing information
about both the exposure and the outcome, but it must be both reliable and valid [20]. This
means that the measure used to assess the exposure and the outcome must be repeatable over
time and accurately convey what it intends to measure. In general, objective measures are
preferred, whereby individuals are not required to recall or report their exposure or outcome
status themselves. This protects against unintentional recall biases and inaccuracies, as well as
intentional adjustments to reporting based on social desirability. However, these considerations
must also be balanced against the burden objective measuring places upon participants and the
other costs that they incur. Researchers may favour a marginally less accurate measure if the
measure can be collected with ease at low cost and is less unlikely to be refused by participants,
such that many participants can be included, thus increasing the power of the study to detect
associations [20].
In planning studies and drawing conclusions, epidemiologists must be attentive to chance,
bias, confounding and reverse-causality that could cause them to draw erroneous conclusions.
For example, if a study reported an association between sleep duration and obesity, the
results must be interpreted with caution and cannot be assumed to constitute evidence of a
causal relationship without further criteria being met [20]. In this example, the relationship
could be spurious and simply the result of chance. The probability of chance explaining the
results diminishes as the number of studies reporting the same finding increases. Further, the
probability of chance diminishes if larger data-sets are used. If the result is not spurious, it may
be the result of reverse causality. Contrary to the initial hypothesis, obesity may be the exposure
variable and sleep may be the outcome. Various methods to help rule-out reverse causality
exist. At minimum, longitudinal studies are required such that sleep measures are collected
prior to the onset of obesity. Further, if exposures are amenable, Randomised controlled trials
(RCTs) can be conducted or, if the genetic determinants of an exposure are well characterised,
Mendelian randomisation (MR) analyses can be performed. For example, a 2019 MR study
using genetically predicted sleep duration as the exposure and BMI as the outcome, suggested
a causal inverse association between sleep duration and BMI in children [21].
1https://www.who.int/topics/epidemiology/en/
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If reverse causality does not appear a likely explanation it remains possible that confounding
from a third, extraneous variable, associated with both the exposure and the outcome but which
does not lie on the causal pathway between them explains the relationship [20]. For instance,
smoking may cause both poor sleep and obesity, inducing a statistical association between the
two variables that may erroneously be interpreted as a causal relationship. In order to account
for confounding, analyses should be controlled for potential confounders or MR analyses using
genetic instruments may be used.
Finally, various forms of bias should be considered. Together these comprise systematic errors
in the design, conduct or analysis of a study that may result in a distortion of the relationship
between exposures and outcomes [22]. There are two major sources of bias in epidemiological
research: selection bias and information bias [20]. Selection bias relates to the study population
in which a research question is addressed. For example, if a study includes only adult men,
the results are only generalizable to adult men and cannot be considered applicable to other
population groups. A common source of selection bias in epidemiological research is that
the individuals who choose enrol in population-based studies are often healthier and better
educated than the general population from which they are drawn [23, 24]. Whilst the results of
studies that suffer from selection bias are still internally valid, they must be generalized with
caution. Biases may also relate to the data collected. This is referred to as information bias
and will be elaborated in the following section.
Overall, epidemiological research requires large data-sets with accurate, cost-effective and
minimally burdensome measures of exposures, outcomes and potential confounding variables.
Ideally, these data-sets should follow participants longitudinally. In the following sections,
the way in which multimodal wearable sensing devices have revolutionised the ability to
interrogate the associations of human activity to health and disease is explored. These abilities
increasingly facilitate accurate epidemiological research at scale in this area for the first time.
1.2.2 Traditional measurement of physical activity through questionnaires
Prior to the advent of wearable sensing and mHealth technologies, researchers primarily relied
upon questionnaire-based methods to measure physical activity. Questionnaires have many
advantages for epidemiological research. They do not require experts or any special training
to administer, they are also cost-effective, non-invasive and widely acceptable to participants.
Further, individuals can be asked to report upon their typical, long-term habits and behaviours
which may not be accurately represented in laboratory settings. These characteristics of
questionnaires facilitate the collection of data from large numbers of individuals and explains




Despite their many advantages, as alluded to in the previous section, questionnaires are not
objective measures and may be subject to information bias. Information bias occurs when
the measures used in a study are inaccurate. In the case of self-report measures, individuals
may inaccurately recall their behaviour, report an idealised version of their habits or some
combination. Previous studies have found that self-reported physical activity suffers from
reporting bias and that this results from a combination of social desirability bias (reporting
behaviour which is seen to be socially desirable), as well as the cognitive complexity of
reporting the duration, intensity and frequency of physical activity behaviours with precision
[16, 25, 26]. In addition, the understanding of a behaviour that is self-reported is limited to
the specific set of questions given to study participants. These may not be enough to reflect a
complete view of complex behaviours. Inaccuracies resulting from reporting errors may be
randomly distributed across the population being studied. In this case, the results of the study
would be biased toward the null, diminishing the ability of the researchers to identify true
associations between exposures and outcomes. However, the errors may also be systematic,
with participants in different population groups systematically under or over-reporting their
activity levels. This could lead to associations being identified which are the result of bias,
rather than cause, and leading to the drawing of erroneous conclusions. This could have serious
implications if public health guidance were to be based on these conclusions.
In order to diminish concern regarding information bias in studies using self-report measures of
physical activity, questionnaires should ideally be validated against a gold-standard measure.
1.2.3 The transition towards objective monitoring of physical behaviours
Objective monitoring of physical activity with devices such as pedometers (step measurement
[27–29]), actigraphy (count-based movement measurement [30]) and accelerometers (raw
movement intensity measurement) have been used to overcome the limitations of self-reported
activity measures [31]. Recently, increasingly sophisticated sensors embedded within smart-
phones have resulted in a proliferation of affective computing and behavioural phenotyping
applications. A non-comprehensive overview of the current landscape for human behaviour
phenotyping using wearable sensors and smartphones is presented in Figure 1.1.
Technological advances in the last 20 years allow for devices like triaxial accelerometers
to record and store data across multiple days without requiring recharging. Further, such
devices are increasingly affordable, reliable and non-obtrusive. Indeed, in 2003, the National
Institutes of Health and the National Cancer Institute funded the National Health and Nutrition
Examination Survey (NHANES) 3, a large epidemiological study that aims to understand the
objective measurement of physical activity through accelerometery, became the first study of
its kind in the United States. Many other large initiatives followed. The UK Biobank Study
3https://www.cdc.gov/nchs/nhanes/index.htm
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Figure 1.1 Overview of the layered, hierarchical framework of mobile and wearable sens-
ing technologies for digital phenotyping. The framework starts with the input layers where
mobile and wearable devices yield different, constantly evolving sensing capabilities. The
middle layers of the framework relate to inferences, from features to behavioural markers. The
output layer comprises the delivery of these inferences and finally behavioural/clinical states
identified through this framework (PPG: photoplethysmography, ECG: Electrocardiogram, HR:
































4, the Whitehall study 5 and the China Kadoorie Biobank (CKB) 6 all exemplify the use of
accelerometry in large-scale observational studies.
These studies allow researchers to perform epidemiological investigations exploring the as-
sociations between activity-related exposures of interest (predominantly comprising physical
activity, sedentary behaviour and sleep) and disease outcomes, whilst controlling for potential
confounders, such as diet, alcohol consumption, smoking habits or socio-economic status, also
collected amongst the study participants. In addition, such large-scale studies often provide
intersecting genome-wide genotyping information. This facilitates MR studies, as well as novel
genome-wide association studies (GWAS) designed to identify the determinants of physical
activity, sedentary behaviour or sleep [32]. These GWAS results can then be used to facilitate
MR studies in other cohorts, designed to assess the causal impact of physical behaviours on







1.2.4 Analysing physical activity: Accelerometers for movement analysis
Although physical activity and exercise are often used interchangeably in the literature, there is
a difference between these concepts. Physical activity can be defined as any bodily movement
that results in energy expenditure being increased above resting levels. Exercise is a particular
type of physical activity that is purposeful, planned, structured and often repetitive [33]. As
such, activities such as housework are considered examples of physical activity, but not of
exercise, because they are typically sporadic and unplanned in nature [34].
Physical activity can be broken down and defined by (1) type (walking, running, cycling,
etc); (2) duration or volume (total time performing the activity); (3) frequency (number of
sessions either per day or per week) and (4) intensity (how much energy is expended during
exercise) [35]. Metabolic equivalent tasks (METs) are often used to describe the intensity of a
given activity. For instance, one MET is equivalent to sitting at rest [35]. Depending on their
intensity, activities can be categorized into: sedentary (≤1.5 METs), light (1.6-2.9 METs),
moderate (3.0-5.9 METs) or vigorous (≥ 6.0 METs) [35]. Different types of activities will
normally fall into one of these buckets repeatedly. For instance, typing on a computer would
be categorised as sedentary, walking is considered light, brisk walking is moderate and running
is vigorous. In order to understand physical behaviours at a population level, it is imperative
to be able to accurately quantify the intensity of activities and link this to health outcomes.
This informs physical activity recommendations, as well as the assessment of whether these
recommendations are being met [34].
Accelerometry is a valuable technique for the accurate estimation of daily energy expenditure
in large population studies, given its feasibility, low cost and the existence of validation studies.
Acceleration signals are composed of a movement component, a gravitational component
and noise [36]. When conditions are static with non-rotational movement, the gravitational
component is visible as the offset of one or more sensor axes and can be used for the detection
of the sensor orientation in relation to the vertical plane [36]. However, this separation
is complicated when rotational movements are included as the frequency domains of the
movement-related component and the gravitational component can overlap, making it almost
impossible to separate these two components using simple frequency-based filtering [37]. The
inclusion of gyroscopes in addition to accelerometry helps to mitigate this problem but they
are not yet feasible for use in large-scale observational research [38, 36]. A schematic of the
processing and analysis of raw accelerometer signals is presented in Figure 1.2. This process
starts with raw measurements and data storage of triaxial acceleration waveforms (usually
between 60-100 Hz), followed by a post-processing step where the sensor is calibrated to local
gravity, time-stamping and re-sampling take place. The filtering of machine noise (≥ 20Hz)
follows and non-wear time is then identified. Once this post-processing step finishes, summary
metrics and feature extraction follows. In this step, statistical metrics and features (i.e. mean
magnitude, pitch, roll, power spectra, etc) are derived (see Fig. 1.2).
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Several accelerometer-derived metrics and constructs are well-defined, established methods to
quantify objective physical activity records. These metrics can then be used to then estimate
energy expenditure (EE) and derive metabolic equivalents (METs) [39]. Some of the best
established metrics are:
Volume of Physical Activity: Volume of physical activity refers to the total volume of activity
in a given time period. In order to compare different records and recordings of different
lengths, volume of physical activity is divided by the duration of the measurement to result in
an average activity intensity rate.
Intensity: As previously mentioned, physical activity intensity can be categorized into: Vig-
orous, Moderate, Light and Sedentary. These categories were originally defined by asking
participants but have since been informed by objective data, cross-referencing with resources
such as the Ainsworth Compendium [40], which is an aggregation of mean activity intensities
that are measured or estimated while performing different activities.
Posture: Posture, limb positioning and the pose of the body are of interest to physical
activity scientists as they can provide new context for other measurements of physical activity,
including work developed for this thesis [41, 42]. Indeed, interest in this domain has grown
in recent years given the complementary nature of these inferences to traditional, intensity-
based metrics also obtained through accelerometers. For instance, the consensus statement
regarding the definition of sedentary behaviour now includes the sitting posture as a defining
characteristic [43]. Advances in micro-electro-mechanical sensors (MEMs) and orientation
estimation algorithms allow wearable sensors to be used for non-restricted human motion
capture applications [44]. Bio-mechanically, human bodies are composed of a series of
connected, jointed links that move and operate with different degrees of freedom (DOF) which
can be measured using these devices. However, proper estimation of consistent and clinically
meaningful joint kinematics using wearable inertial sensors requires a sensor-to-segment
coordinate system calibration and understanding. To describe limb location, six parameters are
required. These comprise: location ((x,y,z) coordinates with respect to the reference system
axes) and orientation parameters ((α,β,γ) angles with respect to the reference system plane) of
a limb segment in space. These six coordinates constitute the DOFs of a given limb segment in
space and can be used to define orientation and spatial location at a given time.
1.3 Digital phenotyping in large population studies
1.3.1 Multimodal sensing
Most conventional studies using either smartphones or wearable sensors to study physical
behaviours have used single sensor approaches for measurement and classification tasks
(accelerometer, pedometers or gyroscopes) [3, 45]. Occasionally they have used GPS for
9
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Figure 1.2 Typical data analysis pipeline for movement sensor data: from raw accelerom-
eter data to appropriate filters and summary statistics. (ENMO: Euclidean Norm Minus One,
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coarse grained location sensing. However, smartphones and new generation wearable devices
often come equipped with a vast array of sensors that enable multimodal sensing. Incorporating
multimodal sensing information can yield additional physiological and environmental cues,
such as sound, heart rate, skin conductance, location or activity type. Indeed, large-scale
longitudinal studies, such as ’All of US’ 7, will incorporate multimodal wearable sensor data
with the aim of better understanding physical behaviours in free-living environments.
Multimodal sensing approaches often rely on traditional shallow models, like Random Forests
or Support Vector Machines, operating on features extracted from each sensor separately
[46]. Subsequently, there are two strategies to perform sensor fusion: Feature Concatenation
([47], [48]) that produces a single feature vector merging all the features extracted upstream;
and Ensemble Classifiers ([49]) where classifiers are trained in single modalities and their
predictions merged at the final step.
A significant challenge arises when attempting to incorporate information from sensor types
that are different in nature (i.e. an accelerometer, an ECG, and a phone camera). Due to the
inherent differences in sampling rates and data distributions or shapes, the aforementioned
approaches struggle to merge these diverse inputs and produce meaningful representations.
An important insight here is to combine and find patterns regarding the latent cross-sensor
interactions that cannot be discovered in isolation or ensembles. This is achieved with shared
or merged layers in deep neural networks that can model different sensor time-series and
extra participant metadata in a joint latent space (see Fig. 1.6). However, this area remains an
important area for improvement in the existing literature. Contributing to the addressing of
this gap in the literature, the merging of accelerometry and heart rate sensor data is one of the
topics addressed in this thesis.
7https://allofus.nih.gov/
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1.3.2 A brief introduction to deep and representation learning
Data-driven insights derived from AI have already had a tangible impact on wearable sensing
and mobile health. These developments have facilitated better HAR models, more accurate
predictive models of human behaviour and the development of personalised lifestyle recom-
mendations. In this section, two schools of thought are presented regarding the application
of AI methods to wearable and mobile data. The first looks for informative features that
represent the time-series through inventive feature extraction, whilst the second is based on
the emerging power of representation learning to automatically extract features from lightly
processed time-series during the training process.
1.3.2.1 Traditional feature-engineering modelling
Usually, mobile and wearable sensor data is transformed into feature vectors in order to
ensure compatibility with the majority of machine learning algorithms. A feature vector is a
matrix-like data structure where each row represents a unique sample and each column is a
separate feature or variable. However, the raw time-series signals arising from, for example
accelerometers, are represented as multiple continuous sequences. Consequently, the next
step after data collection is to summarize the information from each sensor into a number of
independent variables that capture semantic information. This task is called feature-extraction
and researchers work to come up with increasingly complex features that correlate with a given
label.
Depending on the size of the datasets and the computing power available, computing these
features as a pre-processing step can be a time-consuming, multi-step process. Simple statistics
such as the mean, median, standard deviation and inter-quartile range are easier to estimate and
could be used. However, they may not capture the informative features of noisy signals. On the
other hand, higher-order statistics and transformations like the kurtosis, skewness, stationary,
least squares slope, autocorrelation, Fourier transform, and entropy provide more expressive
metrics that reflect real time-series phenomena like the seasonality or repeatability [50, 51].
After the calculation of the appropriate metrics from the time-series signal, they are then fed to
machine learning algorithms. If additional linked datasets (metadata) exist (i.e. demographic,
anthropometric or personality traits) they are concatenated with the sensor features into a big
feature vector. The most common classification algorithms found in the literature are Logistic
Regression, Random Forests, Support Vector Machines, and variants of Neural Networks.
Extensive feature extraction, resulting in a large number of features, can lead to suboptimal
results. Learning algorithms under-perform when the number of features is higher than the
number of samples, in a phenomenon known as (“the curse of dimensionality") [52]. As a
result, researchers try to reduce the number of features before the training, either with feature
selection or dimensionality reduction. For example, in a study that aimed to recognize state
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changes in bipolar patients [53], data was reduced using Linear Discriminant Analysis (LDA).
Other robust approaches include Principal Component Analysis (PCA). In the next section we
will explore some of the most powerful approaches currently used for this type of modelling
by introducing deep learning.
1.3.2.2 Introduction to deep learning
Deep artificial neural networks are the computational engines that power modern AI. To
introduce deep learning, we shall start with some of the simple statistical tools: linear regression
[54]. In linear regression, we take a set of N input-output pairs {(x1, y1), ..., (xN , yN )}, for
instance Resting HR to VO2max observations. Linear regression assumes that there exists a
linear function mapping each xi ∈ RQ to yi ∈ RD (where yi may be corrupted by observation
noise). As such, regression models the relationships between predictions and targets. The
linear model in this case results in an linear transformation of the inputs : f(x) = xW + b,
with W being a Q by D matrix (in R) and b represents a real vector of T elements. In linear
regression, different parameters W, b are used to define different linear transformations with
the objective of finding the optimal parameter combination to reduce or minimize some type of
error, for example the average square error over the observed data: 1N
∑
i ∥yi − (xiW + b)∥
2.
Real-life problems are often non-linear in nature, making the use of linear regression to solve
them futile. In cases where the relationship between x and y is not linear, we ought to define a
non-linear function f(x) that maps the inputs to the outputs. To overcome these limitations we
can use linear basis function models, where input x can be fed through K fixed scalar-value
non-linear transformations ϕk(x) resulting in a feature vector Φ(x) = [ϕ1(x), ..., ϕK(x)] [55].
Here, the basis function ϕk(x) is chosen to suitably model the non-linearity in the relationship
between the input and the target. As such, it can take many forms parametrized by k such as
sigmoidals, sinusoids or polynomials of various degrees. The resulting feature vector ϕ can
then be used for regression as opposed to the original data x. A thorough explanation of this
process and machine learning from a mathematical perspective can be found in [55].
In 1958 Frank Rosenblatt introduced the perceptron model, which is widely considered the
first Artificial Neural Network (ANN). Rosenblatt’s perceptron was a linear classifier that
made predictions based on linear prediction functions combining a set of weights with a
feature vector. A schematic of the simplest ANN or perceptron is provided in Figure 1.3.
ANNs or neural networks are mathematical models loosely inspired by how biological neurons
operate and consist of a set of interconnected model neurons, referred to as units. These
methods were motivated by the different levels of processing observed in the brain, where
it is believed that each level is able to learn different features or representations at different
levels of abstraction [56]. Neuroscientific findings related to the standard model of the visual
cortex have inspired the recent developments in the area of machine learning known as deep
learning. By analogy to real biological neural networks, deep learning models are a form of
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representation learning, where the model is fed data and it develops its own representations
required for appropriate pattern recognition through multiple layers. Deep neural networks use
the ability that perceptrons have of representing elementary functions and combine them in a
network of layers. These layers are usually arranged in a sequential fashion and composed of
a number of non-linear operations, in essence a hierarchical stacking of the aforementioned
parametrized basis functions. It is through this process that representations from one layer
flow to other layers and are transformed to more abstract representations that allow for highly
complex functions to be learned. This ability to adapt with high modularity embodies the true
versatility of deep learning models. Indeed, when comparing to their biological counterparts,
deep neural networks exhibit some similarities in that they are able to generalize, undergo
graceful degradation and are content addressable. An intuitive visual introduction to the
concept of manifold learning in neural networks is presented here 8.
Figure 1.3 Example single layered Artificial Neural Network. The connections from the














For the purposes of this introduction to deep learning, we will provide an overview of simple
neural network models. Throughout this thesis, more complex architectures are explored,




these simple neural networks we will introduce some of the terminology and notation that will
be used throughout this thesis.
Basic feed-forward neural networks:
Rumelhart and colleagues introduced the concept of backpropagation, a process through which
the weights of the connections in the network are adjusted so that the difference between the
actual output vector of the network and the desired output is minimized [57]. An example
network would output:
ŷ = σ(xW1 + b)W2
given an input x, weights (W1 and W2) and element-wise non-linearity σ (which can take the
form of a sigmoid, tanh or ReLu to apply the transformation).
This concept is largely based on an application of the chain rule for derivatives. Through the
process of backpropagation, the gradient of the loss function L with respect to the weights w








Where {y1, ..., yN } are N observed outputs and {ŷ1, ..., ŷN } are the resulting outputs of the
model for inputs {x1, ..., xN }.
Backpropagation enabled the development of gradient methods, like gradient descent, which
allow training multilayer neural networks that are able to distort the input and make it linearly
separable through element-wise non-linear transformations (sigmoid, rectified linear units or
tanh) that take place in the networks’ hidden layers. A basic feed-forward model is depicted
in Figure 1.4. We will now briefly introduce the building blocks of modern deep learning
architectures: convolutional and recurrent neural networks.
Convolutional Neural Networks:
Convolutional neural networks (CNNs) gained popularity due to their strong performance
in computer vision tasks, beginning with LeNet [58]. In essence, these models consist of a
recursive application of convolution and pooling layers that are then followed by inner product
layers at the end of the network. Convolutions are used to extract features from the input data.
In the context of images, convolutions conserve the relationship between pixels by learning
image features (by applying a transformation) using small square portions of the original image
as input data. Pooling layers take the output of such convolution and reduce its dimensionality.
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Next, we introduce recurrent neural networks which are optimal for modelling sequential data
like text, speech or (as in our case) time-series sensor data.















Recurrent neural networks (RNNs) are sequence-based models which allow previous outputs
to be used as inputs while having hidden states [59], as depicted in Figure 1.5. RNNs capture
historical information of all the past elements of a sequence making them particularly attractive
for natural language processing, speech recognition and time-series modelling.
Remark: In our work, various forms of RNNs are used, with Gated Recurrent Units (GRU) and
Long-Short Term Memory (LSTM) units being particularly relevant. These models overcome
the limitations relating to vanishing gradients present in traditional RNNs [60].
1.3.2.3 Introduction to representation learning
Learning high-level representations from labelled data with layered differential models in an
end-to-end fashion is arguably one of the pillars for the success of modern AI. However, a
variety of outstanding challenges remain in this field such as data efficiency, generalisation or
robustness. Importantly, while supervised representation learning has shown state-of-the-art
performance in a variety of real-world applications [61–63], unsupervised learning is yet to see
similar breakthroughs as modelling high-level, valuable representations from raw observations
(like raw sensor data) remains largely elusive [64].
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Self-supervised learning is a representation learning paradigm that leverages the intrinsic
structure present in the input signals [65]. These models make use of large scale of unlabelled
data by learning objectives in order to get supervision from the data itself, using supervised
loss functions. Through this process, objectives are computed from the signals themselves
by applying known transformations to the input data. Most importantly, the intermediate
representations capture semantic and structural meaning that can then be exploited for a variety
of downstream tasks. While there might be conceptual overlaps with unsupervised learning,
its goal is primarily to learn a good geometrical structure of the data using the reconstruction
loss (how well we can compress and decompress the input) so that the result can be used
mainly for clustering purposes. On the other hand, self-supervised learning’s goal is to leverage
relationships between the input data using supervised losses (classification or regression). This
new paradigm has been successfully applied in filling the blanks for image datasets [66], next
word prediction [67], video frame order validation [68], and more recently to small-scale
activity data [69]. In BERT [67], for example, the task at hand is to predict the next word given
the past sequence. BERT outperforms any other language modelling method by adding two
auxiliary tasks within its architecture, both of which are based on self-generated labels. On the
other hand, the pre-trained task of video frame order validation [68] improved the performance
on the downstream task of action recognition when used as first step. More recently, SimCLR
has demonstrated a simplified and improved version of previous approaches to self-supervised
learning on images yielding state-of-the-art classification results with a limited amount of
class-labelled data in the Imagenet dataset [70].
Throughout this thesis, we use the concept of self-supervised learning to leverage the multi-
modal, unlabelled nature of modern wearable sensors.
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1.3.3 Human Activity Recognition
Human Activity Recognition (HAR) can be defined as the challenge of recognizing when a
person is engaging in certain activities. Hence, HAR attempts to identify the activity being
performed by an individual, alongside when the activity is taking place. HAR systems are based
on observations of activities that are captured using a variety of sensors, such as accelerometers
and gyroscopes (to capture movement-related data), heart rate monitors (to study heart rate
variability) and more. These on-body sensors allow for truly ubiquitous and continuous
monitoring of physical behaviors.
The sensors record temporal data, which means that automated HAR methods face a dual
issue. First, the method needs to be able to localize contiguous portions of data relevant to the
activity recognition problem that the system is facing (segmentation). Second, those segments
are then classified by automatically assigning class labels. Indeed, this task is particularly
complex as information regarding the activity is typically required to identify when the activity
took place. However, classification requires previous localization within the sensor dataset
to determine when the activity starts and ends. Importantly, the classification step of HAR
cannot retrieve any segments that are not included in the original segmentation step, making
the task particularly challenging. Due to this dual problem, researchers in HAR often use
sliding-window approaches to avoid missing any important information for the classification
step. The sliding window approach works by providing a small analysis window that shifts
along the continuous data stream, extracting contiguous portions of sensor readings. The
resulting data is then analysed in isolation, showing strong results in identifying periodic
activities such as walking, cycling or climbing stairs. The performance of this analysis largely
depends on how the sliding window was defined (length, steps, etc.). Thus, domain knowledge
is an important factor when considering the configuration of the sliding window.
Once this process is complete, machine learning pipelines pre-process the sensor data extracted
from the sliding window and proceed to extract features and employ probabilistic classification
back-ends that are able to assign activity labels to the corresponding analysis window [71].
Over the last decade, deep learning approaches have been established as valuable alternatives
to conventional machine learning models which have limited ability to perform in the context
of challenging pattern recognition tasks, such as the ones used in HAR. Deep learning models
eliminate the need to manually construct feature spaces by automatically learning (hierarchical)
data representations that are integrated into an overarching classification model. Furthermore,
their modelling power has yielded very impressive results as a result of their ability to learn
extremely complex decision functions. This is of great importance when dealing with the
challenging analytical problems introduced in HAR tasks [72].
Combining multiple sensors for activity recognition purposes has shown promising results.
These multimodal approaches have the ability to capture information that may not be possible
to explore through individual sensors, such as contextual changes or social interactions [46]. In
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Figure 1.6 Multi-modal sensing modelling with deep neural networks. Sensor data is
modelled with time-aware layers whilst participant variables are fed into a separate sub-
network. The network is trained end-to-end and learns joint representations of both modalities,
leveraging latent combinations of sensor features and demographics. (RNN/CNN: Recur-
rent/Convolutional Neural Networks)
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the next section multimodal sensing is introduced, addressing the opportunities and challenges
associated to integrating multiple sensors for digital phenotyping.
1.4 Remaining challenges in free-living inferences of physical be-
haviours addressed through this work
Whilst the mobile and wearable sensing technologies and their associated inferences discussed
throughout this introductory chapter continue to progress at a rapid rate, there are several
areas where important challenges remain. These provide an important rationale for the work
conducted in this thesis.
Indeed, recent technological advancements allow for wearable devices to integrate a plethora
of sensors, better batteries and even perform complex in-device computations [73]. However,
most devices, their applications and inferences remain poorly validated or not validated at all.
Several challenges are worth addressing in the context of wearable device validation. First,
to date, commercial device providers rarely provide details of the methods and algorithms
used for these inferences, severely limiting the transparency of these products. This impedes
the potential use of these technologies for digital health or academic applications as it does
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not allow for scrutiny of the methods or results that constitute the backbone of the inferences.
Second, commercial devices provide inferences reported to high-levels of granularity, for
instance with regards to sleep stages, energy expenditure or fitness. However, academic
research has shown the limitations of these claims [74–76]. It is paramount that the inferences
that these devices claim are subject to thorough and systematic analytical and clinical validation
[77]. Finally, domain adaptation is required to generalise the inferences to other contexts
or to slightly different devices. Most wearable inference derivations have been carried in
constrained laboratory environments, do not include representative multi-ethnic or cross-
cultural samples and are typically constrained to a single device and device placement, severely
limiting generalisability to free-living conditions. These shortcomings regarding the diversity
of research samples have been previously addressed in other health-related domains such as
the treatment effects of specific drugs and how clinical trials should be designed [78, 79].
For instance, it is important to understand how new ubiquitous sensing tools may perform in
different ethnic groups, recent work by Bent and colleagues explored the role of skin tone
in PPG recordings [80], or more broadly where the representation of minorities in samples
matters (i.e.: differences in digital intervention treatment effects).
In this section we will introduce two specific areas where there remains plenty of room for
improvement and validation of wearable inferences, these comprise sleep and cardiorespiratory
fitness monitoring. Further, we introduce a third area, domain adaptation, which is not covered
in the results chapters of this thesis but the author is actively working on and believes is one of
the most important challenges for the field of wearable and mobile sensing.
1.4.1 Challenges in the estimation of sleep using wearable sensors
As described, physical activity data is proliferating in both academic and commercial settings
with the increasing availability and adoption of wearable devices. However, how to use this
data to infer physical behaviours, such as exercise, sedentary behaviours and sleep, remains an
ongoing challenge.
As explored in detail in Chapter 2 of this thesis, actigraphy has been used to infer sleep as
a non-invasive and free-living alternative to polysomnography for decades. However, two
important challenges remain outstanding.
First and foremost, well-established and validated heuristic algorithms for wearable sensors
like the Sadeh [81], Cole-Kripke [82], Scripps Clinic [83] or Sazonov [84] approaches were
developed for use during the night period. This poses challenges for the evaluation of sleep in
free-living conditions at scale when sleep diaries or expert annotations are not present because
the original algorithms require a pre-defined search window. Further, the use of sleep diaries
in general, as well as for this purpose, has proven to be problematic. These self-report tools
are prone to recall bias, with survey data not proving sufficiently reliable labels [85]. When
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using sleep diaries, it can often take more than 6 recorded days to achieve agreement with
objective labels, even amongst those with more regular sleep patterns [86]. Diary-independent
algorithms that do not require intersecting sleep diary data will mean that further improvements
in technology do not need to be limited by the feasibility of keeping long-time records and
could help answer clinical questions about less regular sleepers such as night-shift workers
[87]. Chapter 4 introduces a HR based model for the estimation of sleep windows where sleep
classifiers can then be applied.
Second, although commercial wearable devices claim to be able to classify sleep stages, little
work has been done to showcase the validity of these devices against gold-standard measures
of sleep. Similarly, no study to date has explored the strengths and limitations of leveraging the
multimodal nature of current wearable devices for sleep stage classification. This is explored
in Chapter 3 of this thesis.
It is noteworthy to mention that, while these new wearable technologies are invaluable tools
for the objective monitoring of sleep in free-living conditions, the diagnostic of certain sleep
disorders such as insomnia is likely to still depend, at least in part, on self-report measures such
as the Epworth Sleepiness Scale (ESS). Thus, we would envision that in the near future digital
health solutions for the diagnosis, management and intervention of sleep disorders would likely
consist of both objective monitoring of sleep through one or several of the devices presented in
Chapter 2 as well as an app or resource that allows the user to input their own perceived sleep
health and receive recommendations through this platform.
1.4.2 Challenges in the inference of cardiorespiratory fitness using wearable
devices
Cardiorespiratory fitness (CRF) is prospectively associated with the incidence of type 2
diabetes, cardiovascular disease, various types of cancer [88–90], as well as all-cause and
cause-specific mortality [91, 92]. Despite its importance, routine clinical measurement of CRF
is rare due to its reliance on graded exercise testing, which is costly and unsafe for some patient
groups. RHR could serve as a viable alternative to clinical CRF measurement; it is easy to
measure, scalable to large populations through wearable sensors, and prospective associations
are similar to those reported for CRF [93–98].
In recent work [99], we showed that RHR explains a quarter of the variation in VO2max
among adults in the Fenland study. About half of this association is explained by BMI and
PA, suggesting changes in CRF achieved through altered behaviour can be tracked through
changes in RHR. This association was verified in longitudinal analyses, making RHR a suitable
biomarker of CRF that can be used at a population-level through serial measurement of RHR
facilitating personal goal setting/evaluation and remote patient monitoring. The results of this
work are discussed in more detail in Chapter 7.
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1.4 Remaining challenges in free-living inferences of physical behaviours addressed
through this work
While the inverse association between RHR and CRF is interesting, we hypothesized that the
strength of the association could be improved by leveraging the time-series sensor data used
in the Fenland cohort. This type of data is similar to that captured by most modern wearable
devices. While some commercial devices do provide inferences of VO2max, most approaches
are proprietary and require an exercise recording set by the participant which relies on GPS.
Further, these devices often lack proper validation against gold-standard measures of VO2max
or derived their inferences in very small samples.
In this thesis we explored how deep representation learning approaches can be used to leverage
information from multimodal wearable devices (Chapter 6). First, we showed that forecasting
HR and HRV using movement as a pre-training task in a self-supervised learning set-up
could effectively be used to generate physiologically meaningful representations. These
representation were then used in downstream transfer learning tasks.
For the prediction of CRF, in Chapter 7, we use a deep learning model that learns latent-
state representations that emerge from the sequential and dynamic responses of HR and
HRV to movement and physical behaviours. These physiologically relevant representations
are used to infer VO2max. We demonstrate that those learned representations not only
yield better performance than traditional and state-of-the-art non-exercise models, but also
that this paradigm can adapt with time and given behavioural changes by showcasing strong
performance in the same population 7 years later. These inferences do not require the participant
to record any exercise period manually or rely on GPS and were validated using one of the
largest submaximal VO2max protocols available to date.
1.4.3 Challenges in Domain Adaptation with wearable sensing
Transfer learning and domain adaptation refer to the paradigm where something is learned in a
source domain and is exploited to improve generalizability in another domain.
Differences between source and target data sets for human activity classification and other
wearable sensor-related tasks can significantly reduce classification accuracy. Ideally, a model
trained on a particular wearable device would be seamlessly applied to other devices that
may have a different sampling rate or are slightly different in nature. To achieve this, we
turn to domain adaptation, a discipline that seeks to develop learning algorithms that can be
easily ported from one domain to another, from one device or brand to another [100]. Domain
adaptation techniques have shown strong results in natural language processing, as well as
image and video classification tasks [101, 100, 102]. More recently, these techniques have
been used on wearable and mobile devices in the context of HAR tasks [103–105].
Most existing approaches implement this philosophy of alignment by minimizing a measure-
ment of distributional discrepancy in the feature space, often some form of maximum mean
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Figure 1.7 Visual explanation of domain adaptation. Here, we visualize how representa-
tions may be aligned in the feature space. In (A) we observe the distributions of a Source
(S) and target domain (T). In the S domain an example classifier is applied. (B) Without any
correction, we show that the classifier developed in the S domain doesn’t generalize well to
a context where both the S and T datasets are present. (C) We introduce a potential solution
to this issue by training a shared representation to support a source classifier in both domains
which can then b used to align the S and T domains across one direction. Finally in (D) we
hypothesize that by including multiple self-supervised tasks and learning a number of shared
representations, the alignment of the S and T datasets is much more robust and the original












discrepancy (MMD) [106, 107], or a learned discriminator of the source and target as an
approximation of the total variation distance [108].
While MMD and learned discriminator approaches are valuable, they rely on the formulation
of the training objective as a min-max optimization problem (adversarial learning) which can
be complex and computationally costly. One potential solution to overcome the fluctuations
observed in the discrepancy loss and divergence attributed to these methods is through the use
of self-superevised pre-training tasks in both source and target domains simultaneously. This
an area of research in which the author of this thesis is actively involved and a brief explanation
is featured in Figure 1.7.
1.5 Thesis rationale and aims
The overarching aim of this PhD is to advance understanding of how multimodal sensing
through wearable and mobile devices can be used to characterize physical behaviours in free-
living conditions. In this introduction, we explored the state-of-the-art in mobile and wearable
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sensing, providing an overview of the foundations to some of the fundamental methods and
techniques used in this field. We also established the importance of accurate characterization of
physical behaviours, including sleep, sedentary behaviours and exercise, to understanding their
relationships with health and disease, and ultimately driving the personalized and public health
recommendations of the future. Overall, to date, the modelling methods described throughout
this chapter have helped the field move towards the collection of large-scale data from free-
living conditions with unprecedented granularity. This is likely to have important implications
for industrial and academic purposes, facilitating the types of well-powered epidemiological
studies of physical behaviours, discussed in Section 1.2.
Despite this progress, some important outstanding gaps in the existing literature remain that
motivate the studies reported in this thesis. These will be addressed through four interconnected
sub-aims:
• Aim 1: To estimate sleep and sleep stages in free-living conditions through multi-
modal wearable sensing. The methods used to characterize physical behaviours require
further refinement to ensure their accuracy. This particularly pertains to the study of
sleep. As noted, whilst multimodal sensing has the potential to elucidate free-living
physical behaviour on a hitherto unprecedented scale many longitudinal studies still rely
on sleep diaries [109, 110] which have been shown to be subject to recall biases [85].
Further, in cases where objective sensor data is used, existing algorithms designed to
infer sleep have rarely been validated against gold-standard measures [32]. Existing
algorithms typically pertain only to one type of device limiting the extent to which
they can be used with ease across studies. Additionally, to fully leverage multi-modal
sensing, the merging of information from different sensor modalities is needed, as single
modality approaches may have limited inferential capabilities for specific behaviours.
An example of this is that while actigraphy signals have been used to infer sleep-wake
periods, they are not capable of distinguishing sleep stages when used in isolation [111].
• Aim 2: To explore how wearable sensors can be used to better understand and
characterize physical activity beyond intensity metrics. Conventional wearable de-
vices have focused on reporting counts (actigraphy) and intensity metrics such as VM or
ENMO (accelerometry) [16]. However, the widespread adoption of triaxial accelerome-
try, including in cohorts such as the UK Biobank [112], today enables a more nuanced
analysis of physical behaviours. For example, the analysis of postural changes made
possible through wearable sensing makes it possible to better understand sedentary be-
haviours that traditional, intensity based approaches may have missed [113]. It is helpful
to infer detailed information about physical activity, because characteristics of different
activities, beyond intensity, may have important consequences for health [114]. In order




• Aim 3: To leverage multimodal free-living sensing information to infer meaning-
ful physiological characteristics, including fitness or BMI. Novel uses of multimodal
wearable sensor data need to be explored to make optimal use of existing information.
For example, wearable sensors may be able to be used to infer health-related character-
istics, such as CRF. As these characteristics have known associations with health and
disease [115], being able to infer them in situations when they are not directly measured
will enhance our ability to further interrogate their health relevance and adjust for them
in studies of other traits. A limited number of published works have begun to do this, for
example [116, 46]. However, thus far, they have primarily focused on laboratory-based
activity recognition tasks and have not explored health-related inferences in free-living
conditions in detail. In other fields, these methods have shown great promise. For
example, in computer vision multimodal representation learning has lead to valuable
improvements in audio-visual speech classification [117].
• Aim 4: To summarise and provide recommendations for the future management
of mobile sensing data and digital phenotyping. The number of individuals collecting
their own data through personal devices and contributing data to research has increased
substantially, for instance, the use of wearable devices is projected to increase more
than five-fold over five years from 20169. Unlike for other specialised types of personal
data, such as genetic information [118], there is no governance framework for digital
phenotyping information. Indeed, most digital phenotyping data arises from commercial
products, where the role of this data and the associated research is, at least in part,
designed to support a business model. Most of this data is therefore not used to produce
pure public goods or knowledge and is not freely available under existing governance
frameworks for proprietary data. The current fragmented approach to regulatory over-
sight, classification of data for the purpose of identifying the applicable laws and varying
data governance practices together decrease user trust in digital phenotyping and limits
potential medical research. Thus, there is a clear and growing need for a governance
framework that protects the interests and rights of both individuals and researchers.
The aims of this thesis are addressed, as outlined in Figure 1.8 through Chapters 2-8.
In order to answer these outstanding questions and address the aims of the thesis, we turned to
some of the largest objective monitoring cohorts available to date with gold-standard measures
of sleep, energy expenditure or cardiorespiratory fitness that enable the validation of our
methods. These include: the Fenland Study, the Multi-Ethnic Study of Atherosclerosis and the
Biobank Validation Study among several others. A full description of these cohorts, as they
are relevant to the thesis, is given within each results chapter.
9Wearable Devices https://www.statista.com/study/15607/wearable-technology-statista-dossier/ (Statista, 2019)
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UBIQUITOUS MONITORING IN SLEEP HEALTH:
A DATA-DRIVEN REVOLUTION IN SLEEP SCIENCE
AND MEDICINE
Publications
Parts of this chapter are published elsewhere:
Perez-Pozuelo, I., Zhai, B., Palotti, J., Mall, R., Aupetit, M., Garcia-Gomez, J. M., ... &
Fernandez-Luque, L. (2020). The future of sleep health: a data-driven revolution in sleep
science and medicine. NPJ digital medicine, 3(1), 1-15.
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I planned this project and recruited a working group of global experts on sleep health. I wrote
this chapter and the resulting manuscripts.
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Ubiquitous monitoring in sleep health
2.1 Summary
In recent years there has been a significant expansion in the development and use of multi-
modal sensors and technologies to monitor physical activity, sleep and circadian rhythms.
These developments make accurate sleep monitoring at scale a possibility for the first time.
Vast amounts of multi-sensor data are being generated with potential applications ranging from
large-scale epidemiological research linking sleep patterns to disease, to wellness applications
including the sleep coaching of individuals with chronic conditions. However, in order to
realise the full potential of these technologies for individuals, medicine and research, several
significant challenges must be overcome. There are important outstanding questions regarding
performance evaluation as well as data storage, curation, processing, integration, modelling
and interpretation. In this chapter, we introduce the state-of-the-art in sleep monitoring
technologies and discuss the opportunities and challenges from data acquisition to the eventual
application of insights in clinical and consumer settings. Further, we explore the strengths
and limitations of current and emerging sensing methods with a particular focus on novel
data-driven technologies, such as Artificial Intelligence which is readily used in the results




Sleep is a crucial biological process and has long been recognised as an essential determinant
of human health and performance. Whilst not all of sleep’s functions are fully understood, it is
known to restore energy, promote healing, interact with the immune system and impact upon
both brain function and behaviour [119, 120]. Even transient changes in sleep patterns, such
as acute sleep deprivation, can impair judgement and cognitive performance, whilst long-term
aberrations have been linked to disease development [121, 122]. Global trends in sleep suggest
a decrease on average sleep duration [123–126]. Given these trends and the implications of
sleep for health and well-being, better characterisation of sleep characteristics represents a
public health priority [127–129].
Chapter Significance: In this chapter, an overview of the state-of-the-art and upcoming sleep
sensing technologies is presented, highlighting the strengths and limitations of each on of
these tools. This chapter also introduces the digital sleep framework and outlines the major
challenges associated to this field. Importantly, wearable devices, which are used throughout
this thesis and in the next following chapters for sleep sensing purposes, are of particular
interest given their low user burden and relatively good accuracy.
Sleep is known to be regulated by three main factors: circadian rhythms, sleep-wake homeosta-
sis and cognitive-behavioural influences [119]. With regards to behavioural determinants, poor
sleep quality [130] (as defined by the National Sleep Foundation’s recommendations based on
total sleep time, sleep latency, wake after sleep onset, number of awakenings > 5 minutes and
sleep efficiency) has been associated with stress, anxiety, smoking, sugary drink consumption,
workplace pressures, financial concerns, regularity of working hours, physical activity, sleep
regularity and commuting times [127, 131]. Indeed longitudinal research has linked changes in
physical activity to changes in the severity of sleep-disordered breathing and, hence, disturbed
sleep [132]. Further, dietary patterns have shown associations with sleep quality [133]. It is
now understood that the associations between diet, physical activity and sleep are bidirectional.
Thus, poor sleep, high levels of inactivity and a poor diet comprise inter-related public health
priorities [134]. The mental and physical impairments associated with a single night of poor
sleep can outweigh those caused by an equivalent lack of exercise or food [135].
Sleep loss affects every major system in the human body. Chronic changes in sleep have
been associated with a plethora of serious medical problems from obesity and diabetes to
neuropsychiatric disorders [131, 136, 137]. For example, chronic insomnia is associated with
both incident cardiovascular disease and all-cause mortality [138, 122]. A 2011 meta-analysis
of prospective studies, which included 470,000 individuals, explored the association between
sleep duration and cardiovascular disease [139]. Relative to those who slept between 7 and 8
hours per night, those who slept less than 6 hours exhibited a 48% increase in the incidence
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of coronary heart disease and 15% increase in the incidence of stroke, whilst those who
slept greater than 8 to 9 hours exhibited a 38% increase in coronary heart disease, a 65%
increase in stroke and a 45% overall increase in cardiovascular disease [139]. Other large
epidemiological studies have also reported associations between sleep and cardio-metabolic
disease, including reports studying the effects of shift-work [140–143]. Short sleep duration
has further been associated with incident diabetes and weight gain, as well as impaired appetite
control [144, 136]. Shortened sleep and poor sleep quality have also been identified as risk
factors for cognitive decline, neurodegenerative disease, mood changes and depression, as well
as other neuropsychiatric conditions [145–148]. There is also mounting evidence linking sleep
to both immune function [149] and cancer [150, 151]. In a seminal study published in 2002,
Spiegel and colleagues demonstrated an association between sleep deprivation and a muted
immune response to flu vaccination [152].
Besides its ramifications for the health of individuals, sleep has macro-level economic impli-
cations. A recent study estimated the annual economic cost of poor sleep to the Australian
population at $45.2 billion, comprising direct health care costs, the cost of associated health
conditions, reduced productivity, accidents and informal care [128]. Moreover, in a 2016
report, RAND Corp quantified that the combined cost of insufficient sleep across 5 OECD
countries (Canada, USA, UK, Germany and Japan) exceeds $600 billion a year [127].
Following mounting evidence of the role of sleep in well-being, its relationship with disease
and mortality and its economic impact, there has been increased interest in measuring sleep
characteristics. This has led to an expansion in the development and use of sleep-related
technology. In particular, recent developments in digital technologies designed to improve
the measurement and characterisation of sleep have demonstrated particular potential. These
advances facilitate the objective and unobtrusive measurement of sleep characteristics in
large, free-living populations at scale, facilitating well-powered epidemiological investigations
designed to explore the relationships between sleep and disease [32]. Furthermore, these
developments are set to have clinical implications for the monitoring and diagnosis of sleep
disorders and, ultimately, could be used for the modulation of sleep [153].
The core objective of this chapter is to discuss the implications of digital technologies for
the study, monitoring and modulation of sleep. To aid this discussion, we introduce a 5-step
Digital Sleep Framework, which comprises the complete process from sleep data acquisition to
end-user applications of insights. Figure 2.1 depicts the framework. This chapter is structured
around the framework’s 5 steps: data acquisition; data storage and curation; data processing;
modelling; and applications. Finally, we discuss the biggest challenges and opportunities in
this field followed by conclusions based on our findings.
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Figure 2.1 The digital sleep framework covers the path of sleep data from its acquisition
to when its insights are used for medical or consumer applications. The framework begins
with the acquisition of sleep-related data. This can be done using a variety of sensors. This
data is then stored and curated, a step that comprises privacy-aware storage, cleaning, filtering
and anonymization. Once that data has been appropriately treated, the processing step takes
place whereby data is transformed and integrated based on the end-model. For example it may
undergo different transformations like normalization or featurization. The next step entails
modelling, which can consist of simple heuristic methods, statistical learning or deep learning
methods, for example. Finally, the resulting model can be deployed for a variety of either
medical or consumer applications.
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2.3 Sleep data acquisition
Sensors have been used to study sleep for decades. Traditionally, polysomnography (PSG),
paired with clinical evaluation, has been the gold-standard and de-facto technique to study
sleep in clinical and laboratory settings as well as to diagnose a subset of sleep disorders [154].
However, in recent years, industry and academia have invested heavily in the development of
smaller, less obstructive and more portable devices for the continuous monitoring of sleep [155].
This is motivated by a desire to enable data acquisition in larger participant groups over more
extended periods and in a more natural setting by decreasing both the cost of monitoring
and the burden to participants. However, challenges remain in data acquisition, including the
provision of ubiquitous, less obtrusive and stigmatising long-term acquisition mechanisms.
Moreover, long-term patient monitoring usually suffers from missing periods that may mislead
the estimations of health markers. Here we discuss the current state-of-the-art of sleep data
acquisition in clinical and free-living settings, including an overview of traditional and novel
approaches and their strengths and weaknesses.
Traditional sleep monitoring and monitoring in laboratory settings
Since the 1960s, polysomnography (PSG) has been used in clinical settings to monitor sleep
through a battery of simultaneous, complementary sensors [156]. These sensors typically allow
for the measurement of: (1) brain activity through electroencephalogram (EEG), (2) airflow,
(3) breathing effort and rate, (4) blood oxygen levels, (5) body position, (6) eye movement,
(7) electrical activity of muscles and (8) heart rate. Traditionally, PSG requires participants to
sleep in a laboratory setting. The results are then scored by an expert who has received training
on how to interpret these signals. Ambulatory PSG is an alternative modality which often uses
a reduced number of sensors and allows monitoring to occur at home, outside of the laboratory.
This facilitates the monitoring of patients with disorders that may not be easy to evaluate in a
laboratory setting [157].
To-date PSG remains the gold-standard for sleep measurement. However, the technology is
limited in its use as it remains impractical for long-term home use. This precludes its use in
long-term sleep monitoring or sleep in free-living settings beyond the laboratory. Furthermore,
PSG is expensive, time consuming and requires trained technicians to administer and interpret.
As a result, the scalability of this technique for large-scale population-based studies is very
limited, particularly when the aim is to assess typical sleep patterns in free-living, naturalistic
conditions. Whilst Ambulatory PSG provides a partial solution to some of the issues, it remains
both expensive and burdensome.
Another conventional method used in clinical settings to evaluate sleep is Videosomnography
(VSG). VSG encompasses a range of video-based methods used to record a person as they sleep.
These video recordings are subsequently used score sleep behaviours. VSG has been typically
paired with PSG in clinical settings to study sleep disorders. However, recent advances in
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telemedicine have made the use of home VSG increasingly possible. Although VSG is typically
scored by experts in a time-consuming manner, advances in signal processing and AI have led
to the new possibility of automatically-scored VSG [158]. However, VSG presents similar
scalability issues as PSG. It is costly and, at present, requires expert monitoring and scoring.
Data on sleep can be also obtained from devices to treat sleep apnoea such as Continuous
Positive Air Pressure (CPAP). These devices can be used both in laboratory and home settings.
For example, Aggarwal and colleagues showed that CPAP can be used to classify and track
sleep metrics which could be used to monitor the response of CPAP therapy in sleep apnea
patients [159].
Sleep monitoring outside the laboratory.
To understand the role of sleep in health and disease sleep must be monitored in a free-living
environment and in a non-obtrusive way to ensure the sleep captured is as representative of
typical sleep as possible. As such, low-cost, wearable sleep detection systems are a promising
tool to study sleep architectures in free-living individuals at a population level. At present,
there are several options for the monitoring of sleep outside the laboratory. These comprise
actigraphy, heart rate sensing and other wearable technologies. Multiple published works
have demonstrated that a single modality sensor representation, such as heart rate alone,
is not sufficient to accurately complete sophisticated sleep stage classification [160]. The
availability and range of digital technologies for the measurement of sleep has significantly
expanded in the last decade. Both consumer and medical grade devices across a variety of fields
(wearable, remote sensing, mobile health, clinical-grade) have become more sophisticated
and affordable. Nevertheless, comparing performance across different platforms and methods
remains a challenge and few methods have been validated against gold-standard PSG or
undergone systematic reliability assessment [161].
Traditional free-living sleep sensing and measurement approaches: actigraphy and ac-
celerometry.
Actigraphy and accelerometry are non-invasive methods to monitor human activity and rest
cycles. They have been used to describe physical activity levels in large scale populations [162]
and can also be used to monitor sleep. These methods offer an affordable, scalable alternative
to PSG to monitor sleep-wake cycles and have now been recognised by the American Academy
of Sleep Medicine as a valid method for the assessment of sleep [163]. Recent advances in AI
and larger studies in conjunction with PSG have resulted in the refinement of the method [164].
However, three key limitations of actigraphy and accelerometry remain. These are: (1) the
lack of validation studies for the different consumer-grade devices (2) lack of standardisation
of approaches for human-activity recognition, and (3) the lack of assessment techniques
for daytime sleeping. Nowadays, wearable sensors can be used in combination with other
minimally invasive sensors (such as heart rate monitors, miniaturised ECG, pulse-oximetry,
blood pressure monitors, galvanic skin conduction, light sensors, gyroscopes, barometric
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Figure 2.2 Emerging Sleep Sensing Technologies. Emerging sleep technologies range from
non-contact methods like RF sensors to miniaturized, wireless or in-ear EEGs.
altimeters and GPS trackers). Sleep can also be monitored through a combination of wrist
actigraphy, hip sensors, smart phone sensors and under-mattress sensors [165]. Nevertheless,
this increased availability of sensors also results in a greater challenges when optimising the
match between the end-application and the sensor used [161]. A description of actigraphy
specific sleep metrics is provided in the supplementary material.
Emerging sleep sensing technologies.
The fundamental aim of ubiquitous computing in sleep tracking is to achieve miniaturisation of
sensors and non-intrusive sensing that can pervasively monitor physiological signals related to
sleep activities. Embedding different types of ambient sensors into objects that we interact daily
is more attractive than using multiple redundant sensors collecting homogeneous information.
Embedded devices, such as bed sensors, have been developed to track different sleep-related
metrics such as sleep time, breathing, snoring, heart rate, body and room temperature or
humidity levels [166–168]. Whilst these sensors are interesting and potentially valuable for
clinical and epidemiological research, as well as wellness and sleep education, very little
is known about how their performance against gold-standard measures and more research
is required to evaluate their usability. Some have emerged in recent years but remain at an
early stage of development (e.g., WiFi and radio-signal approaches), whilst others have been
around for longer (e.g., smartwatches). They are depicted in Figure 2.2 and discussed below.
Some of the potential techniques to unobtrusively measure sleep through the acquisition of
physiological signals include the following:
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Bed sensors: Bed sensors may be defined as any sensor that sits on the bed and can be used for
monitoring physiological processes. Body movements, breathing and even cardiac activities
can be detected by the volume change of the pneumatic underneath an individual whilst they
are lying in bed [169–171]. For instance, using micro-bend fibre optic sensors underneath the
mattress allows for monitoring of breathing and body movement activities that can be then
used to extrapolate some valuable sleep metrics [172]. Similarly, fibre-optic based systems
have allowed not only for the analysis of different motion types but also for the introduction of
retroactive feedback based on those movements [173]. Unobtrusive sleep monitoring using
bed sensors (either on the mattress or the bed frame) usually entails monitoring of movement,
but also respiration rate and occasionally heart rate. Several companies, including Apple
(Beddit), Nokia and Withings, have released new sensor accessories that can be attached
to a person’s mattress or bedframe and often interact with a separate mobile application or
dashboard. Nevertheless, a range of determinants can influence the performance of these
methods, from postural differences to inter-subject variability in BMI and pre-existing clinical
conditions [171].
Consumer-graded wireless EEG and reduced-array EEG: EEG is an integral part of PSG
and is also used in a variety of neuropsychiatric tests and applications. Conventional EEG
requires expert set-up and can be burdensome, uncomfortable and is not portable. Wireless
EEGs have gained traction in recent years, with several established companies, as well as
start-ups, launching products. Their performance for sleep monitoring has been compared
to conventional EEG that is part of PSG and has demonstrated strong results [174, 175].
Further, Koley and colleagues showed that automatic-scoring using ensemble models on a
single channel EEG could yield agreement rates of 0.87 when compared to expert scoring of
the same signal [176]. Whilst this study was conducted in a clinical environment, and hence
lacks the recording conditions required for free-living validation, together these investigations
show that the results of conventional EEG can be approximated by simpler devices that may
be able to be scored automatically.
Similarly, several miniaturised EEG devices have shown promising results with regards to
their ability to classify sleep stages [177, 178]. In-ear EEG is a modality that has shown
promise in recent years, for instance, Mikkelsen and colleagues compared in-ear mobile EEG
analysed through machine-learning-based automated scoring to conventional, manual scored
PSG and commercial-grade actigraphy showed promising results, although also constrained to
a laboratory environment [179]. A 2019 study showed that automatic sleep stage prediction
based on a single in-ear sensor demonstrated a 74% agreement with the hypnogram generated
from full PSG, which is promising but still requires further work for it to be at a clinical
standard of performance (≈ 90% agreement) [180]. These devices are particularly interesting
given their potential for free-living application. They also have the advantage of conserving
much of the granularity and information that a conventional PSG-based EEG would offer in
non-laboratory set-ups [181].
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Although the performance of these wireless, miniaturised and in-ear EEG devices is promising,
more extensive studies are required to determine the feasibility for use in population science
and in a free-living environment as well as for applied sleep research studies.
Smartwatches and fitness trackers: A plethora of wearable smartwatches and activity bands
have been developed to infer sleep. These devices often derive their metrics using a combination
of movement signals (accelerometry, as explored in previous sections) and heart rate and heart
rate variability. Henriksen and colleagues assessed the validation or reliability of some of the
most common brands on the measurement of physical activity and sleep (Fitbit, Garmin, Misfit,
Apple, Polar, Samsung, Withings and Mio) [75].
Mobile phone sensing: Mobile phones offer a wide range of sensors, such as gyroscopes,
microphones and accelerometers, that can be used to monitor sleep patterns [182]. For instance,
iSleep, developed by Hao and colleagues, leverages a smartphone’s built-in microphone to
detect events that happened during sleep such as body movement, cough, and snoring by
processing the acoustic signals [183]. The software achieves accuracy of over 90% for event
classification (snoring, cough, sleep) under different environmental conditions. An important
limitation of the system is that the high-rate microphone sampling represents a significant
source of energy (and battery) consumption.
Several other sleep applications can be found on the different app stores these days. Sleep
Cycle is among the most popular ones, using both accelerometry and the built-in microphone
to track sleep and provide personalised alarm clocks, waking up the users at ideal timings
(during light sleep) [184].
Ultrasound sensors: Ultrasound sensors can be used to detect body movement and breathing
patterns during sleep [171, 185, 186]. These sensors provide information regarding the
frequency and type of body movement through the Doppler technique. This technique mirrors
that used in conventional radar systems and allows the retrieval of parameters related to
breathing rate, heart rate and body motion. The method has been shown to detect physical
movements with an 86% recall rate and error rates of less than 10% [187]. The most pressing
limitations of this method are, however, the fine-tuning required based on the type of targeted
body and the sensitivity to small movements [188].
WiFi and radio signal approaches: In the past decade, high frequency and sub-millimetre
wavelength radio technologies have demonstrated the ability to capture physiological signals
without body contact. The principle is to send a low-energy radio wave towards an individual
who is in bed and then to detect the signal bounced back from the body. Through signal
processing, it is possible to extract biological information such as breathing patterns, heart
rate and full-body motion from these findings [189–191, 187]. These biological signals can be
used to determine sleep stages as shown by Zhao and colleagues [192], as well as to monitor
insomnia [193]. The main challenge with this approach is that the signal is subject to a lot of
’noise’ and the information related to sleep needs to be extracted. Moreover, the measurement
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Figure 2.3 Selected methods for the measurement of sleep and their accuracy and usabil-
ity trade-off. This chart plots the accuracy of sleep sensing methods at inferring sleep-related
metrics against their ease of use. For example, while polysomnogry is considered the "gold-
standard" technique to measure sleep, it is cumbersome and expensive.
conditions are also strongly dependent on the individuals being monitored. In particular,
the signal reflects all objects in the bedroom and is affected by the sleeping position of the
individual [194].
Some of the methods described in this section are, in general, more accurate or more usable
than others. Figure 2.3 shows a scheme of the accuracy versus usability trade-off for the main
methods described in this section.
Data collected from different modalities representing diverse physiological information may
have varying predictive power and noise topology as explored in Figure 2.4. However, different
modalities and the information they collect may be highly complementary and, in practice,
aggregating sleep data from various sources may make models more robust and tolerant both to
noise and missing data. Such complementary fusion protocols have been shown to significantly
improve the classification performance of sleep stages [195, 196].
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Figure 2.4 Holistic evaluation of sleep-monitoring methods. Some methods, such as PSG,
are accurate but inappropriate for use in daily sleep monitoring, as they require professional
set up and are intrusive. Other methods, such as bed sensors, are unobstrusive but more prone
to noise than PSG.
2.4 Sleep data storage and curation
Regardless of its intended end-use, all the data collected using the methods and sensors
previously discussed requires appropriate storage, curation and processing prior to analysis.
Until the turn of the century, analogue PSG systems, limited to analogue amplifiers and paper
tracings, were common practice for storing sleep information. However, with the development
of digital recording systems, these types of analogue recordings have become outdated as
different challenges have emerged for handling data from new digital sleep technologies.
For example, in the era of digital medicine, systems often require real-time storage and
processing of data collected as part the so-called Internet of Things (IoT) [197] and Big Data
Analytics [198]. IoT links all sorts of connected devices into comprehensive networks of
inter-correlated computing intelligence without with need for human input. With regards to
sleep, the integration of IoT technology has several challenges. These include data storage,
management and exchange across different devices and sensors, alongside privacy, security
and data access concerns.
Cloud computing integration with IoT is gaining traction in healthcare and is being used for
digital sleep applications. For instance, 3-layered architectures composed of (1) an IoT layer
sensor acquisition/data compilation; (2) a Fog computing layer for event processing; and (3)
a Cloud layer for data management and Big Data Analytics have been proposed for sleep
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monitoring use cases that integrate several sensors [199]. In Figure 2.5, an overview of data
acquisition and the movement of information from sensors to the cloud is explored. The
remainder of this section discusses the fog computing and cloud storage layer more fully.
Figure 2.5 Overview of cloud-computing based sleep data acquisition and storage. This
illustration provides an overview of the process starting with device layer (which includes
fast, real-time processing and data visualisation, embedded systems, gateways and micro data
storage), followed by the fog layer (which includes local networks, virtualisation, data analysis
and reduction) and finally cloud layer (which consists of data centres and big data storage and
processing)
Fog computing layer
Fog computing entails data analysis on edge devices, which enables real-time data processing,
reducing costs and also improving data privacy. Fog computing is commonly deemed mini-
cloud computing as it performs all the processing locally. The fog computing layer abstracts
the heterogeneity of the incoming data formats, communication technologies and protocols
from the sleep-sensor IoT layer. Platforms, such as Smart IoT Gateway, have emerged as
solutions to communicate with all the heterogeneous IoT sensors potentially deployed in home
environments and perform local processing before transmitting the data to the cloud layer
[200]. Fog computing seeks to achieve a seamless continuum of computing services connecting
the cloud to the devices (IoT). This contrasts to edge computing which isolates and keeps
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the computing at the "network edges" [201] and facilitates the aggregation of multi-modal
physiological data from different devices and sensors that are then processed locally (e.g.
processing data directly on an IoT Gateway). This architecture can provide near real-time
decision-making to support sleep monitoring and intervention.
Following the receipt of signals from the devices, pre-processing at the fog computing layer
includes 3 main operations: (1) the fusion of signals provided by different IoT sensors; (2)
detection of periods containing missed data; and (3) imputation of missed data. When sleep
sensor signals contain missing data, it is usually because the user did not wear or was not in
contact with the sensors. However, functional errors can also occur. For example, smartwatches
may run out of battery or memory and may fail to communicate with the user’s smartphone.
Missing data can be detected by various algorithms, including through simply thresholding the
smoothed signal.
Besides data pre-processing, the fog computing layer also enables the inter-operability of
heterogeneous sources of the data. Inter-operability is a key function of Smart IoT Gateways. It
allows for communication and integration of devices which are operated on different protocols
and use different technologies. Furthermore, the Gateways facilitate the sharing of information
and the driving of actuators or components that meet the required needs of the system [202].
For instance, it can be used to detect sleep apnea events and activate motors designed to change
the users’ body position or to play sounds or music during particular sleep stages [203].
Cloud storage layer
Cloud computing architectures include servers, networking, software, databases and data
analysis over the internet which enable fast deployment, flexibility and economies of scale.
Cloud computing is often considered the centralised paradigm, while the fog computing
layer previously described would be a decentralised paradigm. Nevertheless, as explained in
Figure 2.5, they can effectively work together.
Sensor data integrity is paramount for successful application and analysis in digital medicine
and requires appropriate data storage in order to be realised [204]. Relational databases can
be limited when storing and analysing semi-structured data obtained from multi-modal sleep
sensing technologies. Hence, current trends to store and query digital sleep data are based on
Not Only SQL (NoSQL) databases such as MongoDB, Cassandra, HBase or CouchDB, which
allow for better representation of heterogeneous data structures and batch data. Moreover,
several of these NoSQL databases provide connectors to cluster-computing frameworks, such as
Apache Spark, Storm, Flink and Hadoop, enabling Big Data Analytics. These Apache products
are a good fit for both batch processing and stream processing via in-memory computation and
processing optimisation [205]. Resilient Distributed Dataset (RDD) allows Apache Spark to
simultaneously store data on memory and write to storage media based on pre-defined criteria
from the real-time data stream. Hadoop allows for batch processing and the use of MapReduce
algorithms to analyse data stored in Hadoop Distributed File System (HDFS). HDFS can
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handle petabyte level data analysis, which can be used to provide in-depth statistical analysis
of clinical sleep data and can also be used in large population epidemiology studies.
2.5 Data pre-processing
Before sleep data can be used for modelling, it must be pre-processed. As discussed in the
preceding sections, there is a growing trend toward the integration of sleep data from various
sensors. As such there is a preponderance of unstructured multi-modal time-series data with
substantial noise. For example, different equipment brands and models may be equipped with
different quality of sensors, amplifiers and electrodes that result in different noise topology as
a result of their unique materials and manufacturing process. Data measurement, processing
and storage may also differ between sensors. For example, depending on the application and
device, it might store RR interval instead of raw ECG. Hence, data needs to be cleaned and
filtered, removing artefacts that differ depending on the modality employed before any feature
extraction or modelling can take place.
Depending on the nature of the data, several pre-processing approaches can be applied. Smooth-
ing and de-noising can remove unwanted spikes, trends and outliers from a signal [206]. For
example, polynomial de-trending methods can remove continuous quadratic or linear trends
that may be caused by impedance changes on the skin. Similarly, Hampel filtering can remove
unwanted spikes from sinusoidal signals. Noise arising from other sources should also be
be considered. This may include power line interference, thermal based resistive changes
or contact conductive artefacts. These noises can be filtered by applying various band-pass
filters. The ultimate objective of de-noising is to ensure that the noise is subject to a specific
distribution, such as a Gaussian distribution, as far as possible.
Beyond de-noising and smoothing, re-sampling and standardising can be used to improve data
integrity and consistency in the pre-processing stages. Linear or higher-order interpolation
can be used to fill missing or corrupted data, as well as for data scaling, through methods
such as linear scale-transformation [207]. These methods can suppress the noise levels and
variability in the signal and transform the data into a pre-defined range without altering its
distribution. Data standardisation, such as min-max standardisation and z-score standardisation,
can suppress noise levels and variability in the signal and transform the signal such that it
approximates a normal distribution.
2.6 Artificial intelligence-based sleep modelling
Once sleep data has been pre-processed, data modelling can be commenced for different
applications. Today, many of these modelling and application tasks are based on AI, which
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entails the use of algorithms and techniques that mimic human cognitive functions, reasoning
and problem-solving skills and have brought a paradigm shift to digital medicine. Indeed, the
influence of AI in medicine is growing rapidly and is being exploited in a variety of fields from
clinical medicine to population studies [208]. In essence, the application of AI in medicine
aims to aid clinical decision-making through analysing complex medical data. The insights
generated can then be used in diagnosis, treatment, the prediction of clinical scenarios and
to aid scientific discovery [209]. Increasingly, AI is changing research methodology and
facilitating the personalisation of medicine through its advancements [208].
With regards to sleep science, the impact of AI is multifaceted. First, it can aid clinicians
in making sleep disorder diagnoses [210]. This is achieved by translating collected sensor
data into pre-defined knowledge (e.g., class label), providing an inexpensive and objective
alternative to manual sleep stage scoring [211]. Similarly, through its automated analysis
capabilities, AI can provide wellness and lifestyle recommendations based on the interpretation
of data collected from wearable devices and mobile apps [212, 213], enable clinicians and
researchers to track changes in sleep patterns from people’s homes [214] or interact with smart-
home set-ups to provide better quality sleep through the adjustment of lights and temperature
in rooms [215]. Here we discuss methods of AI-based sleep modelling.
AI applied to sleep science.
Traditional AI systems were rule-based, requiring the programming of pre-conceived rule sets
and demonstrating limited flexibility. By contrast, machine learning (ML) provides a more
flexible alternative to data modelling, especially when applied to the raw unstructured signals.
In plain terms, ML aims to train, learn and optimise a mathematical model which can transform
or map the collected (complex) signals into comprehensible knowledge.
Usually, ML approaches, which include logistic regression, support vector machines and
random forest, tend to use structured data as input. This makes feature engineering or feature
extraction a standard procedure before model training. Feature engineering can be achieved in
various forms. For example, given a sliding window (from the raw time-series data), statistical
features such as mean, standard deviation, energy, entropy and so on, or time-frequency
features such as wavelet/Fourier transform coefficients can be extracted and used as input for
the traditional ML models. Moreover, in some applications, domain experts can also design
features based on their understanding of the signal in certain fields. Compared with the raw
signals, the engineered features tend to be low-dimensional with information redundancy
suppressed, making the model training tasks more effective.
From a ML perspective, the most common tasks for sleep research are the classification of
sleep-wake cycles and stages as well as the derivation of sleep-wake metrics. Although heuristic
approaches and some traditional ML approaches have demonstrated reasonable performance
in some tasks, the feature engineering process tends to be time-consuming, and may require
domain knowledge in some circumstances, making the whole system design an expensive
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process. On the other hand, the new methodologies offer more flexibility in sleep modelling.
For example, deep learning methods can be used to perform end-to-end training, which directly
maps the raw signal into the target labels. It is a pure data-driven process, and latent patterns
can be automatically learned without the feature engineering process.
In Table 1 , we highlight several popular ML models that can be applied to different sensing
modalities.
Conventional sleep classification methods.
Following the American Academy of Sleep Medicine (AASM) guidelines, traditional sleep
scoring in neurophysiology laboratories assigns 1 of 6 labels to each 30 second epoch. These
are as follows: (1) awake; (2) rapid eye movement sleep (REM); (3) non-rapid eye movement
(Non-REM); (4) sleep stage 1 (N1); (5) sleep stage 2 (N2); and (6) sleep stage 3 (N3). This
task is performed manually by trained sleep technicians based upon data generated through
PSG. Sleep stages themselves are associated with physiological changes that are useful for
the diagnosis and assessment of specific sleep disorders such narcolepsy [216]. For example,
respiratory monitoring in PSG facilitates the detection of sleep-disordered breathing, such as
obstructive sleep apnea. In this disorder, abnormal breathing events are less severe in N3 than
N1 sleep due to the change in central control of breathing, and more severe again during REM
given upper airway muscle tone reduction [217].
Manual sleep scoring suffers from several draw-backs. It is time-consuming, subject to biases,
inconsistent, expensive and must be done offline. Rosenberg and colleagues reported that the
average inter-scorer reliability for sleep stage scoring was approximately 83% [218]. This
estimate is similar to that reported in other studies [219]. By contrast, the use of AI and
automated sleep stage classification algorithms represents a fast, non-subjective, inexpensive
and scalable alternative to this traditional sleep scoring approach. Aside from issues of
reliability, it can take 1-2 hours for an expert to score a night of clinical PSG recordings [220]
while the automated system can finish the same task in seconds. Thus, multiple approaches
and methods have been used to distinguish sleep from wake automatically as well as to
characterise specific sleep stages. In broad terms, sleep classification algorithms fall into
different categories, but these categories can be closely interrelated, as shown in Figure 2.6.
The different categories comprise traditional algorithms and both ML and deep learning
approaches. These are elaborated below.
Traditional algorithms for scoring of sleep from either PSG or actigraphy signals tend to
be based on heuristic approaches [221]. These heuristic approaches are themselves based
on prior knowledge of the sensing modality and sleep physiology. In actigraphy, the use of
the magnitude feature as a proxy of movement for sleep/wake classification provides one
example. This approach offers quick solutions with fast implementation but also tends to be
biased by the programmer’s understanding and interpretation of the problem and to perform
differently depending on the population in which they are applied. For example, the algorithm
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Figure 2.6 Sleep classification algorithms can be based on heuristic approaches or Arti-
ficial Intelligence. We describe machine learning/statistical learning approaches and deep
learning approaches within AI.
developed for a nocturnal sleep pattern may not suitable for non-nocturnal sleep. Penzel and
colleagues provided an in depth review of some of these approaches in clinical settings, offering
a quantitative analysis of their performance and requirements [222]. Palotti and colleagues
evaluated the performance of some of the most common approaches, including statistical ML,
on actigraphy data [223].
Machine learning and deep learning approaches have gained traction in recent years for the
task of classifying sleep-wake cycles and sleep stages in multi-modal sensor data [224, 225].
With the availability of raw actigraphy signals, several deep learning techniques such as
convolutional neural networks [226] and recurrent neural networks [227] have been used to
exploit the temporal nature of this unstructured data to distinguish the sleep-wake cycles
[223] robustly and understand the role of activity in sleep related disorders [228]. While the
evaluation of most traditional and ML algorithms are performed using standard quality metrics
such as accuracy, precision and recall per class, it is also important to measure clinically
relevant metrics such as waking after sleep onset (WASO) and sleep efficiency [223]. By
optimising clinical metrics, ML methods enable the physicians to make informed, clinically
relevant decisions. Adequate performance defined by quality metrics varies depending on the
task intended. For instance some sleep disorders may not require high-levels of granularity for
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their diagnosis whereas interventions that aim to boost deep sleep ought to rely on accurate
granular classifications of sleep stages.
Table 1 2.1 provides a holistic overview of the most common classification methods based
on the modality used (PSG/EEG, wearable device (accelerometry/actigraphy), Others (heart
rate/PPG/etc)). References are provided for methods by modality in the appropriate cells.
It is important to note that different methods are ought to be used based on the objective at
hand. For instance, deep learning methods often provide better performance than traditional
statistical learning methods, but require large computational power and lack the interpretability
that other models offer [223]. Performance and model evaluation is discussed in further detail
on the supplementary material.
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Table 2.1 Sleep classification techniques across different sleep sensing modalities
Technique Technique Variations PSG/EEG Wearable Sensing
Statistical
Latent Dirichlet Allocation [229]
Support Vector Machines [230] [231]
Hidden Markov Model [232] [233]
Quadratic [234]
Bayesian [235]
Logistic Regression [236] [237]
Instance Base K-Nearest Neighbors [224] [225]








Spectral Clustering GMM [247]
ANN and DNN
Convolutional NN [248] [237, 192]











Emerging approaches for sleep classification.
There are a plethora of methods available for the predictive modelling of sleep-related problems,
as mentioned in previous sections. However, several outstanding questions remain regarding
their application. Issues such as model sustainability, handling the heterogeneity of data and
variability in the demographics, behaviour and lifestyle of the population and generalisation to
unseen data, need to be investigated more comprehensively. Below we highlight some of the
emerging technological solutions for the handling of these issues.
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Model sustainability. An important consideration is that the majority of existing ML models
perform a task (such as sleep-wake classification and sleep-related disorder prediction) by
learning from an underlying distribution of data. However, in real-world conditions, the data
generated from participants can change over time due to age, lifestyle changes, new sensing
modalities, the progression of sleep/health disorders or other changes. An imperative question
then is how to make the trained model sustainable in response to changing domains. Life-Long
learning might be the first step to address some of these challenges. This would facilitate
sustainability by allowing the model to evolve over time [258].
Personalised sleep classification. One of the major challenges that AI encounters when facing
sleep classification tasks is inter-subject differences. That is, the intra-class variability (e.g.,
differences in length of REM sleep between participants) can be too large to be captured by
the trained model, making inference process prone to errors. By contrast, by taking personal
information into account, a human analyst can address this problem easily. In the case of PSG
scoring, a skilled neurophysiologist may consider demographic characteristics (such as age
and gender) and adjust their scores accordingly. Despite advances in AI methods for sleep
classification across different sensing modalities, most of the current models do not adapt to
individual characteristics. There may exist large inter-subject variation and the trained model
(on the population-level data) may not be the optimized one for certain individuals.
In the future, personalisation could be a useful approach to improving the performance of the
AI-based sleep modelling systems, improving the performance of algorithms [259, 260]. It
has been suggested that personalisation may be especially useful when using data from noisy
modalities, such as wearable devices [261]. Model personalising has been successfully applied
in other fields such as mood recognition [262] and seizure detection [263]. However, it remains
relatively untapped in sleep science. Recent works have shown that transfer learning could be
used to realise personalisation. For example, based on EEG modality deep neural networks
were trained on a large population, followed by a fine-tuning process at the subject-level [261].
The results suggested that substantial performance gain can be achieved [261].
The process of personalisation can also be applied in the aforementioned distributed network-
ing environment. Federated learning proposes a distributed way of updating a centralised
model by aggregating each patient’s local updates into a central server [264]. The distributed
update framework not only provides a model parameter update mechanism but also creates a
personalised predictive model by feeding individual data to a global model in the localised
updating process.
Generalised sleep classification. Another way of improving the performance of AI-based
systems is to reduce the effect of the contextual information for better generalisation [265].
Based on adversarial training process, some of the most recent works performed subject-
invariant learning, which makes the system less sensitive to personal and environmental factors
[228, 266]. Similarly, by undergoing an adversarial training procedure, temporal dependencies
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can be learned. These then transfer well to new subjects and different environments in sleep
classification tasks [192]. Pillay and collegues used EEG data in combination with a generative
modelling process to obtain agreement between the labels estimated and clinician’s labels for
automatic 4 stage sleep classification in infants [183]. In general, by learning the representative
features that are less sensitive to contextual factors and thus robust in various (complex) sleep
classification tasks (such as diagnosing sleep apnea or insomnia), these approaches aim to
increase the generalisation capabilities for better performance. This is an alternative to the
aforementioned personalisation approaches.
2.7 Data-driven sleep applications
There is a wide and growing range of commercial, health and clinical situations for which data-
driven sleep applications are being used. In hospitals, sleep medicine units have traditionally
used PSG and more recently actigraphy/accelerometry, for the diagnosis and monitoring
of sleep disorders [267]. One of the main challenges in sleep medicine is the increasing
incidence of sleep disorders, which in turn leads to higher demand on sleep labs to provide
diagnoses. Consequently, software for sleep medicine is being gradually upgraded to include
automated sleep-metric calculations and seamless integration of sleep data sources, such as
sleep questionnaires. These upgrades have the potential to compliment Electronic Health
Records, enabling health care practitioners to better manage their patients sleep disorders
[268]. Figure 2.7 gives a brief overview of key areas that will be affected by the impact of
sleep technologies and newly generated sleep data.
Sleep data in health and disease As discussed, disturbed sleep has been linked to reductions
in quality of life and to a higher risk of a plethora of chronic conditions [269, 270]. Thus, it
is of vital importance for digital self-management and monitoring solutions to include tools
that allow accurate monitoring and assessment of sleep quality. Aside from its direct role in
ill-health, poor sleep quality can worsen the symptoms of many serious and chronic conditions
including cancer and multiple sclerosis [271–273]. Moreover, pharmacological treatments
may in turn worsen sleep disorders as side effects. For example, smoking-cessation drugs and
some treatments for cancer have been shown to reduce patients’ sleep quality [274, 271]. Due
to the complexity of the relationship between sleep and health, there is a need for the design
of digital intervention methods to address the unique requirements of sleep within long-term
or chronic conditions. There are early examples of mHealth interventions to improve sleep
quality on people with cancer and diabetes, amongst others [275–277].
Amongst otherwise healthy individuals, there is also an increasing interest in mobile and
wearable applications for health and wellness [213]. Ultimately, it has been proposed that such
technologies could be used to direct personalised sleep health recommendations to individual
users [153]. Furthermore, other consumer sleep technologies have gained traction in recent
years, and although they still need appropriate clinical evaluation, they could enhance patient-
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clinician interaction and sleep self-management [278]. Some of the most common commercial
and familiar technologies, such as Fitbit or SleepAsAndroid, offer monitoring and tracking
sleep quality. In addition, new sensing technologies, such as those discussed in the sleep data
acquisition section, are gaining traction and devices like Beddit have attracted investments
from large technology companies [279]. These monitoring technologies are complemented
by applications aimed at improving quality of sleep by supporting a more suited wake timing
using approaches such as smart lighting or smart alarms that only ring when the user is in
light sleep. Despite their growing popularity, at present, most of these consumer-oriented
technologies lack validation and their underlying models change frequently [213, 278]. This
fast growing industry needs to be matched by multidisciplinary scientific efforts that evaluate
the performance, usability and value proposition of new sleep technologies.
When exploring the impact of the digitisation of sleep on wellness and health promotion, it is
also important to mention occupational health applications. Often sleep disorders are the result
of lifestyle factors including, for example, prolonged screen-time before bed. The resulting poor
quality of sleep can feedback to that lifestyle, by reducing productivity. Consequently, corporate
and health insurance wellness programs are starting to offer incentives and personalised
coaching to clients and employees, with some initiatives directly promoting sleep quality at
the workplace [280]. For instance, FirstBeat provides a solution for companies that comprises
personalised sleep and physical activity monitoring for employees combined with personal
face-to-face coaching with the aim of increasing employee health and employment satisfaction
[281]. However, these technologies can also be exploited, as in West Virginia prior to the
teacher’s strike, where declining to wear a fitness tracker and meet a certain step count resulted
in a $500 penalty annually for their healthcare payments.
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Figure 2.7 Key areas of impact for sleep health. Emerging sleep health technologies will
have an impact on patient monitoring, clinical care, insurance, the pharmaceutical industry and
health and wellness applications, as well as other impacts including on digital therapeutics and
sports performance.
Data visualisation and visual analytics.
Data visualisation, in general terms, is the graphic representation of data. Abstract data is
processed such that they can be represented using visual objects (e.g., points, lines, bars,
etc.) ease of interpretation and better understanding. Visualisation relies on human’s high
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throughput visual perception channel, and the ability to connect data representations to human
knowledge and expertise which are not encoded directly in the data [282].
Visualising health-related data goes back to the days of paper charts and maps. Since the rise
of internet and mobile application, digital displays are ubiquitous and people are now widely
educated to read standard graphics representing data. Typically, activity data is presented based
on the time component, which is usually visualised using line charts, where the horizontal
x-axis is time. Raw signal visualisation is mainly meaningful for domain experts trained and
experienced to interpret complex patterns. Specific patterns can be automatically detected or
highlighted on the chart, for instance, when activity levels go above or below a threshold [283].
Projection techniques are also a popular means of reducing the dimension of high-dimensional
data for better visualisation and knowledge generation [284, 285].
Sleep data visualisation is only meaningful if the resulting visualised data make sense to the
end-user, which can be challenging for non-expert users of wearable technology. SleepExplorer
is an example of visualisation research aimed at understanding how users can benefit from
visualising their own personal sleep data [286]. SleepExplorer organises a flux of sleep data
into sleep structure, guides sleep-tracking activities and highlights connections between sleep
and other related factors such as napping, coffee and alcohol intake, as well as mood. Recent
studies have analysed behavioural change resulting from techniques implemented in activity
trackers and their visualisation, but few studies are focused on sleep [287]. Ravichandran
and colleagues’ conducted a study of user’s experience and understanding of sleep metrics
provided by sleep sensing devices. Their findings suggest that visual feedback may be helpful
to users [288].
However, several challenges remain in regards to sleep data visualisation. (1) Scalability: For
large-scale historical health data, visualisation requires adapting to large time scales (from
minute-level to year-level information) and displaying meaningful data summaries to the user
or primary care practitioner. (2) Heterogeneity: The data collected from different devices varies
greatly from, for example, GPS location or glucose levels to pictures of food or phone-screen
time. This poses a challenge for the visualisation of personal data for patients and for the
health care professional [289, 290]. (3) Usability: Sleep data visualisation should be tailored
to end-users and their specific needs [291].
2.8 Challenges and opportunities
With advances in technology, the volume of physiological and clinical data resources available
to biomedical research is expanding [292]. This includes open-source data from Electronic
Health Records, medical image repositories, genomic archives and massive person-generated
data from wearable technologies [292–294]. Recently, sleep data repositories, such as Sleep-
data.org, have been created to advance the field [295]. These repositories include multi-modal
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sleep data (from clinical-grade PSG to actigraphy and questionnaires) [295] and are being used
to create ML benchmarks [223]. These developments are crucial for the creation of generalised
ML models that can be applied reliably to clinical and commercial settings to further our
understanding of the role of sleep in well-being and disease.
Sleep-related technologies are not only useful for monitoring but may also be used to aid
intervention. For example, the portability and pervasive use of mobile phones makes them
an attractive option for the delivery of interventions and several studies have already shown
promising results when using mobile phone platforms for sleep interventions. These interven-
tions include, but are not limited to sleep advice for behavioural change [296, 297], optimised
alarms based on sleep stage [298] and sleep tracking and feedback [212, 299]. Furthermore,
new sleep-technologies may be able to complement or augment current clinical-grade diagnos-
tic tools for sleep disorders. A 2017 review by Shin provides an in depth overview of this area
of research as well as the strengths and limitations of the current efforts [300].
Despite the potential of technologies and open resources, challenges must be overcome if
their potential is to be realised. Their heterogeneity, variability (both between sources and
over time) and data quality is, at present, a strong barrier to efficient data reuse. Appropriate
analysis also remains a challenge. To overcome this, temporal and source variability of signal
repositories must be characterised [301, 302] and common representation spaces should be
defined to exploit shared latent information among data distributions. Indeed, appropriately
representing data and metadata originating from different sensors (type, make, version, etc)
is critical in order to later harmonize and integrate data from disparate sources as well as for
sensor data fusion. Models should adapt their inferences from different data sources and at
different points in time.
In addition to data handling and analysis challenges, new sensing technologies require sys-
tematic validation [303]. These validation requirements vary based on the end-use of the
technology and must be held to higher standards if they are to be used in clinical settings
[303]. On a population level, there is a wide and growing interest from the general public
in wellness mobile and wearable applications, which in many cases are related to sleep and
inform people’s lifestyle decisions and understanding of their health [288]. Nowadays, there
are hundreds of sleep applications and a plethora of wearable devices that claim to track sleep
quality [304]. However, most of those devices have little or no information regarding their
reliability and validity, the testing they underwent or how the data is acquired (i.e. sampling
rates, pre-processing, etc) and processed [305, 306]. As such, individuals could become
concerned or reassured about their sleep based on unreliable data. Further, concerns have
been raised about the performance of these devices in populations with chronic conditions and
mobility problems [307]. Whilst this has, to-date, mainly been confined to concern regarding
the tracking steps and physical activity, these devices must be tested in a range of populations,
in particular, those with sleep problems. Massive usage of consumer-grade sleep tools may
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also increase individual’s health concerns and have a ripple effect on overstretched health-care
systems [278].
Lack of reliability and validity testing also poses several obstacles to the use of data-driven
applications in sleep medicine and research. As explained in a 2016 editorial by Wilbanks and
Topol [308], the lack of transparency in these technologies limits researchers’ capabilities to
study any potential bias due to the lack of information on the characteristics of the cohorts.
Further, this lack of transparency makes it more difficult for researchers and clinicians to use
these devices and mobile applications. Despite some initiatives, such as Apple HealthKit or
C3-PRO [309], which aim to facilitate data sharing across platforms, these data tend to be
highly summarised and in a post-processed state. Summary level data is not always appropriate
for use in academic research or some AI applications as the processing steps are often not
described.
To generate maximum benefit to the end-user or other stakeholders (e.g., hospitals, researchers,
public health officials, regulators, industry) there is an increasing need for a safe and effective
clinical biomarker ecosystem with algorithmic transparency, inter-operable components and
sensors and open interfaces that allow for high integrity measurement systems [310]. This will
allow for the verification and validation of digital biomarkers for sleep health.
Finally, there are data-privacy concerns. Sleep tracking mobile applications and wearable
technologies often collect information such as movement, GPS location and sound, which
could have potential applications beyond the tracking of sleep. These privacy concerns may be
mitigated through the deployment of data processing functions on the user’s mobile equipment,
without requiring server processing [311]. Similarly, an alternative is to empower users to
decide what data they want to send to the server [311].
2.9 Conclusions
The impact that sleep has on human health is undeniable. Recent advances in sensing tech-
nology, big data analytics and AI allow for truly ubiquitous and unobtrusive monitoring of
sleep and circadian rhythms. However, challenges remain to realisation of the benefits of
this monitoring for individuals, research and clinicans. Here, we introduced the Digital Sleep
Framework, a framework outlining the steps required from the multi-modal acquisition of
sleep-related data through to its clinical and commercial application and exploring all aspects
of this chain. As the number and scope of sleep monitoring technologies continues to grow
and the diversity of digital sleep solutions and applications continues to multiply, the need for
careful, risk-based product validation has become increasingly important. The heterogeneity of
sensors used for the monitoring of sleep-wake cycles and circadian rhythms poses a unique set
of challenges for modelling and interpretability. Hence, the identification and standardisation
of robust, reproducible digital sleep biomarkers is of paramount importance. Modelling based
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on these signals must be as free as possible from conscious and unconscious bias and the
development of algorithms must be transparent and readily available for all stakeholders.
The digitisation of sleep is likely to have repercussions across industry, healthcare, academia
and personal health. With regards to disorders of sleep, reliable and scalable sleep monitoring
is set to provide a better understanding of sleep disorder progression and severity. This could
facilitate better and earlier diagnosis and decision-making for individual patients, including
in instances where individuals need to be progressed to a new treatment. Digitisation may
also be used in disease prevention and to provide lifestyle recommendations. Objective
ubiquitous monitoring of sleep-wake cycles, combined with multi-modal data inputs reflecting
an individual’s physical activity profiles, nutrition, all-day heart rate and genetic information
will allow users to receive personalised feedback for health and well-being purposes and
disease prevention. New technological advancements will allow for improved sleep coaching
interventions that are aimed to improve sleep hygiene or provide with better recovery for
example. Furthermore, data generated from these technologies could be used to help monitor
the impact of pharmaceutical and post-operative interventions. Similarly, the accrued data
gathered from clinical and epidemiological studies, as well as from commercial wearable
devices, represents an unparalleled opportunity to deepen our understanding of the role of
sleep in well-being and disease.
From the perspective of pharmaceutical companies, there are several benefits to the digitisation
of sleep. Wearables offer the potential to deploy sleep monitoring at scale, in large populations
that are required for late-phase clinical trials and can be used to provide better and earlier
evidence of treatment efficacy in sleep disorders, thus facilitating the progression of promising
candidates through trial phases. Further, there are implications for patient centricity. Across
diseases, sleep is meaningful to patients and their health. It is therefore important to objectively
assess sleep metrics such as sleep quality, WASO or time spent sleeping through quantitative
measures, instead of relying on questionnaires. A summary of these metrics is provided in the
Supplementary Figure 2.8. Low-burden monitoring will facilitate sleep collection in trials and
potentially help to increase trial participation and reduce attrition. Moreover, many metrics
of sleep are strongly tied to the quality of life, thus, industry may welcome the use of these
sensing technologies for post-market surveillance. The added knowledge of a potential positive
impact of medicine on patients’ sleep quality may enable better reimbursement rates.
Ultimately, the digitisation of sleep could facilitate a truly personalised sleep monitoring
experience, empowering people to improve their sleep [208]. However, the reproducibility and
robustness of novel sleep monitoring and data analysis methods must be addressed prior to
their use on large, longitudinal and multi-modal collaborative studies. The impact that these
technologies can have on the management and understanding of sleep, as well as the treatment
and prevention of sleep disorders, is set to be paradigm-changing. Industry, academic, public
policy and clinical stakeholders should collaboratively enable this process of validation to take
place, moving a step closer to truly personalised digital health.
54
2.9 Conclusions
In sum, digitisation of sleep and ubiquitous sleep monitoring will have important implications
on the characterisation of sleep, diagnostics and therapeutics. Large-scale collection of
objective, longitudinal sleep data through unobtrusive sleep sensing devices, as explored
throughout this thesis, will facilitate epidemiological studies exploring the impact of sleep
on health and disease. Furthermore, these applications will likely expand into sleep health,
becoming increasingly accessible to individuals with the potential to empower and enable
individuals to understand, manage and change their sleeping habits [153].
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Supplementary Note 1
Sleep Metrics
Beyond the sleep staging guidelines provided by AASM, there are several sleep metrics that
are commonly used when assessing sleep-wake cycles and are referred to throughout the first
few chapters of this thesis. Sleep onset time is defined as the boundary that determines the
transition between a period where the person is awake to when they are sleep. Similarly, the
boundary between when a person is asleep and the transition to wake is known as the sleep
awakening time. The following table introduces some of the most readily used sleep metrics
based on these definitions which are used frequently used in the next few chapters.
Additionally, recently Phillips and colleagues described the Sleep Regularity Index (SRI) as
“the likelihood that any two time-points, on a minute –to-minute basis, 24-hours apart were the
same wake-sleep state, across all days [312]”. So if we were to derive SRI using 30-second
epochs on accelerometer data the SRI equation would be:
SRI = 100 + 200






Given N days of recorded divided into M (epoch=30s) daily epochs, suppose that si,j = 1 if
sleep on day i and epoch j and 0 if they are awake.
New sleep metrics based on EEG data are currently being derived, in search of establishing
reliable sleep EEG biomarkers that could be used to phenotype patients [313, 314]. However,
it is important that new sleep metrics also address the prevalence and representativeness of the





Table 2.2 Conventional Sleep Metrics
Metric Formula
Sleep Period Duration ∥ Sleep Awakening Time – Sleep Onset Time ∥
Sleep Period [Sleep Onset Time, Sleep Awakening Time]
Wake After Sleep Onset (WASO)
∑awake
n=onset ∥ Wakefulness ∥
Sleep Latency [Preceding Sedentary Time, Sleep Onset Time]
Total Time in Bed (mins) ∥ Sleep Awakening Time – Preceding Sedentary Time ∥
Total Sleep Time (mins) ∥ Sleep Period Duration - WASO - Latency ∥
Sleep Efficiency (SE) Total Sleep Time / Total Minutes in Bed
Supplementary Note 2
Classification Metrics
Understanding how well a specific method is performing at the classification task is of great
importance for research, clinical, industry and lifestyle applications. While evaluating a
method or model’s accuracy can be insightful, it is not sufficient. In sleep-wake and sleep stage
classification task not all errors are equal. Indeed, there are two categories of error: predicting
a negative when the instance is positive and predictive a positive when the instance is negative.
Moreover, there are two categories of good prediction: successful prediction is termed true and
unsuccessful prediction is termed false. These four variants form a confusion matrix:
Supplementary Table 2
Table 2.3 Confusion matrix: understanding false positives and false negatives in classifi-
cation tasks
Data Class Classified as pos Classified as neg
pos True positive (TP) False negative (FN)
neg False positive (FP) True negative (TN)
From this, a variety of performance metrics can be derived, offering different perspectives
on how the chosen method performs. Supplementary Table 3 introduces the most common
metrics used for sleep-wake classification algorithm performance evaluation.
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Supplementary Table 3
Table 2.4 Assessing Classification Model Performance Through Metrics
Measure Formula Function/ focus





T P +F P Agreement between the data la-
bels and positive labels given by
the algorithm
Recall (Sensitivity) T PT P +F N Effectiveness of the algorithm to
identify positive labels
Specificity T NT N+F P Effectiveness of the algorithm to
identify negative labels
F1 Score 2·P recision·RecallP recision+Recall Conveys the balance between the
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Figure 2.8 The Importance of Classification Metrics: Precision, Sensitivity and Specificity
for Sleep Classification are paramount to understand if the model is not only accurate, but also
capable of discerning sleep from sedentary behaviours or other bed activities.
Supplementary Note 3
Performance Metrics on Sleep-Wake Classification
From a classification perspective, the correctness of the classification algorithms can be
evaluated by the number of instances or events correctly recognised class examples (true
positives), the number of instances or events that are correctly identified as not belonging to a
certain class (true negatives), as well as the instances or events that are wrongly classified as a
given class (false positives) or were not recognised as a class (false negatives). Given these
four metrics, we can compute what is known as a confusion matrix:
Based on the results obtained from the confusion matrix, there are several important metrics of
performance that are derived to evaluate sleep classification algorithm performance. These are
described in Supplementary Table 3.
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Furthermore, when evaluating classification performance, other metric’s are used depending
on the characteristics of the data set. For instance, Cohen’s Kappa is a metric that offers a
comparison of the observed accuracy with respect to an expected accuracy (random chance,
e.g. sleep-wake classification ) and is defined as:
κ = Pr(a) − Pr(e)1 − Pr(e)
Where Pr(a) is the observed accuracy and Pr(e) is the expected accuracy. Other commonly
used metrics of classification accuracy are Hamming and hinge loss, the Matthews correlation
coefficient or zero-one classification loss.
Figure 2.8 exemplifies the classification performance of a classifier. There are several difference
instances in which the participant may be sleeping or engaging in other, sedentary, activities
(like reading or watching TV). The task of the classifier is to correctly classify sleep as such
in blue and in purple as other waking activities (like sedentary behaviors). The sensitivity (or
recall), specificity and precision are presented for this example classification outcome.
Supplementary Note 4
Actigraphy Specific Sleep Metrics
Actigraphy data can be analyzed and studied to focus in either sleep or circadian rhythms.
Traditional sleep metrics like the ones explored previously (Wake after sleep onset, total
sleep time, etc) can be extracted from actigraphy data. Moreover, metrics related to circadian
rhythms can also be derived. Some of the most common ones are interday stability (IS),
intraday variability (IV), amplitude at rest (L5) and relative amplitude (RA) [315]. These
metrics provide information beyond that of traditional sleep metrics derived from actigraphy
data. For instance, intraday variability (IV) is a measure of sleep fragmentation and interday
stability (IS) can be used to asses sleep regularity.
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CHAPTER 3
MULTIMODAL SLEEP STAGE CLASSIFICATION
IN A LARGE, DIVERSE POPULATION USING
MOVEMENT AND CARDIAC SENSING
Publications
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Zhai B.*, Perez-Pozuelo I.*, Brage S., Guan Y. (2019). Ubiquitous monitoring of sleep-wake
cycls using combined sensing and deep learning models. In 2019 41st Annual International
Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE..
Zhai, B.*, Perez-Pozuelo, I.*, Clifton, E. A., Palotti, J., Guan, Y. (2020). Making sense of
sleep: Multimodal sleep stage classification in a large, diverse population using movement and
cardiac sensing. Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous
Technologies, 4(2), 1-33.
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As explored in Chapter 2, wearable devices that collect movement and heart rate (HR) data
increasingly provide a viable alternative to expensive, burdensome traditional methods of sleep
monitoring, including polysomnography (PSG). However, few studies have combined actigra-
phy and HR data for sleep-wake and sleep-stage classification tasks. Further, as highlighted
in the introductory chapter of this Thesis, the validity of wearable sensors at inferring sleep
stages remains to be studied systematically.
Methods
Here, we present a set of algorithms for sleep-wake and sleep-stage classification based upon
actigraphy and HR amongst 1,743 participants, with labels for training and model evaluation
derived from PSG data. We present a processing pipeline, applicable to most research grade
devices, deriving models and results in the largest open-access dataset for human sleep science.
Results
Our results demonstrated that neural network models outperform machine learning methods
and heuristic models for both sleep-wake and sleep-stage classification. Convolutional neural
networks (CNNs) and long-short term memory (LSTM) networks were the best performers for
sleep-wake and sleep-stage classification, respectively. Using SHAP (SHapley Additive exPla-
nation) we identified that frequency features from cardiac sensors are critical to sleep-stage
classification. Finally, we introduced an ensemble-based approach to sleep-stage classification,
which outperformed all other benchmarks, achieving an accuracy of 78.2% and F1 score of
69.6% on the classification task for three sleep stages.
Conclusions
Together, this work represents the first systematic multimodal evaluation of sleep-wake and
sleep-stage classification in a large, diverse population. Alongside the presentation of a novel,
accurate sleep-stage classification approach, the results highlight multimodal wearable sensing
approaches as scalable alternatives to PSG for accurate sleep-classification, providing algo-





Sleep is a reversible physiological state that is essential for life, health and performance. Whilst
the functions of sleep are not yet fully understood, it is known to restore energy, promote
healing, rejuvenate physical systems, interact with the immune system and influence brain
function, with manifold consequences including for memory consolidation and behaviour [316–
319]. As a result of its importance to vital human processes and the incomplete understanding
of its function, accurate sleep monitoring is of interest to the understanding of human health
and an active area of research for the ubiquitous computing community [320].
Chapter Significance: This chapter provides a holistic overview of the strengths and limita-
tions of multimodal (movement and heart rate) wearable sensors on sleep-wake and sleep-stage
classification. The strength of this work lies on the diversity and size of the population used,
the systematic nature of the experiments conducted and the explainability section of these
approaches. Overall, the chapter highlights that while modern wearable devices using PPG
and acceleration can do a fairly good job at classifying sleep-wake and NREM, REM and
wake, when the level of granularity is higher than that, the performance of these devices is
compromised.
Traditionally, human sleep has been monitored in laboratory settings using polysomnography
(PSG). PSG is a multi-sensor approach to monitoring, involving the collection and conveyance
of a range of different signals from many sensors operating simultaneously. These sensors
include electroencephalography (EEG), electromyography (EMG) and electrooculography
(EOG), which together facilitate the measurement of brain activity, alongside both muscle
and eye movement. Measurements of respiratory and cardiac activity are also often included.
PSG recordings are processed and segmented into epochs, typically of 30-second duration, and
an expert or technician then assigns a sleep stage to each epoch. This sleep stage "scoring"
typically follows the rules set out by the American Association of Sleep Medicine (AASM),
which defines five stages of sleep-wake cycles: wake (W), rapid eye movement (REM) sleep
and three types of non-REM sleep (NREM), known as N1, N2 and N3 [321].
Whilst traditional PSG is considered the gold-standard for sleep monitoring, as a result of
the need for sensing equipment, its use is limited to laboratory settings and typically to just
one or two nights. These single nights of observed sleep in an unfamiliar environment may
not reflect normal sleep. Further, it is impractical to measure sleep using this method for
more than two consecutive nights as it is burdensome to patients or study participants. PSG is
also expensive and requires expert set-up and analysis. For these reasons, efforts to monitor
individual’s typical sleep duration and quality longitudinally in large, free-living populations
have generally relied upon sleep diaries or self-reported questionnaire data. Whilst sleep diaries
are cost-effective, scalable and able to collect information regarding typical sleep patterns,
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there are concerns as to the validity and reliability of participant responses [322]. Wearable
sensors offer a potential solution. Such sensors provide valuable, unobtrusive tools through
which to objectively monitor physical activity in large population studies studies, with potential
applications for sleep monitoring.
Conventional approaches to monitoring sleep using wearable devices are primarily based on
actigraphy (count-based movement information) and accelerometry (raw, high frequency data
which is often triaxial) [81, 323, 82, 324]. However, recent technological and battery life
advances increasingly facilitate multimodal sensing (i.e., combining accelerometry with HR
sensing). Multimodal sensing facilitates more intricate human activity recognition (HAR) tasks
and has shown promise for sleep-stage classification [325]. The validity of actigraphy for the
classification of sleep-wake transitions has been demonstrated over the past three decades [81,
324, 323, 82]. Algorithms applied to actigraphy for this purpose exploit differences in body
movement between wakefulness and sleep. Recent work has demonstrated how different
methods for binary sleep-wake classification using actigraphy compare when applied to the
same, standardized dataset [237]. Furthermore, HR variability (HRV) metrics could be valuable
for multistage classification as autonomic function fluctuations occur between non-REM sleep
and waking/REM sleep, whilst these same functions are consistent when comparing wake to
REM [326–329].
Understanding time spent in different sleep stages (beyond binary sleep-wake classification)
in free-living environments has important implications for commercial applications, as well
as for research. For example, accurate sleep architecture inferences may provide better
information to guide sleep-related behavioural changes and recommendations [330]. To
date, sleep stage assessment could only be achieved using PSG, which cannot be applied to
large, population-based studies of free-living individuals with the power to make inferences
regarding the implications of sleep for health and illness. There exists very limited literature
regarding the performance of multimodal sensing using wearable technologies in sleep-wake
classification or sleep-stage classification, and the methods used for these tasks [331]. Given
the increasing popularity of these technologies for both commercial and research applications,
the development of a set of benchmarks to evaluate the performance of sleep-wake and sleep-
stage classification methods on multimodal wearable data using actigraphy and HR sensing
would address a major gap in the existing literature.
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Remark: In order to address this gap, this work focused on five major contributions:
1. We introduce a framework for pre-processing and analyzing multimodal sensor data
from movement (actigraphy) and cardiac (RR intervals from ECG) sensors. We use the
same signals that are derivable from research-grade ECG or photoplethysmogram (PPG)
devices.
2. We systematically compare single modality sensors to combined sensing (actigraphy
+ HR/HRV) approaches for classifying sleep-wake using different machine learning
models.
3. We extended this systematic comparison to explore the performance of single modality
approaches and combined sensors across three different multistage classification tasks:
(A) Task 2, conventional three-stage classification(NREM, REM, Wake), (B) Task 3,
four-stage classification (light sleep, deep sleep, REM and wake) and (C) Task 4, five-
stage classification (AASM-standard), also using benchmark machine learning (ML)
and deep learning (DL) models.
4. We introduce time deviation per class, a new evaluation metric that represents an easy-to-
interpret measurement of the predicted results from a healthcare practitioner perspective.
This complements conventional machine learning metrics, including confusion matrices.
Furthermore, we explore model explainability and individual sensor contributions using
SHAP, a unified approach to explain the output of tree model based ML and DL models.
5. We introduce an ensemble structure for multistage sleep classification based on multi-
timescale and multimodal DL ensemble architecture. This architecture aims to address
the needs encountered in free-living environments whilst exploiting the individual
contributions and strengths of different classifiers.
To our knowledge, our work presents the first systematic multimodal and multistage evaluation
of sleep-wake cycles and sleep stages in a large, diverse population. We examine each individ-
ual method and modality, as well as exploring how sensor fusion leads to better performance.
Additionally, we explore the features that contribute the most to the different classification
tasks, developing an understanding of the physiological underpinnings of our models.
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3.3 Related work
Since the 1980s, a vast number of studies have explored new methods and techniques to infer
sleep-wake cycles using actigraphy with either single-axial [82, 81, 324] or, more recently,
tri-axial accelerometry [332]. While these methods have proven valuable, they were often
derived in small cohorts. The recent availability of large datasets, provided by initiatives such
as the National Sleep Research Resource [333, 334]1, makes it possible for researchers to
create large standardized benchmarks, such as that proposed in our work, for the first time.
For example, Palotti et al. leveraged one of the available datasets, the Multi-Ethnic Study
of Atherosclerosis (MESA) Sleep Study2, to compare the performance of the most relevant
heuristic approaches and ML methods for binary sleep-wake classification [237]. Whilst novel,
their work was limited by: (1) exclusively comparing methods for sleep-wake classification,
rather than multistage classification; (2) only using actigraphy data. Here we address these
limitations in the MESA Sleep Study dataset, the only dataset suitable for such experiments
to-date.
Beyond actigraphy data, in this work, we explore the use of HR and HRV data. HR can
be defined as the average number of heartbeats per minute, while HRV is a measure of the
variability in beat-to-beat intervals, known as RR intervals. These measurements are powerful
biomarkers that have been used to understand training and recovery, address chronic disease
and monitor stress and sleep [335–337]. HRV is typically higher during the night, reflecting the
fact that sleep is a state in which vagal activity, characterized by rapid fluctuations in activity
controlling coronary artery tone, HR and systolic blood pressure, is dominant [335–337]. Thus,
HRV shows a nocturnal increase in the deviation of mean RR intervals. These deviations
also differ between sleep stages. Conversely, several studies have shown that HR does not
change significantly between sleep stages, although some work has suggested a rise during
REM sleep [338, 339]. HRV analysis has demonstrated that the High Frequency (HF) band
doubles in relative power when going from quiet wakefulness to non-REM sleep [328]. Hence,
a full-feature set of HRV-relevant features is a powerful tool for sleep-stage classification [340].
Recently, Radha et al. have reported that HRV has great potential to classify sleep stages [341].
However, their work was performed in a private dataset and conducted using some features
that are often not present on wearable devices. In our work, we devise HR/HRV features that
could be extracted from research-grade wearable sensors and evaluate their performance in the
largest public dataset to date.
Beyond ML and DL models, ensemble architectures are becoming increasingly prevalent for
HAR tasks. For instance, in 2015, Single et al. adopted an approach consisting of three variants
of long-short term memory (LSTM) networks that worked in parallel to tackle a biological





prediction [342]. In [343], Guan and Ploetz developed a LSTM ensemble model via epoch-wise
bagging for efficient training. They injected several random factors to increase the diversity of
the classifiers and improve performance in several HAR tasks.
Recent work has explored the application of ensemble models for automatic sleep classification
using PSG/EEG signals. These studies have shown promising results, improving the perfor-
mance of shallow ML and even DL approaches [344–346]. Koley et al. used an ML ensemble
architecture approach consisting of five binary support vector machine (SVM) classifiers to
classify different sleep stages [344]. Using a "winner-takes-all" ensemble method [347] the
researchers achieved significantly better discriminant capability relative to single SVM models
applied to EEG signals. Recently, Huy et al. applied an ensemble method to multimodal PSG
data (EOG, EEG and electromyography (EMG)) by fusing classifiers [348]. All these previ-
ously reported models are based on sleep epoch (30 seconds) level feature extraction protocols
and use classifier ensembles derived in sensors which often exceeded 100Hz sampling rates
(EEG data, etc). These methods demand high specifications with regards to computing power.
Currently, the limited data storage and processing capabilities of wearable devices mean that
they are unlikely to be able to support these models in free-living conditions.
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3.4 Methods
The MESA Sleep dataset is introduced and described in Section 3.4.1 [333, 334]. All exper-
iments reported here were conducted based in this dataset. In Section 3.4.2, we provide an
overview of the data pre-processing and feature extraction method for modalities which consist
of cardiac sensing (HR and HRV) and movement sensing (actigraphy). All tasks explored,
including our ensemble method, are introduced in Section 3.4.3. In Section 3.4.4, we introduce
the models used for our benchmark work. Section 3.4.5 describes how we designed our
experiments. Finally, in Section 3.4.6, the metrics used to evaluate the classification models
are discussed.
3.4.1 Dataset Description
The Multi-Ethnic Study of Atherosclerosis (MESA) dataset is a multi-centre longitudinal study
designed to investigate the characteristics of sub-clinical cardiac disease. The study comprises
6814 asymptomatic men and women of black, white, Hispanic and Chinese-American ethnicity,
of which 2,237 were also enrolled in the MESA Sleep Study. As part of the MESA Sleep Study,
all participants wore an actigraphy device for one week and underwent concurrent PSG for one
night. Data for this study was acquired in six different centers across the US and followed the
appropriate Institutional Review Board approvals and written informed consent for participant
data acquisition [333, 334].
The MESA Sleep Study was conducted using a Compumedics Somte System for PSG, which
includes the ECG signals here used to derive HR and HRV and their associated features,
alongside an Actiwatch Spectrum from Philips Respironics to record actigraphy data. This
device captures measurements of movements defined as “activity counts”3 and aggregates them
into 30 second epochs. The Actiwatch was securely fastened to participant’s non-dominant
wrist. These actigraphy signals and their associated features can be derived in most research-
grade wearable devices. The sensors for the Compumedics PSG comprised: cortical EEG,
bilateral EOG, chin EMG, abdominal and thoracic respiratory inductance plethysmography,
airflow, ECG, leg movement sensor and finger pulse oximetry. These sensors collected three
types of signals: bioelectrical potentials (EEG, EOG, EMG, ECG), waveforms received
from transducers (thermistors on the airflow devices, inductance respiratory bands, piezo leg
sensors and position sensors from the leg device) and auxiliary devices (oximetry measures of
oxyhemoglobin saturation and nasal pressure records). Full details of the setup, protocol and
sampling rates are available 4,5. All participants included in our study had at least one full night
of PSG recording with concurrent actigraphy and ECG. An illustration of the experimental set






Figure 3.1 Experimental setup and tasks: Our models are trained using a combined-sensing,
multimodal approach which incorporates two time-series signals: actigraphy and ECG derived
HR and HRV and uses Gold-Standard PSG for the training labels
Polysomnography (PSG) is the 
gold standard to measure sleep 
stages and diagnose sleep 
disorders. 
Actigraphy is a noninvasive 
method to monitor gross motor 
activity, commonly found on 
smartwatches.
Electrocardiogram (ECG) 
measures the electrical activity 
and rhythm of the heart using 
electrodes placed on the 
participants skin.
Table 3.1 Breakdown of population based on sex, age and demographic characteristics, by
dataset (training or test).
Dataset Total Female Male Black Chinese-American White Hispanic Age (µ ± σ) Min Age Max Age
Training 1395 752 (54%) 643 (46%) 383 (28%) 153 (11%) 511 (37%) 348 (25%) 69.29 ± 8.73 54 94
Test 348 198 (57%) 150 (43%) 103 (30%) 39 (11%) 128 (37%) 78 (22%) 68.52 ± 9.21 55 89
Numbers are N, N(%) or mean (SD). Age is given in years.
Table 3.2 Sleep statistics of participants in the study.
Dataset Total Sleep Time (TST) Total Time in Bed (TIB) Sleep Efficiency (%) Wake After Sleep Onset (WASO) N1 N2 N3 REM
All 359.0±80.7 475.0±85.3 76±13.1 90.3±62.7 49.42±30.9 207.0±60.1 40.0±33.4 66.9±28.9
Training 357.5±80.2 473.5±84.9 75.9±13.1 90.5±62.7 49.3±31.1 206.6±60.4 39.6±33.3 66.6±29.3
Test 365.1±82.5 480.9±87.0 76.4±12.8 89.2±62.6 49.8±30.4 208.5±58.9 41.68±33.7 68.3±27.4
Numbers are minutes except sleep efficiency measured in percentage(mean ± SD)
center at the Brigham and Women’s Hospital (Boston, MA, USA) and data was scored by
trained technicians using AASM guidelines. For our training labels, we used the expert scoring
and epoch staging annotations on PSG data provided by Bild et al [349]. Note that the MESA
Sleep dataset is the only large open-access dataset combining gold-standard measures of
sleep through PSG with wearable sensor data from actigraphy as well as ECG (HR/HRV) and
thus the only existing dataset appropriate for our purposes.
Table 3.1 summarizes the main demographic characteristics of the participants by training and
test splits.
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3.4.2 Data Pre-processing and Feature Extraction
In this work, we synchronized PSG, ECG and actigraphy records into 30-second sleep epochs
for 1,743 of the 2,237 participants included in the study. A total of 494 participants were
excluded on the basis of: (1) lack of concurrent PSG, ECG and actigraphy data; (2) lack
of enough quality standard data (< 1.5 h of usable data from the concurrent three sensing
methods); or (3) lack of data integrity or misalignment of data, we removed actigraphy outlier
epochs based on human expert annotations. These outliers are either non-wearing periods
or equipment failure periods. For actigraphy epochs labeled as outliers, their corresponding
HR/HRV epochs were also removed [350].
For generalisability purposes, we included diseased participants in our analysis; full details are
presented in Supplementary Table S1. Similarly, we did not exclude a total of 30 subjects (about
2% of the total cohort) who do not have any REM epochs at all, although we do understand
that these sleep patterns are physiologically very unlikely. The sleep stages for subjects in
this dataset were scored by individual sleep technicians, blind to the disease status of the
participants, into five classes (wake, N1, N2, N3, REM) according to AASM guidelines [349].
For the ECG signal, we derived features that are only based on RR intervals instead of using the
raw ECG signal. The rationale behind this was to make our work as transferable as possible to
data collected from research-grade devices such as miniaturized ECGs or wrist wearables that
incorporate PPG sensors (i.e., the Empatica E4 wristband). Participants whose ECG records
did not include a full night of sleep, or whose data was corrupted were excluded from further
analysis.
QRS complexes (R-points) were detected using Compumedics Somte (Abbotsford, VIC,
Australia) software Version 2.10 (Builds 99 to 101). The R-points were classified as normal
sinus, supraventricular premature complex or ventricular premature complex. Data cleaning,
filtering and noise removal took place during this step of the process using the Python package
HRV-analysis6. First, RR interval outlier data was filtered using a threshold method with
a range between 300 to 2000 ms following the method previously described by Tanaka et
al. [351], then the ectopic beats were removed by through the methods described in Malik et
al. [352]. Second, we linearly interpolated the removed R-points. We grouped the RR intervals
into 30 seconds to match the time interval of actigraphy data. Recalling the description in
Section ??, the HRV describes the physiological variation of the beat-to-beat interval that can
be extracted from the time-distance between adjacent R wave peaks. Thus, we calculated 30
cardiac features from each 30-second window length that matches the epoch of the actigraphy
data. Following the approach used by Radha & Fonseca et al. [341], we extracted features in
four domains (time, geometrical, frequency and non-linear domains). Table 3.4 details the full




Table 3.3 Full set of features extracted from the actigraphy signal.
Feature name Description
Activity Count Raw activity count from the actigraphy device
Log Activity Count Natural Logarithm of the activity count
Mean Activity Mean value for the window of activity of size N. 1 ≤ N < 20
Median Activity Median value for the window of activity of size N. 1 ≤ N < 20
Std Activity Standard deviation value for the window of activity of size N. 1 ≤ N < 20
Variance Activity Variance value for the window of activity of size N. 1 ≤ N < 20
Minimum Activity Minimum value for the window of activity of size N. 1 ≤ N < 20
Maximum Activity Maximum value for the window of activity of size N. 1 ≤ N < 20
NAT Activity Number of epochs, in a window of size N , which the value for the activity
count is larger than 50 and lower than 100. Devised from [81]. 1 ≤ N <
20
Any Activity Number of epochs that contain any activity in the window of size N. 1 ≤
N < 20
Skewness of Activity Skewness for the window of activity of size N. 4 ≤ N < 20
Kurtosis of Activity Kurtosis for the window of activity of size N. 4 ≤ N < 20
We adopted two strategies for extracting actigraphy-related features. For DL approaches, that
can automatically extract features from the raw inputs, the raw activity counts (sampling rate
at 1/30 Hz) were extracted from the device as the input. For the other ML models, a total of
370 handcrafted time-series features were extracted, as described below. These features have
been commonly used in the literature (i.e., [353, 354, 237]).
For each sleep epoch T , we calculated summary statistics (i.e., mean, variance, median,
kurtosis) for actigraphy data that considering both centered and non-centered sliding windows
of N sleep epochs (with N = {1, 2, ..., 19}), where each sleep epoch contain a scalar value.
We also calculated other commonly used metrics, such as the raw and natural logarithm values
of the activity counts for each epoch T . These features are listed in Table 3.3.
Our full feature set (i.e., both activity and cardiac features) were normalized using the z-score
method. A summary of the pipeline used in this work is shown in Figure 3.2.
3.4.3 Tasks
We structured our work on 5 different tasks that allowed us to explore the objectives of this
work and test several hypotheses based on multimodal fusion and new model development.
Our first task, Task 1, aims to establish benchmarks for sleep-wake (binary) classification using
single modality (either actigraphy or HR/HRV) and multimodality approaches (combining
both modalities). In doing so, we compare conventional statistical learning methods and simple
neural network methods across modalities. This task is the most explored one among the
research community in this area [82, 81, 323, 354, 356] and we also aimed to augment the
benchmarks previously reported by Palotti et al. [237].
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Table 3.4 Full set of cardiovascular related features grouped by domain.
Time Domain Features
Mean HR Mean heart rate for that window
Maximum HR Maximum heart rate for that window
Minimum HR Minimum heart rate for that window
Std HR Standard deviation for the heart rate for that window
SDNN Standard deviation of Normal-to-Normal interval (NNi)
SDSD Standard deviation of NNi differences
NN50 Number of NNi differences greater 50ms
pNN50 Ratio between NN50 and total number of NNi
NN20 Number of NNi differences greater 20ms
pNN20 Ratio between NN20 and total number of NNi
RMSSD Root mean of squared NNi differences
Median NNi Median of NNis
Range NNi Range between smallest RR intervals to largest RR intervals
CVSD The coefficient of variation of successive differences , the RMSSD divided by mean NNi
Coeff. of Variation of
NNI
The Coefficient of Variation of NNi, i.e. the ratio of sdNN divided by mean NNi
Geometrical Domain Features
Triangular Index The HRV triangular index measurement is the integral of the density distribution (that is, the
number of all RR intervals) divided by the maximum of the density distribution (class width of
8ms)
Frequency Domain Features
Low Frequency Low Frequency is the variance (i.e., power) in HRV in the Low Frequency (.04 to .15 Hz).
Reflects a mixture of sympathetic and parasympathetic activity
High Frequency High Frequency is the variance (i.e., power) in HRV in the High Frequency (.15 to .40 Hz).
Reflects fast changes in beat-to-beat variability due to parasympathetic (vagal) activity
Variance in Low Freq. VLF is the variance (i.e., power) in HRV in the Very Low Frequency (.003 to .04 Hz). Reflect
an intrinsic rhythm produced by the heart which is modulated by primarily by sympathetic
activity
Low/High Freq. Ratio The LF/HF ratio is sometimes used by some investigators as a quantitative mirror of the
sympathy/vagal balance
Norm. Low Freq. Ratio Normalized low frequency ratio calculated from the raw values of low frequency band (LF or
HF) divided by the total spectral power
Norm. High Freq. Ra-
tio
Normalized high frequency ratio calculated from the raw values of high frequency band (LF or
HF) divided by the total spectral power
Mean NNi Mean over the RR intervals




Cardiac Sympathetic Index [355]
Mod. Cardiac Symp.
IdNx
A modified cardiac sympathetic index calculated by SD2
2
SD1
Cardiac Vagal IndeNx Cardiac Vagal IndeNx [355]
SD1 Poincaré plot standard deviation perpendicular the line of identity
SD2 Poincaré plot standard deviation along the line of identity
SD1/SD2 Ratio Ratio of SD1 to SD2
Task 2 consisted of the same systematic evaluation, but this time, the simplest sleep staging
paradigm was introduced (Wake, NREM, REM). Here, the AASM scores provided in the
MESA dataset are simplified and collapsed into a simpler representation of sleep staging. Wake
and REM remain the same, but N1, N2 and N3 are grouped together to become NREM sleep
as an entity. The feasibility of this task has also been tested by other studies [341, 331].
Taking a step further in the level of granularity, Task 3 classifies the data into Wake, REM,
Light Sleep and Deep Sleep. Here, light sleep captured both N1 and N2 which is often
considered a transition state between light and deep sleep and usually takes up the largest
percentage of time during a full sleep cycle [357]. Given the heterogeneity and prevalence of
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Figure 3.2 Multimodal data processing pipeline: after removing low quality data, the
signals from the actigraphy device and ECG are synchronized and features are extracted and
normalized.





























N2, the difficulty of the task has risen significantly. The models are expected to perform worse
than they did on previous tasks.
Task 4 explored the classification of sleep stages based on AASM rules (Wake, REM, N1,
N2, N3). This task has the highest level of granularity, and it is, in fact, a task in which
even the current state of the art, DL approaches on gold-standard PSG recordings often do
not achieve satisfactory performance [346]. This task faces two challenges. The first being
the class imbalance, as N1 and N3 sleep epochs account for only 11% and 7% of the data
respectively. The second challenge is the nature of our modalities that do not capture direct
cortical signals, compromising the performance in more granular classification tasks.
Finally, we introduced an ensemble method which aims to combine the unique perspectives
and capabilities of DL classifiers with different window sizes containing discriminant power
from different temporal dependencies that could be characteristic of different sleep stages.
3.4.4 Models and settings
Conventional heuristic approaches have been readily used in the past 30 years for Task 1
(binary sleep-wake classification). It has recently been shown that feature-based ML and DL
approaches greatly outperform all these methods [237].
ML and DL techniques are increasingly used in medical sciences [346, 331]. Here, we use
supervised learning techniques on time-series data. This entails generating models that learn
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Table 3.5 Experiment settings based on input modalities, where l is the window length of
the input (l = {20, 50, 100}), the inputs are for each sleep epoch
Algorithm
Type Modality Input Dimension Features Used (Full list on Tables 3.3 and 3.4)
ML
[Actigraphy] x ∈ R370 370 features were derived from Activity Counts
[HR/HRV] x ∈ R30 30 features were derived from RR intervals
[HR/HRV, Actigraphy]
x ∈ R400 Concatenation of the two modalities above
DL
[Actigraphy] x ∈ Rl Activity Counts
[HR/HRV] X ∈ Rl×8
8 features were derived from RR intervals: Mean NNi,
Standard Derivation of RR interval (SDNN),
RR interval differences (SDSD), Very Low Frequency, Low Frequency,
High Frequency Bands, Low Frequency to High Frequency Ratio and Total Power.
[HR/HRV, Actigraphy]
X ∈ Rl×9 Concatenation of the two modalities above
mappings between input and output spaces. For instance, Random Forest (RF) approaches
have shown strong performance on activity recognition tasks [358]. Similarly, Radu et al. [46]
showed promising results using DL approaches on multimodal sensor data for activity and
context recognition tasks. Indeed, wearable sensors exploiting multimodal approaches have
shown the advantages of this methods over single modality approaches for human activity
recognition tasks [359]. Going beyond traditional activity recognition tasks, ML and DL
models have been shown to outperform conventional heuristic approaches for actigraphy sleep-
wake classification [237, 353]. DL models have also shown great promise in the automatic
classification of sleep stages using EEG or multimodal sensor data [348]. Here, we expand that
work to multimodal wearable and minimally obtrusive sensors by systematically evaluating
how the most well-established ML and DL models perform based on different sensor modalities
and when using combined sensing.
For all included tasks and modalities, we explored the most common shallow ML and DL
architectures. These comprise linear support vector machines, logistic regression, random for-
est, perceptrons, convolutional neural networks (CNN) and long-short term memory networks
(LSTM). We hypothesised that given the large amounts of data DL models would be better
suited. Details on the ML and DL classifier settings can be found in Table ??.
3.4.5 Experimental Design
Once the feature sets were built for our two input streams, we randomly split the dataset
into training and test sets following an 80/20 split where 80% (1,395 subjects) went to the
training set and 20% (348 subjects) went to the test set. More details including demographic
information can be found in Table 3.1 and a summary of sleep statistics is introduced in
Table 3.2. .
The inputs to our single modality and multimodal experiments can be found in Table 3.5. When
using multimodal approaches, we used a channel-wise stacking approach prior to inputting the
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resulting matrix into our models. These methods were adopted across all benchmarks for our
tasks. Following the method used in [237], our hyperparameter search is described below:
• ML hyperparameter search: we employed 5-fold cross-validation on the training set.
• DL hyperparameter search: we employed a hold-out method to randomly split the
training dataset into a validation set of 279 subjects (20%) and a training set of 1,116
(80%).
The full detailed list for our hyperparameter tuning can be found in Table ??. We used Scikit-
learn7, Keras8 and Tensorflow9 to implement our models. For our feature set, we emulated
previously used approaches [341, 237] for movement and cardiac sensor feature extraction in
traditional ML and DL setups, which were mentioned in section 3.2. In our ML experiments,
each input vector contains 400 features that combined 370 statistical features extracted from
actigraphy and 30 HR/HRV features as we describe in the feature engineering section. As such,
the single modality approaches for actigraphy input 370 features whereas for HR/HRV 30
features for each sleep epoch were included for each input vector. These were used as inputs
for our feature-based ML benchmarks.
In our DL experiments, given that we wanted our work to be as transferable and device-agnostic
as possible, we decided not to use the raw ECG signal. ECG signals are expensive and are not
currently available in most of the wearable sensors. Thus, instead, we used an 8-dimensional
HR/HRV feature set (see Table 3.5) that can be derived from many wearable cardiac sensors,
such as Epatica10, or ActiHeart11. For movement data, we simply use the activity counts that
can be acquired directly from the wrist-worn actigraphy device.
Due to the fact that the DL techniques used CNN and LSTM are able to learn high-level
features from the data, their input is a window of a size which can be either 20, 50 or 100 sleep
epochs in width. Similarly, the conceptualization of the proposed ensemble model is based
on how domain experts, in this case physicians and laboratory technicians who examine PSG
records, approach multistage sleep classification.
For PSG annotation, sleep technicians and physicians often use adjacent information as well
as contextual temporal information to inform their decisions in scoring a particular epoch.
Indeed, they may look at information and trends within a 30 minute or 1 hour period as well as
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Figure 3.3 Ensemble model: The model starts by taking inputs from different window lengths
(l) from the multimodal sensors. A total of six different classifiers are used, combining a
mixture of CNNs and LSTMs and exploiting their individual strengths. This results on
posterior probability confusion matrix that is then combined through concatenation as part of
the ensemble architecture. Finally, the decision making layer takes place by either (a) using a


























0.6 0.7 0.5 0.8 0.7 0.6
0.2 0.1 0.3 0.1 0.15 0.25



























l = 50 l = 100 
Inspired by this procedure that expert PSG scorers undergo when analyzing laboratory datasets,
we use an ensemble classifier model to create an “aggregation” of individual learned models
which are trained using different temporal perspectives of the data. By doing so, individual
learners focus on different aspects of a particular sequence, which is to lead to a more robust,
and typically, a better outcome for recognition performance when using aggregated results.
Our ensemble model combines the best 6 classifiers (a combination of CNNs and LSTMs)
with various sliding window lengths (20, 50 and 100 sleep epochs, their corresponding sleep
recording length of 10, 25 and 50 minutes). This approach aims to offer low bias and low
variance due to it’s capabilities in capturing various temporal dependencies. Following the
previously described ensemble model pipelines, we explore two score-level fusion methods for
variance reduction. These methods are model-averaging and maximum posterior selection.
The sleep stage ensemble classification model is based on standard single-layer CNN and
LSTM networks, as summarized in the previous four tasks. Figure 3.3 illustrates the structure
for individual classifiers and their score level fusion mechanism. At the training stage, each
classifier is trained independently given the hypothesis that data from sliding windows of
different lengths carry different discriminative information for each sleep-stage class.
After the forward propagation takes place for a sleep epoch, each classifier’s softmax layer
produces a K-dimensional probability vector pmt ∈ RK , where K is the number of classes in
a particular task and t is the sleep epoch index(for instance,a 450 minutes sleep recording has
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900 indexes , so t = {1, 2, ..., 900}), m is the mth DL classifiers in our ensemble model and
we have 6 classifers so m = {1, 2, ..., 6}. Probability vectors from all M = 6 models are then
combined into a probability matrix (each mode is independent of each other). Then, the two
different score-level fusion methods are applied on these posteriors. The first method takes







and then a class(k̂t represents the predicted sleep stage) is assigned to the one with the highest
probability:
k̂t = arg max pfusiont ,
The second method is to take the maximum posterior probability across all classifiers for a
certain class k, and then the class label k̂t is assigned to the one with highest probability which
is the kth class such that:
k̂t = arg max
k
Pt, Pt = [p1t , p2t , ...pmt ]
where pmt is the posterior probability of the mth classifier. This method will firstly find the
posterior probability vector that contains the highest value, then finds the the maximum value’s
index k which refers to the kth class. And t refers to the sleep epoch index. The whole
ensemble scheme is also shown in Figure 3.3.
3.4.6 Evaluation Metrics
We adopted commonly used metrics in machine learning and medical sciences to evaluate the
performance of the different classification algorithms based on task and modality combination.
All of our performance metrics were derived at both a subject level (first derived on an
individual by individual basis and then averaged across the population) and a group level.
To assess class imbalance and evaluate performance, we adopt several popular metrics based
on True Positive (TP), False Positive (FP), True Negative (TN) and False Negative (FN)
classifications. These evaluation metrics can be summarized as follows:
• Accuracy counts the number of correctly classified sleep epochs, normalized over the
total number of sleep epochs (Acc = T P +T NT P +T N+F P +F N ).
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• Recall measures the proportion of positives that are correctly identified as the given
stage (R = T PT P +F N ).
• Specificity, also known as true negative rate, measures the proportion of negatives that
are correctly identified as the given stage (S = T NF P +T N ).
• Precision is the fraction of correct classified instances among the overall positive
predictions (P = T PT P +F P ).
• F1 score (F1) conveys the balance, with the harmonic mean, between precision and
recall (F1 = 2 × P×RP +R ).
• Cohen’s Kappa (κ) measures inter-rater reliability/agreement, comparing observed
accuracy with an expected accuracy (κ = Po−Pe1−Pe , where Po the observed proportional
agreement and and Pe the expected proportion of agreement). In this context, Cohen’s
κ factors out agreement by chance arising from the class imbalance of different sleep
stages throughout the night.
With the exception of Task 1 (binary sleep-wake classification), all other tasks were multi-
class classification and we average the results with macro average given the consideration of
imbalanced data for the classification task.For all of our classifiers, we also computed confusion
matrices to understand further where the different approaches excelled and where they fell
short. We computed Cohen’s Kappa to evaluate agreement across the whole population.
Moreover, we used two-tailed t-tests with a significance level of 95% (significant differences
when p < 0.05).
We also propose in this work a measure to intuitively understand how long, in terms of minutes,
a classifier is under/over estimating sleep in a given sleep stage. We called this metric Time
Deviation, which, for an algorithm Alg, measures the average difference on the number of
epochs assessed as in sleep stage s (TimeInSleepStages) between Alg and the ground truth
(GT ). This can be defined, for a study with Q participants as:





TimeInSleepStages(Alg, i) − TimeInSleepStages(GT, i)
Many sleep classification studies have reported accuracy and F1 for the proposed models,
where these indicators measure the predictive performance of the algorithm based on a time
indexing manner without directly summarizing the total time at each sleep stage throughout
the night. However, for clinicians and other health practitioners, confusion matrices are not
the most obvious way to present the time deviation of sleep stages that predicted by each
classifier. Here we introduce time deviation as a complementary metric to what is offered
by confusion matrices, allowing healthcare practitioners to gain an intuitive understanding
of how some stages are either over or under estimated. The time deviation metric calculates
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the difference between the predicted minutes for each sleep stage and the ground-truth PSG
annotation. Additionally, to understand individual sensor contributions within our multimodal
set-up, we evaluated feature importance and the effect of features on the different models and
classification tasks using SHAP analysis [360, 361]. SHAP values allow explaining the output
of a function f as the sum of the effects ϕi of each individual feature that is introduced to a







v(P Ri ∪ {i}) − v(P Ri )
)
,
where ϕ is the Shapley value, N is the number of features, P Ri is the set of features with
order, v(P Ri ) is the contribution of the set of features with order and finally v(P Ri ∪ {i}) is the
contribution of the set of features with order and feature i. By using Shapley, SHAP returns
individual contributions to the full feature set in each particular task we introduced allowing us
to understand individual feature contributions not only for a particular task, but also for each
sleep stage. Here, to understand global importance of the features imputed into the models, we
average the absolute Shapley values per feature across the data and then sort those features by
decreasing importance.
Similarly, to gain a better understanding of how each classifier performs at each task beyond
conventional statistical learning metrics, we include a measure of the total deviation in time on
a model-by-model basis for the class (stage) predicted and standard deviation. For instance,
a classifier might be prone to over-classify NREM sleep and miss out on epochs that were
supposed to be Wake or REM.
3.5 Results
For our experiments, we used a total of 1,743 nights of sleep, representing 1,903,900 sleep
epochs of 30 seconds. The prevalence of sleep stages (AASM convention used) within these
epochs is reported in Table 3.6.For consistency, all of our architectures and models were
evaluated during sleep recording period across tasks, with performances reported in Table 3.7
for binary classification and Table 3.8 for multistage classification. Within each table, results
were sorted by mean accuracy in descending order. In this section, we only show the top three
DL classifiers alongside the best classifier from ML. Table 3.10 provides a summary of sleep
measured by PSG and the time spent in different sleep stages for the best classifier in each task.
3.5.1 Task 1: sleep-wake classification
The best performing algorithms for Task 1 are presented in Table 3.7, and a full breakdown
of all classifiers is presented in the supplementary tables for this task. We used baseline
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Table 3.6 Number of 30-seconds sleep epochs for each of the four tasks studied in this work.
The numbers in parentheses were obtained within sleep period time which measured from the
first to the last non-wake detected sleep epoch.
Task 1 Task 2 Task 3 Task 4
Sleep Stages # Epochs % Sleep Stages # Epochs % Sleep Stages # Epochs % Sleep Stages # Epochs %
Wake 652,509(314,784) 34%(20%) Wake 652,509(314,784) 34%(20%) Wake 652,509(314,784) 34%(20%) Wake 652,509(314,784) 34%(20%)
Sleep 1,251,391 66%(80%) NREM 1,022,346 54%(65%) Light 893,472 47%(57%) N1 171,027 9%(11%)
REM 229,045 12%(15%) Deep 128,874 7%(8%) N2 722,445 38%(46%)
REM 229,045 12%(15%) N3 128,874 7%(8%)
REM 229,045 12%(15%)
Total 1,903,900(1,566,175) 100% Total 1,903,900(1,566,175) 100% Total 1,903,900(1,566,175) 100% Total 1,903,900(1,566,175) 100%
Table 3.7 Sleep wake classification results (mean ± standard error at 95% confidence
interval) and predicted minutes by multimodal and single modality approaches (full
recording period); Actigraphy modality: , HR/HRV modality: ; (*Full Table available on
supplementary, **Average time deviation from ground truth across all subjects ± standard
error )
Sleep-Wake Classification Benchmarks*
Method Specifics Performance Metrics Time Deviation**
Modality Sensors Top 3 Classifiers Accuracy Specificity Precision Recall F1 Cohen’s κ Sleep (mins)
Multimodality
[HR/HRV, Actigraphy]
CNN (100) 84.4 ± 1.0 67.9 ± 2.0 84.8 ± 1.3 92.4 ± 1.2 87.6 ± 1.1 62.0 ± 2.0 36.2 ± 7.3
LSTM (100) 84.4 ± 1.0 67.4 ± 1.9 84.7 ± 1.2 92.5 ± 1.1 87.8 ± 1.0 61.6 ± 2.1 36.0 ± 6.7
CNN (50) 84.3 ± 1.0 67.3 ± 2.0 84.5 ± 1.3 92.7 ± 1.2 87.6 ± 1.1 61.7 ± 2.1 39.0 ± 7.2




LSTM (100) 79.5 ± 1.2 62.2 ± 2.1 81.8 ± 1.4 88.9 ± 1.3 84.1 ± 1.1 51.5 ± 2.2 35.3 ± 4.4
CNN (100) 79.1 ± 1.2 57.0 ± 2.1 79.9 ± 1.5 91.0 ± 1.4 83.9 ± 1.3 49.8 ± 2.1 54.4 ± 4.7
LSTM (50) 78.6 ± 1.2 61.1 ± 2.0 81.2 ± 1.4 88.2 ± 1.3 83.4 ± 1.2 49.5 ± 2.1 34.5 ± 4.6
Random Forest (300) 70.3 ± 1.2 39.2 ± 2.3 73.6 ± 1.4 86.7 ± 1.9 77.6 ± 1.5 27.1 ± 1.7 70.4 ± 12.5
[Actigraphy]
CNN (100) 84.9 ± 1.0 67.1 ± 2.0 84.7 ± 1.3 93.8 ± 1.0 88.3 ± 1.0 63.0 ± 2.0 43.0 ± 6.9
CNN (50) 84.4 ± 1.0 67.6 ± 2.0 84.6 ± 1.3 92.9 ± 1.1 87.8 ± 1.1 62.2 ± 2.1 39.0 ± 7.1
LSTM (100) 84.3 ± 1.0 69.7 ± 1.8 85.5 ± 1.2 91.2 ± 1.1 87.6 ± 1.0 62.0 ± 2.0 26.5 ± 6.6
Random Forest (300) 81.2 ± 1.0 63.4 ± 2.0 82.9 ± 1.3 89.7 ± 1.1 85.4 ± 1.0 54.1 ± 2.1 32.6 ± 7.2
approaches, namely, Always Sleep and Always Wake, which showed that 66.5% of the epochs
are sleep. Given the fact that for the purpose of this work, we only explored classification
during the night period, we established that 66.5% was the minimum accuracy threshold
for our models. Furthermore, although not reported on this work, we tested several of the
well-established heuristic algorithms such as Cole-Kripke [82] and Sadeh [81] on our single-
modality actigraphy data. Our results agree upon what was reported by Palotti et al. [237]. All
of these approaches were outperformed by both the feature-based ML and DL models explored
in our work.
All traditional ML modalities showed similar performance. Corroborating what had been
shown in the related work that, when these algorithms are applied to actigraphy data, they
result in high sensitivity but poor specificity [237]. Interestingly, for this task, adding HR and
HRV to actigraphy for a combined sensing modality on the top classifier of CNN (100) did
not significantly improve F1 (p = 0.347), accuracy (p = 0.499) or Cohen’s κ (p = 0.506). As




Table 3.8 Sleep stage classification results (mean ± standard error at 95% confidence in-
terval and predicted minutes by multimodal and single modality approaches (full record-
ing period); Actigraphy modality: , HR/HRV modality: ; Three different tasks: Task 2: 3
stages, Task 3: 4 stages, Task 4: 5 Stages (*Full Table available on supplementary, **Average
time deviation from ground truth across all subjects ± standard error)
Task 2: Wake, NREM, REM
Method Specifics Performance Metrics Time Deviation*
Modality Sensors Top 3 classif. Accuracy Specificity Precision Recall F1 Cohen’s κ Wake REM NREM
Multimod.
LSTM (50) 76.2 ± 1.0 85.6 ± 0.5 72.2 ± 1.3 68.8 ± 1.2 67.9 ± 1.3 58.4 ± 1.8 -13.2 ± 6.8 -10.7 ± 3.8 23.9 ± 7.1
LSTM (100) 76.1 ± 0.9 85.1 ± 0.5 71.9 ± 1.4 66.8 ± 1.2 66.4 ± 1.3 57.4 ± 1.9 -3.2 ± 6.8 -23.3 ± 3.4 26.5 ± 7.0
CNN (100) 76.0 ± 1.0 85.6 ± 0.6 72.2 ± 1.2 69.7 ± 1.3 68.1 ± 1.3 58.6 ± 1.9 -32.7 ± 7.2 2.5 ± 4.5 30.2 ± 7.7
Random Forest (300) 70.5 ± 0.9 79.9 ± 0.5 59.2 ± 1.5 53.0 ± 0.7 50.3 ± 0.7 47.6 ± 1.7 -20.0 ± 7.6 -63.6 ± 2.9 83.5± 7.8
Single
Modality
LSTM (100) 73.8 ± 1.2 84.3 ± 0.6 69.8 ± 1.5 66.1 ± 1.3 64.9 ± 1.5 50.0 ± 2.2 -27.8 ± 8.5 -8.6 ± 4.2 36.4 ± 8.1
LSTM (50) 72.9 ± 1.1 83.8 ± 0.6 67.9 ± 1.4 64.1 ± 1.3 62.9 ± 1.4 45.5 ± 2.1 -17.9 ± 8.5 -16.2 ± 4.3 34.1 ± 8.3
CNN (100) 71.0 ± 1.2 83.6 ± 0.6 66.3 ± 1.4 65.4 ± 1.4 62.7 ± 1.4 46.1 ± 2.0 -12.9 ± 9.4 2.3 ± 5.0 10.6 ± 9.1
Random Forest (300) 59.6 ± 1.0 73.8 ± 0.4 48.4 ± 1.4 43.4 ± 0.6 39.2 ± 0.8 19.7 ± 1.4 -26.8 ± 13.5 -65.3 ± 3.1 92.0 ± 13.2
LSTM (100) 71.4 ± 0.9 80.1 ± 0.6 51.7 ± 1.1 52.9 ± 0.7 49.8 ± 0.8 49.7 ± 1.7 -16.8 ± 7.3 -67.0 ± 3.0 83.8 ± 7.7
CNN (100) 71.0 ± 1.0 79.5 ± 0.6 50.1 ± 0.8 52.1 ± 0.8 49.1 ± 0.8 48.0 ± 1.8 -34.9 ± 7.5 -67.6 ± 3.0 102.5 ± 7.9
LSTM (50) 70.9 ± 0.9 79.7 ± 0.6 49.0 ± 0.8 52.4 ± 0.7 49.2 ± 0.8 48.3 ± 1.7 -20.3 ± 7.4 -67.6 ± 3.0 87.9 ± 7.8
Random Forest (300) 68.6 ± 0.9 78.8 ± 0.5 53.4 ± 1.1 51.0 ± 0.7 48.5 ± 0.8 44.3 ± 1.7 -20.5 ± 7.2 -60.7 ± 2.9 81.2 ± 7.4
Task 3: Wake, Light Sleep, Deep Sleep, REM
Method Specifics Performance Metrics Time Deviation*
Modality Sensors Top 3 classif. Accuracy Specificity Precision Recall F1 Cohen’s κ Wake REM Deep Sleep Light Sleep
Multimod.
LSTM (50) 70.3 ± 1.0 87.4 ± 0.4 57.9 ± 1.3 54.0 ± 1.0 51.9 ± 1.0 53.8 ± 1.9 -1.0 ± 6.9 -5.6 ± 4.0 -36.2 ± 3.5 42.8 ± 7.4
LSTM (100) 70.2 ± 1.0 86.9 ± 0.4 59.9 ± 1.5 52.4 ± 1.0 51.3 ± 1.1 51.7 ± 1.8 -18.9 ± 6.6 -24.7 ± 3.7 -32.4 ± 3.5 76.0 ± 7.3
CNN (100) 69.0 ± 1.0 87.0 ± 0.4 58.0 ± 1.4 53.7 ± 1.0 51.2 ± 1.1 51.6 ± 1.8 -15.9 ± 7.5 4.4 ± 4.8 -34.5 ± 3.5 46.1 ± 8.1
Random Forest (300) 63.6 ± 1.0 83.3 ± 0.4 44.7 ± 1.3 40.1 ± 0.6 36.7 ± 0.6 34.4 ± 1.3 -15.2 ± 7.6 -61.3 ± 2.9 -38.9 ± 3.6 115.3 ± 8.3
Single
Modality
LSTM (100) 67.4 ± 1.2 86.2 ± 0.4 56.2 ± 1.6 51.3 ± 1.1 49.5 ± 1.2 44.6 ± 2.2 -13.1 ± 8.4 -13.5 ± 3.8 -33.7 ± 3.5 60.4 ± 8.1
LSTM (50) 66.2 ± 1.1 85.6 ± 0.4 54.4 ± 1.5 49.5 ± 1.1 47.4 ± 1.1 41.2 ± 2.1 -15.0 ± 8.1 -14.6 ± 4.1 -36.4 ± 3.5 65.9 ± 7.9
CNN (100) 64.3 ± 1.1 85.3 ± 0.4 54.4 ± 1.6 50.2 ± 1.1 47.1 ± 1.1 40.9 ± 2.1 -23.0 ± 9.5 8.2 ± 5.1 -34.8 ± 3.5 49.6 ± 8.9
Random Forest (300) 53.3 ± 1.0 79.2 ± 0.4 35.5 ± 1.1 33.2 ± 0.5 28.6 ± 0.6 12.6 ± 1.1 -4.3 ± 14.0 -64.7 ±3.0 -39.0 ± 3.6 -39.0 ± 3.6
LSTM (100) 64.1 ± 1.0 82.9 ± 0.5 35.6 ± 0.7 39.6 ± 0.7 35.8 ± 0.7 33.5 ± 1.4 -32.5 ± 7.4 -67.6 ± 3.0 -39.3 ± 3.6 139.4 ± 8.5
CNN (100) 63.9 ± 1.0 83.0 ± 0.4 36.3 ± 0.9 39.6 ± 0.7 35.7 ± 0.7 33.5 ± 1.4 -26.4 ± 7.6 -67.5 ± 3.0 -39.3 ± 3.6 133.2 ± 8.7
LSTM (50) 63.6 ± 1.0 82.7 ± 0.4 35.6 ± 0.8 39.3 ± 0.7 35.5 ± 0.7 33.0 ± 1.4 -36.3 ± 7.1 -67.3 ± 3.0 -39.3 ± 3.6 143.0 ± 8.2
Random Forest (300) 61.4 ± 1.0 82.6 ± 0.4 39.6 ± 0.9 38.1 ± 0.5 35.0 ± 0.6 31.2 ± 1.3 -15.6 ± 7.3 -59.3 ± 2.9 -37.1 ± 3.6 112.1 ± 8.1
Task 4: Wake, REM, N1,N2,N3
Method Specifics Performance Metrics Time Deviation **
Modality Sensors Top 3 classif. Accuracy Specificity Precision Recall F1 Cohen’s κ Wake REM N3 Sleep N2 Sleep N1 Sleep
Multimod.
LSTM (50) 63.7 ± 1.0 88.7 ± 0.3 47.1 ± 1.4 43.0 ± 0.8 39.9 ± 0.8 56.3 ± 1.8 22.2 ± 7.1 -12.9 ± 3.9 -35.2 ± 3.5 71.9 ± 7.5 -46.0 ± 3.0
LSTM (100) 63.6 ± 1.0 88.7 ± 0.3 47.8 ± 1.3 43.3 ± 0.8 40.5 ± 0.9 57.0 ± 1.8 -3.3 ± 6.8 -15.9 ± 3.9 -32.3 ± 3.5 97.7 ± 7.5 -46.2 ± 3.0
CNN (100) 63.1 ± 1.1 88.8 ± 0.3 51.5 ± 1.4 44.7 ± 0.9 41.9 ± 0.9 56.2 ± 1.8 -26.2 ± 7.1 8.2 ± 5.0 -34.3 ± 3.5 92.4 ± 8.0 -40.2 ± 3.1
Random Forest (300) 56.9 ± 1.0 86.2 ± 0.3 36.4 ± 1.2 33.1 ± 0.5 28.8 ± 0.5 46.3 ± 1.6 18.6 ± 8.1 -54.9 ± 3.1 -38.7 ± 3.6 123.6 ± 8.4 -48.6 ± 3.2
Single
Modality
CNN (20) 55.6 ± 1.1 86.4 ± 0.3 40.4 ± 1.2 37.3 ± 0.8 33.6 ± 0.9 36.2 ± 1.8 -15.6 ± 10.1 -3.9 ± 5.8 -39.1 ± 3.6 103.0 ± 9.8 -44.4 ± 3.0
CNN (100) 55.6 ± 1.1 86.7 ± 0.3 44.9 ± 1.4 38.9 ± 0.9 35.9 ± 1.0 37.1 ± 1.8 1.1 ± 10.7 -12.0 ± 4.8 -29.5 ± 3.6 81.2 ± 9.4 -40.8 ± 3.1
CNN (50) 54.2 ± 1.1 86.0 ± 0.3 41.2 ± 1.3 35.6 ± 0.8 32.1 ± 1.0 32.3 ± 1.9 35.7 ± 12.1 -28.2 ± 5.1 -36.4 ± 3.5 69.5 ± 11.0 -40.6 ± 3.1
Random Forest (300) 46.6 ± 1.0 83.1 ± 0.3 29.9 ± 1.0 27.1 ± 0.4 22.3 ± 0.5 17.6 ± 1.4 48.5 ± 14.3 -61.3 ±3.1 -38.9 ± 3.6 97.8 ± 13.7 -46.2 ± 3.2
LSTM (50) 56.9 ± 1.0 85.7 ± 0.4 26.1 ± 0.8 32.2 ± 0.6 27.1 ± 0.7 46.9 ± 1.7 -12.9 ± 7.5 -67.6 ± 3.0 -39.3 ± 3.6 169.2 ± 8.5 -49.4 ± 3.2
LSTM (100) 56.9 ± 1.0 85.7 ± 0.4 25.3 ± 0.7 32.3 ± 0.6 27.1 ± 0.7 47.1 ± 1.7 -3.3 ± 7.5 -67.6 ± 3.0 -39.3 ± 3.6 159.7 ± 8.7 -49.4 ± 3.2
CNN (100) 56.8 ± 1.1 85.8 ± 0.3 27.7 ± 0.9 32.2 ± 0.5 27.2 ± 0.6 46.9 ± 1.7 9.6 ± 8.3 -65.6 ± 3.0 -39.3 ± 3.6 144.7 ± 9.1 -49.4 ± 3.2
Random Forest (300) 54.4 ± 1.0 85.6 ± 0.3 31.7 ± 0.8 31.1 ± 0.4 27.2 ± 1.6 42.7 ± 1.6 16.2 ± 7.6 -56.0 ±2.8 -36.7 ± 3.5 120.8 ± 8.0 -44.3 ± 3.3
3.5.2 Task 2: wake, Non-REM sleep, REM sleep classification
Task 2 evaluated sleep stages from a low granularity perspective by aggregating the different
partitions of NREM. As observed in the supplementary table for this task, although some ML
models had reasonable performance, the DL approaches were superior. It is important to note
that at this level of granularity, NREM is overestimated while REM is underestimated for
almost all models except for CNN (50) and CNN (100). In contrast to what was observed in
Task 1, all models explored have a higher specificity than sensitivity and accuracy higher than
F1 score due to the imbalanced dataset.
As reflected in the top part of Table 3.8, the best classifiers for this task were all DL models
for all sensor modalities. These models were significantly better than the best traditional ML
model (Random Forest), with p < 0.001 for all metrics evaluated. The best DL algorithm
with respect to accuracy was LSTM (50) which was also statistically better than CNN (20)
(p < 0.001) achieving an accuracy of 76.2%. However, it was not significantly better than
CNN (100) in terms of F1, sensitivity and specificity (p = 0.364, p = 0.138, p = 0.063 and
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p = 0.399). Nevertheless, CNN (100) achieved the lowest mean time deviation with a 2.5-
minute overestimation of REM sleep. Interestingly, for this task, most algorithms’ specificity
significantly improved (e.g. LSTM (50) p < 0.001, reaching a specificity of 86%) when
compared to Task 1 with the exception of the perceptron model.
In this task, it becomes apparent that multimodality is required for better performance at
multistage classification, with the single modality approaches being significantly (p < 0.001)
outperformed in all performance metrics and yielding much larger time deviations.
3.5.3 Task 3: wake, light sleep, deep sleep and REM-sleep classification
Task 3 explored sleep staging at a higher level of granularity than Task 2, with class imbalances
being perhaps more apparent, as shown in Table 3.6. Here, DL approaches continued to outper-
form all feature-based ML models except for the Random Forest, which was not significantly
worse than the CNN (20). The full results are available in supplementary tables. The best
performing model was LSTM (50), although it was closely followed by LSTM (100) and CNN
(100). Multimodal approaches were significantly better (p < 0.001) across all metrics upon
comparison of the best classifiers for each category explored, depicting the value of these
combined sensing approaches for multistage classification. Across all sensing modalities and
all algorithms, deep and REM sleep were underestimated, with the exception of CNN (100)
in the multimodal setup. In contrast, light sleep was overestimated, with wake being slightly
underestimated across all setups, due to the class imbalance, except for LSTM (50).
3.5.4 Task 4: wake, N1, N2, N3, REM sleep classification
Finally, Task 4 aimed to classify sleep stages following AASM rules (N1, N2, N3, REM and
Wake). This task is the most complex due to its level of granularity and high-class imbalance,
and as expected, the models performed worse here than in the previous tasks. An example of
the best performing model LSTM (100) and the mistakes it makes is highlighted in Figure 3.4.
Like in previous tasks, the performance of DL algorithms was significantly better than feature-
based ML algorithms as depicted in Table 3.8. The three best performing DL algorithms were
not significantly different from each other with respect to accuracy(p > 0.05) and F1 scores
(p > 0.05). The best performing algorithm was LSTM (50), with an accuracy of 63.7% and
an F1 score of 39.9%. Even in the best performing multimodal approach, N2 tended to be
severely overestimated (71 minutes more on average across the population). Nevertheless,
the multimodal and HR/HRV approaches were good at classifying wake and REM, with only
moderate deviations in time for those classes.
It is important to note that although the performance in terms of accuracy for the single modality
approaches was comparable, each method struggled or had strengths at very different things.
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Figure 3.4 Classification performance for multimodal, 5 stage classification using LSTM.
On the top, the ground truth PSG, at the bottom, the predicted stages by the model. Highlighted
in red are areas where the model does poorly.
Ground Truth (PSG) 5 Stage Prediction (LSTM)
For instance, HR/HRV was significantly better at classifying REM sleep in this modality than
actigraphy. Similarly, upon evaluation of the algorithms only during the sleep period only
(Table ??, multimodal approaches were significantly better at detecting awakenings, yielding a
more accurate wake after sleep onset (WASO) metric.
Figure 3.5 shows the confusion matrix for the best classifiers per task, allowing us to observe
how models have an easier time classifying REM and wake and struggle to classify N1 and
N3 (NREM). The observed time deviation in minutes substantiates this finding.
Finally, we evaluated the performance of different ensemble methods for each task. To validate
the performance of our ensemble model, we conducted t-test based on both subject level as well
as the group of subjects level. The difference between the two experiments lies in that for the
second approach, we randomly divide all test subjects into 29 groups, each group containing
12 individuals. The purpose is to test whether the benefits of using ensemble methods are due
to random chance.
The results of the two ensemble architecture models explored (based on different score-level
fusion approaches) are shown in Table 3.9. We found no significant differences between the
two ensemble models for all performance metrics assessed. However, they achieve better
accuracy than single classifier approaches for all tasks and are significantly better on several
performance metrics.
In Task 2, the ensemble approaches significantly outperformed LSTM (50) in terms of accuracy
(p < 0.05), F1 score (p < 0.05) and Cohen’s κ (p < 0.05) and CNN (100) in terms of accuracy
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Figure 3.5 Confusion matrix for the best classifier per Task
Table 3.9 Results (mean ± standard error at 95% confidence interval) of different en-
semble methods for each task.(Mean over classifiers and Maximum selection are ensemble
models)
Ensemble method Accuracy Cohen’s κ F1 Precision Recall Specificity Time Deviation (mins)
Task 1 (2 Stages) Sleep
Maximum selection 85.3 ± 1.0 64.4 ± 2.0 88.4 ± 1.1 85.7 ± 1.2 92.8 ± 1.1 70.1 ± 1.9 33.4 ± 6.7
Mean over classifiers 85.4 ± 1.0 64.3 ± 2.1 88.5 ± 1.0 85.4 ± 1.3 93.4 ± 1.1 69.1 ± 2.0 37.5 ± 6.8
Task 2 (3 stages) Wake REM sleep NREM sleep
Maximum selection 77.9 ± 1.0 61.4 ± 1.8 69.6 ± 1.3 74.5 ± 1.3 70.6 ± 1.2 86.5 ± 0.5 -16.1 ± 6.8 -11.1 ± 4.2 27.3 ± 7.5
Mean over classifiers 78.2 ± 0.9 61.9 ± 1.8 69.8 ± 1.3 75.2 ± 1.3 70.7 ± 1.3 86.5 ± 0.5 -21.7 ± 6.8 -13 ± 4.2 34.7 ± 7.5
Task 3 (4 stages) Wake REM sleep Deep sleep Light sleep
Maximum selection 71.1 ± 1.0 55.7 ± 1.8 52.4 ± 1.0 58.3 ± 1.3 54.8 ± 1.0 87.7 ± 0.4 -11.1 ± 6.7 -3.5 ± 4.6 -37.4 ± 3.5 52.0 ± 7.8
Mean over classifiers 71.6 ± 1.0 56.1 ± 1.8 52.1 ± 1.0 57.1 ± 1.2 54.3 ± 1.0 87.6 ± 0.4 -17.8 ± 6.7 -8.9 ± 4.4 -38.5 ± 3.5 65.2 ± 7.8
Task 4 (5 stages) Wake REM sleep N3 sleep N2 sleep N1 sleep
Maximum selection 65.2 ± 1.0 59.6 ± 1.8 41.4 ± 0.8 49.7 ± 1.4 45.2 ± 0.8 89.3 ± 0.3 3.0 ± 6.9 4.7 ± 5.1 -37.1 ± 3.5 76.4 ± 7.8 -47 ± 3.1
Mean over classifiers 65.4 ± 1.0 60.1 ± 1.8 41.2 ± 0.8 48.6 ± 1.4 44.9 ± 0.8 89.2 ± 0.3 -5.1 ± 6.9 -2.1 ± 4.8 -38.4 ± 3.5 91.9 ± 7.8 -46.3 ± 3.1
(p < 0.05) and Cohen’s κ (p < 0.05) based on both subject and group level t test. These
models were the best two performers for that task prior to the introduction of the ensemble
approach. Interestingly, on Task 4 (highest level of class granularity) the ensemble models
only outperformed the best classifier (LSTM (50)) in terms of Cohen’s κ and accuracy (for
both subject and group level t test).
A summary of results per class and model are presented in Figure 3.6.
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Figure 3.6 Performance (accuracy, F1) per Task and model. Task 5 (ensemble architec-
tures) are depicted against all benchmarks per each task on green
Table 3.10 Sleep parameters and predicted minutes of each sleep stage in the test dataset.
Numbers are minutes except for the sleep efficiencies which are reported as percentages.
Results are in mean +- SD/ and numbers in parentheses indicate the range in 95% CI (Mean
over classifiers and Maximum selection are ensemble models)
Minutes of Sleep Stages
Task Methods Wake Sleep
1
Ground truth 187.8±81.6 (179.2-196.4) 365.7±81.8 (357.1-374.3)
Mean over classifiers 150.2±73.2 (142.5-157.9) 403.3±92.0 (393.6-413.0)
Wake REM NREM
2
Ground truth 187.8±81.6 (179.2-196.4) 68.6±27.2 (65.7-71.5) 299.7±66.5 (292.7-306.7)
Mean over classifiers 166.1±77.2 (158.0-174.2) 57.4±39.0 (53.3-61.5) 332.7±87.8 (323.5-341.9)
Wake REM Deep Sleep Light Sleep
3
Ground truth 187.8±81.6 (179.2-196.4) 68.6±27.2 (65.7-71.5) 41.8±33.7 (38.3-45.3) 258.8±65.7 (251.9-265.7)
Maximum selection 176.7±78.3 (168.5-184.9) 65.4±43.1 (60.9-69.9) 5.2±6.2 (4.5-5.9) 310.6±85.4 (301.6-319.6)
Wake REM N1 N2 N3
4
Ground truth 187.8±81.6 (179.2-196.4) 68.6±27.2 (65.7-71.5) 50.1±30.5 (46.9-53.3) 209.1±58.7 (202.9-215.3) 41.8±33.7 (38.3-45.3)
CNN (100) 161.6±79.1 (153.3-169.9) 76.7±46.8 (71.8-81.6) 9.6±14.6 (8.1-11.1) 301.5±87.0 (292.4-310.6) 7.7±8.7 (6.8-8.6)
Sleep Parameters
Task Methods Total Sleep Time Wake After Sleep Onset Sleep Period Duration Sleep Efficiency(Recording Period)
Sleep Efficiency
(Sleep Period)
Ground truth 365.7±81.8 (357.1-374.3) 89.4±62.5 (82.8-96.0) 455.1±90.0 (445.6-464.6) 66.5±12.9 (65.1-67.9) 80.9±11.8 (79.7-82.1)
1 Mean over classifiers 360.7±84.0 (351.9-369.5) 70.9±57.4 (64.9-76.9) 474.2±92.9 (464.4-484.0 65.5±13.2 (64.1-66.9) 76.9±14.0 (75.4-78.4)
2 Mean over classifiers 359.5±84.3 (350.6-368.4) 81.7±60.1 (75.4-88.0) 469.1±93.0 (459.3-478.9) 65.3±13.2 (63.9-66.7) 77.4±13.9 (75.9-78.9)
3 Maximum selection 358.2±84.1 (349.4-367.0) 86.5±61.4 (80.0-93.0) 463.3±92.3 (453.6-473.0) 65.0±13.2 (63.6-66.4) 78.1±13.7 (76.7-79.5)
4 CNN (100) 361.1±83.3 (352.3-369.9) 94.6±68.6 (87.4-101.8) 486.5±90.7 (477.0-496.0) 65.6±13.1 (64.2-67.0) 75.0±14.2 (73.5-76.5)
3.5.5 Feature importance analysis
To understand how different modalities contribute to the prediction of each sleep stage, models
that rank feature importance can be implemented. Many traditional ML approaches can
provide feature importance ranking, such as logistic regression, linear Support Vector Machine
or Random Forests. Of those, Random Forest is one of the most powerful traditional ML
models, and it can rank feature importance by calculating the mean Gini impurity or mean
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information gain over all its decision trees. However, these approaches only yield features that
are important to the holistic classification task, and do not provide information on how these
features contribute to recognizing certain classes (e.g., a sleep stage like REM sleep). We used
SHAP [362] with Random Forest, which can generate class-wise feature importance. More
technical details of SHAP can be found in [362].
By using this SHAP implementation with Random Forest, we can calculate the most important
features per class, as shown in Figure 3.7. We report the top 20 features on Tasks 1-4,
respectively. It is interesting to see how the top ranked features differ from task to task,
pointing towards what contributes to more granular levels of classification.
For instance, in Task 1 (i.e., binary sleep/wake classification), the most informative features
are from movement sensors (15 features out of 20), in contrast to those obtained from cardiac
sensing (5 out of 20). However, cardiac features become more and more important as multi-
stage classification tasks get more granular. In Tasks 2-4, with the increased class granularity,
the most important features are cardiac features (8, 10, and 13 cardiac features, respectively)
indicating the key role of cardiac sensing in distinguishing detailed sleep patterns.
In multi-stage sleep classification (i.e., Tasks 2-4), it is also interesting to see feature importance
associated to the different classes. Specifically, we observe high frequency HRV is the most
discriminant feature in recognizing REM sleep, a finding that is consistent across all 3 multi-
stage classification tasks. However, high frequency HRV is not as valuable in recognizing
wake status. In Task 3 and 4, the non-linear HRV features such as SD2 which is the normalized
Poincare plot parameter, SDNN, and coefficient of variation of NNI become more important
than time domain features of HRV. Among these features, SD2 is ranked higher than many of
the other HRV features except high frequency HRV in Task 4.
3.6 Discussion
3.6.1 Summary
This work presents the first systematic analysis of sleep-wake and sleep-stage classification
using multimodal sensor data in a large, diverse population of both healthy and sleep-disordered
participants. The main aim of this work was to understand how different models performed
based upon details of the task (sleep-wake or multistage sleep classification) and sensor
combination. To achieve this, we applied a series of traditional ML and DL approaches to each
individual modality (i.e., actigraphy, ECG) and sensor combination (multimodal sensor fusion).
Furthermore, we ran four different tasks to gain a deeper understanding of the strengths and
limitations of the different approaches.
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Figure 3.7 SHAP feature importance (Random Forest) for each Task is used to further un-
derstand feature contributions for each individual class (stage). The figure introduces the
performance on Task 1-4, starting with binary sleep wake classification all the way to AASM’s
5 stage classification
These tasks include: sleep-wake (Task 1); wake, NREM and REM (Task 2); wake, light sleep,
deep sleep and REM (Task 3); and wake, N1, N2, N3 and REM (Task 4). The framework
and analysis we provide were based on sensor modalities and signals that can be obtained
from research grade wearable devices. Hence, RR-based metrics were used instead of raw
ECG signals. Unlike raw ECG, these metrics may be derived from commercial research-grade
wearable devices and in the near future also from non-clinical smartwatches that use both
actigraphy/accelerometers and photoplethysmogram (PPG) [363]. With this work, we aim to
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provide with a set of benchmarks for commercial and research studies and to inspire others to
create open-access large population repositories to study the role of sleep and other physical
behaviors in health and disease.
Here, we systematically evaluated how sensor modality affects classification outcomes and
how model choice leads to differences in performance. Yuda et al. also explored a multimodal
approach for sleep classification. Although their work is strong methodologically, the cohort is
much smaller than that presented here, almost 70% of their cohort is male and the majority
of their subjects had sleep disorders, limiting the generalisability of their findings [331].
Furthermore, they only explored the classification of three sleep stages. Here, we show that
although multimodal sensor approaches do not lead to great improvements in classification
performance for sleep-wake classification tasks, they are essential to classify sleep stages. For
instance, actigraphy by itself struggles to classify REM sleep in Tasks 2-4 (Table 3.8), but
it’s performance improves when combined with HR/HRV. To-date, conventional sleep-wake
classification algorithms have mostly exploited count-based movement data [81, 324] and
models that combined HR information have mostly been confined to commercial devices based
on device-specific algorithms.
Furthermore, this work highlights the strengths and limitations of the different models used,
for instance, while CNN models do well at classifying high frequency transitions, LSTMs
excel at classifying smooth patterns. LSTMs outperformed all other classifiers at multistage
classification, due to their deep temporal modelling characteristics which align well with the
multi-class, time-series classification problem that sleep-stages introduce. Meanwhile, CNNs
were the best performers for binary sleep-wake classification tasks due to their ability to track
exponentially longer sequences, such as those used in this type of task where the objective is
less granular and has lower transition frequencies than the multi-class scenario. As such, our
ensemble approach aimed to exploit individual model strengths to achieve better performance.
Remark: In sum, this work presents the first systematic analysis of single modality (actigraphy,
HR/HRV) and multimodal sensing approaches for sleep-wake and sleep-stage classification
using the most common feature-based ML and DL frameworks. Furthermore, a new ensemble
architecture is introduced, outperforming all other models.
3.6.2 Transparency in algorithm development in machine learning for sleep
health
All our analyses were performed in MESA [333, 334], a publicly available dataset for which
access can be requested through: https://sleepdata.org/datasets/mesa. This creates transparency
and facilitates reproducibility in human sleep science. We encourage others to use this resource
to develop novel, more accurate models that exploit multimodal data. Here we provide an
example of how the performance of well-established methods can be surpassed by an ensemble
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architecture of DL models of different window sizes. Similarly, we found that the performance
of our models was influenced by optimal hyperparameter search. In particular, we observed
that although there was no significant improvement in terms of accuracy and F1 on our search
space, certain patterns did emerge. For most CNNs and LSTMs, increasing the length of the
sliding window improved performance (except for Task 1, sleep-wake only). Different search
spaces may be able to yield more significant results and shall be explored in future work.
In this work, we advocate for and demonstrate the value of including performance metrics
beyond the conventional accuracy, specificity, precision, recall and F1 scores. For instance,
introducing time deviation metrics allowed us to understand what precisely each model over-
or underestimated. This is of particular value for the translational applications of this work
which may be implemented by HCI researchers, clinicians or epidemiologists and have an
impact on the field of digital health. These metrics are more interpretable for non-machine
learning experts who may seek to understand how certain inferences should be interpreted.
Clear, interpretable measures that allow non-specialists to understand the limitations of our
models is critical both to the development of better study cohorts and to understanding the
inferences made by these models.
3.6.3 Sleep classification performance by task
Binary sleep-wake classification (Task 1) using actigraphy had been previously explored by
Palotti et al. in the same cohort [237]. Our results corroborate this study, with the CNN
architecture narrowly outperforming the LSTM architecture. Interestingly, our multimodal
approach did not add much to this binary classification task when exploring conventional
metrics, but did yield a lower time deviation of overall sleep time than actigraphy alone.
Models based only on cardiac signals had a slightly worse performance than both actigraphy
alone and the multimodal approach, with accuracy estimates in the high 70s (79% for the
LSTM (100)).
Task 2 consists of Wake, NREM and REM classification. This represents a valuable yet
holistic overview of sleep stages and is what most free-living commercial devices aim to
measure. Actigraphy and HR/HRV yielded an accuracy of around 74% and F1 scores between
49% and 65%. Our time deviation metrics allowed us to observe that actigraphy cannot
accurately determine REM sleep, whilst HR/HRV perform better. Both sensor modalities tend
to overestimate time spent in NREM sleep. This finding also pertained to the multimodal
approach, where NREM overestimation was the most error-prone estimate of the three states
classified, at around 24 minutes mean deviation from gold-standard measures per participant
on average when using the LSTM (100) and 24 minutes deviation when using the LSTM (50).
NREM could be overestimated because it is the most common state among all participants
on average, meaning that errors could be magnified. Accuracy estimates for our multimodal
approach were in the high 70s for the majority of the classifiers, with LSTM (50) reaching
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76% accuracy. These results are in line with the best performance previously reported in the
literature. However, none of these previous studies had the scale and diversity that the MESA
dataset offers [349].
Task 3 explored classification into Wake, REM, light sleep and deep sleep. In this classification,
N1 and N2 were considered part of light sleep and N3 was classified as deep sleep. Actigraphy
and HR/HRV reached accuracies of around 67% through LSTM (100). However, F1 scores
for the single modality approaches were between 35-50%. Similarly, both approaches overes-
timated time spent in light sleep and also struggled to pick up REM sleep. The multimodal
approach outperformed the single modality approach with a higher accuracy of around 70%
and an F1 score of 52% for LSTM (50) (the highest performing model). Interestingly, LSTM
(50) has a very strong performance at classifying wake and REM but struggles to discern light
sleep and deep sleep, overestimating light sleep, probably given the transitional characteristics
and high prevalence of the N2 stage nested in the light sleep class.
Task 4 aimed to evaluate classifiers that followed AASM scoring rules of Wake, REM, N1,
N2 and N3. This task is the most complex of the four, given the high level of granularity
required and the imbalance severity between sleep stages increased. Actigraphy and HR/HRV
performances at this task were poor, with F1 scores ranging from 27-36%. Both heavily
overestimated the most prevalent state, N2. The multimodal approach struggled to discern
among the different NREM stages and, again, overestimated time spent in N2. Its performance
on Wake and REM was much better but, intriguingly, worse than what had been observed
in Task 3. Accuracy did not exceed 64% and F1 scores were between 40-42%. A visual
illustration of this task is presented in Figure 3.4, where overestimation of N2 can be observed,
alongside how the model struggles to discern transitions between N1, N2 and N3.
Across all multistage classification tasks LSTMs, outperformed every other modeling ap-
proach. This is most likely due to its ability to learn temporal dependencies from longer
window sizes, contrasting with CNN models which focus on local dependencies. This makes
LSTMs a particularly attractive candidate for multistage sleep classification given the intrinsic
transitional nature of the task. The ensemble model approach serves as an example of how
multistage classification benchmarks ought to be improved by new model architectures. The
example approach is a rather simple one and thus only improves the performance marginally.
Nevertheless, the results are promising. By incorporating different temporal domains and
classifier types, these new models are able to pick up nuances that may have been tougher to
identify by using a single convolutional or recurrent neural network.
Understanding sleep stage dynamics at a population level could be of value for digital health,
epidemiology and clinical studies. We envision that research on behavioral change (i.e., [330])
can take advantage of ubiquitous systems for sleep stage classification to recommend changes
for better sleep hygiene and healthier sleep architectures.
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3.6.4 Physiological underpinnings of classifiers and sensor modality contribu-
tions
Our classification tasks aimed to explore how the different modalities performed with regards
to the level of granularity and detail generated. Physiologically, sleep stages are quite different
and one objective of this work was to understand the individual contributions of each sensor,
as well as model biases and preferences. Following the AASM staging convention:
1. N1 (the first stage of NREM sleep) is the stage in which the change between wakefulness
and sleep occurs. During this stage, heart rate, breathing and eye movement slow, with
occasional muscle twitches. Similarly, slow-wave activity starts to appear on the PSG’s
EEG signal.
2. N2 (the second stage of NREM sleep) is the transition period between light and deep
sleep. Heartbeat and breathing slow, muscles relax even further and body temperature
drops. This stage is the most repeated across all sleep cycles. Together with N1, it is
often referred to as light sleep.
3. N3 (the third stage of NREM sleep) is often referred to as deep sleep. Heart rate and
breathing are at their lowest, muscles are very relaxed and it is rare for the person to
awaken during this stage. These changes are also observed on the PSG’s EEG signal,
where the lowest frequency and highest amplitude waves can be found. Together with
N1 and N2, this stage constitutes NREM sleep.
4. Finally, as explored in the introduction, REM sleep occurs in a cyclical fashion, ap-
proximately every 90 minutes. Breathing is faster and irregular, heart rate increases
and, in healthy people, the body is in a state of temporary paralysis that prevents sharp
movements related to dreams.
Given the physiological differences between sleep stages, we hypothesised that depending on
the sensors used and the measurements they enabled, performance at classifying certain stages
may differ. This is of high importance when considering the deployment of these technologies
in clinical settings or for the exploration of the association between sleep characteristics and
disease end-points in population-based research. Understanding time spent at different stages
over a long-term period is of great importance for the greater sleep scientific community.
For instance, during non-REM sleep, slow-wave activity has been shown to support memory
consolidation [319] and reduce next-day anxiety [364]. In [319], for example, these slow-wave
oscillations have been shown to affect the way the brain cerebrospinal fluid dynamics work,
leading to oscillations in blood volume that draw this fluid across the blood-brain barrier.
We used SHAP to further understand how different sensor features contribute to the individual
classification of sleep stages. Through this method, it became apparent that whilst actigraphy
features were the most informative for sleep-wake classification, when moving to multistage
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classification tasks, HR/HRV features were also important. This is reflected in Figure 3.7
where the top features contribute more to the model than the bottom ones, indicating their
higher predictive power. For example, frequency domain features were very informative
for recognizing non-REM sleep. Similarly, the application of this method to the different
tasks allows for the direct comparison of feature importance across different levels of sleep
architecture granularity. When exploring SHAP results, for Task 1, we found that the most
informative features came from actigraphy, although maximum HR and NN intervals were also
notable contributors. Activity coming from the wrist actigraphy was particularly important
for wake classification. This finding carried through all 4 tasks and makes sense given the
considerably higher amount of movement present during wake than in any sleep stage unless
a sleep disorder is present. For Tasks 2–4, SHAP results helped us understand why the
multimodal approach performs significantly better (p < 0.001) than individual sensors at sleep-
stage classification. We observed that while HRV features were not particularly informative
for wake classification, they added a lot of value to NREM and REM predictions. Interestingly,
we observed that frequency domain HRV features were amongst the most informative for
light and REM sleep classification, confirming our initial hypothesis derived from previous
clinical reports [337, 338]. These findings emphasise the importance of including HR/HRV
measurements combined with movement for multistage classification tasks using wearable
devices.
3.6.5 Future work and limitations
The strengths of this work derive from its novelty, population size and generalisability. It is
the first systematic assessment of multistage sleep classification using non-obtrusive sensors.
This makes an important contribution to the literature with potential applications for clinicians,
researchers and the wellness industry. The population used is uniquely diverse, including a
breadth of racial backgrounds, balanced sex and a representative sample of sleep-disordered
participants. This enhances the generalization capabilities of the findings in contrast to previous
studies [341, 331].
Here, we only explored benchmark models, but more complex networks can be designed, for
example, by training deeper architectures, bi-directional architectures or using attention mech-
anisms. A natural next step for this line of research would be to incorporate multi-task learning
approaches as well as models that combine a convolutional base with LSTMs/bi-directional
LSTMs on deeper layers. Similarly, given the temporal dependencies of these tasks, attention
mechanisms may be well suited to improve model performance [365]. Another architecture that
may yield interesting results is the addition of a dense layer to merge representations learned
by RNNs and CNNs, also exploiting the unique contributions of each classifier (temporal
representations by the RNNs and spatial representations by CNNs). Similarly, one potential
avenue that is an alternative to the current approach would be to keep the same window size
while using different model stride sizes.
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Given the scope of our work and objectives, we did not explore in detail how different
models perform in diseased versus healthy populations, or highlight the differences between
them. Similarly, our models did not exploit the well-known reciprocal interaction model
first introduced by McCarley and Hobson [366], which describes ultradian periodicity, the
approximately 90-min sleep cycle, which indicates that NREM-REM stage transitions are
regulated by both cholinergic and monoaminergic neuronal structures. This inherent sleep
architecture shall be explored in future work to improve model performance. Furthermore,
the ensemble model used in this chapter is a just an example of how our benchmarks can be
improved by using a novel approach tool, many other models can be used inspired by what
has been already done in automatic sleep scoring in EEG, as the tasks will follow the same
temporal dependencies. Here, we did not explore bespoke deep network architectures neither
covered the various possible approaches for multi-modal fusion. Our future work may consider
exploring these areas of research.
Furthermore, given the scope of this work, we did not enforce strict quality control on the
polysomnography data, which could have lead to the models to perform more poorly than if
those practices and more stringent exclusion criteria had been applied. For instance, we found
that a total of 30 subjects (about 2% of the total cohort) did not have any REM epochs at all.
Similarly, on a small percentage of participants (less than 1%) accuracy scores were very low
(< 45%). After post-hoc visual inspection of those cases, we found that their sleep patterns
were abnormal and five of them had a reduced number of sleep transitions. However, for the
purposes of this work, those participant results were included in the final performance metrics.
To exclude non-wear time and activity measurement failure from actigraphy data, we used
human noted tags as the selection criteria. Full processing pipelines shall integrate automated
non-wear time and data corruption detection algorithms in the preprocessing phase.
One limitation of this work is that the MESA cohort only includes adult participants. Thus
the results cannot be generalised to teenagers or children. Further, as with all studies in this
area to-date, all inferences are derived in laboratory settings, whilst the potential applications
are in a free-living environment. Good quality “ground truth” data collection in free-living
environments is complex and expensive although it is interesting to explore the possibility of
larger studies using ambulatory PSG or wireless EEG for this purpose. Similarly, commercial,
non-research grade devices have been shown to be unreliable at collecting longitudinal sleep
measures [367]. Thus, we encourage these companies to be more transparent about the way
they collect data and the algorithms they use.
3.7 Conclusion
In conclusion, this work introduces a systematic benchmark approach to sleep-wake and sleep
stage classification using ML and DL approaches in single modal and multimodal settings.
This approach advocates for model transparency, alongside reproducibility by exploring these
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methods in the only open-access dataset, which includes diseased participants. The findings
indicate that multimodal approaches combining movement with HR and HRV data were a
valuable tool for the monitoring of sleep stages when those stages were aggregated to the level
of NREM, REM, Wake. We further provide information regarding the performance of specific
algorithms and guidance regarding algorithm selection depending on the classification tasks.
Moreover, we introduce a deep ensemble model architecture which shows promising improve-
ments in performance across the different multistage tasks explored. Overall, the findings
highlight the promise of using wearable sensors as a low-burden, cheap and scalable approach
for large, population-based studies. Future work should explore new model architectures to
improve performance on more granular tasks, such as Tasks 3 and 4. These new architectures
should aim to mimic the results obtained by EEG-based systems in both healthy and diseased
populations as closely as possible. Furthermore, other auxiliary learning tasks and the inclusion
of new, minimally obtrusive sensors may improve the performance of these models.
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CHAPTER 4
DETECTING SLEEP IN FREE-LIVING CONDITIONS
WITHOUT SLEEP-DIARIES: A DEVICE-AGNOSTIC,
WEARABLE HEART RATE SENSING APPROACH
Publications
This work is under review for publication in Lancet Digital Health.
Contributions
I planned this project and devised the analysis plan in collaboration with my coauthors. In
collaboration with Jõao and Marius I generated the code, conducted the statistical analyses
and jointly interpreted the results. I wrote this chapter as well as the resulting manuscript
incorporating feedback from all other co-authors.
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4.1 Summary
Background: The rise of multisensor wearable devices offers a unique opportunity for the
objective inference of sleep outside of laboratory environments, enabling scalable, longitudinal
monitoring in large populations. To enhance objectivity and facilitate cross-cohort compar-
isons, sleep detection algorithms in free-living conditions should ideally rely on personalized
but device-agnostic features, validated without the constraint of human sleep annotations or
sleep diaries. Most commercial wearable devices can be used for sleep inferences but their
algorithms are device specific, lack thorough validation against gold-standard measures and are
not open-source. While on the previous chapter, we have shown that both Machine Learning
and Deep Learning can yield strong results in supervise settings, many datasets and applications
do not have these types of labels for use. In this Chapter we developed and validated a heart
rate based algorithm that captures inter- and intra-individual differences in sleep, does not
require annotations or diaries and can be applied in free-living conditions making it an optimal
candidate for large cohort studies.
Methods: The algorithm was evaluated across four study cohorts, comprising over 2,000
nights of sleep using different research- and consumer-grade devices. The recording periods
included both 24-hour free-living and conventional lab-based night-only data, facilitating
the evaluation of our method under free-living and laboratory conditions. Our method was
systematically optimized and validated against gold-standard polysomnography (PSG) and
detailed sleep logs, and was compared to the results obtained from sleep period estimation
arising from postural changes detected through accelerometry.
Results: We evaluated our approach in four separate cohorts comprising two free-living studies
with detailed sleep logs and two PSG studies. In the free-living studies, the algorithm yielded
a mean squared error (MSE) of 0.06 to 0.07 and a total sleep time deviation of -0.60 to -14.08
minutes. In the laboratory studies, the MSE ranged between 0.06 and 0.10 yielding a time
deviation between -23.23 and -33.15.
Conclusions: Our results suggest that our heart rate-based algorithm can reliably and objec-
tively infer sleep under longitudinal, free-living conditions, independent of the wearable device
being used. This represents the first open-source algorithm to leverage heart rate data for




Human sleep is a physiological reversible state that is homeostatically regulated and vital
for health and performance [368]. The functions of sleep are not fully understood but its
influence on energy restoration, brain function, cognitive performance and behaviour, alongside
interactions with the immune system, promotion of healing and consequences for numerous
health conditions have been studied extensively [369–377]. As a consequence of its personal
and public health significance, objective monitoring of sleep is paramount such that we can
further understand its role in human health and behaviour. The gold-standard method to
monitor sleep and diagnose most sleep disorders is PSG. PSG involves the collection and
conveyance of different signals from many sensors operating simultaneously. Traditional PSG
is limited to laboratory settings and requires an overnight stay for one or two days, expensive
and obstructive equipment and trained laboratory technicians. These factors limit its scalability
and prevent its use in objective sleep monitoring in large-scale population studies, as well as
for long-term surveillance. Furthermore, the unfamiliar environment in which PSG monitoring
takes place may result in atypical sleep that does reflect the study participants’ or patients’
typical pattern [378].
Chapter Significance: Sleep studies in free-living conditions are becoming easier to scale due
to advances in sensor technology and affordability of consumer-grade wearables. Adoption has
been driven by interest in long-term health monitoring, with incentives for person-generated
health data insights. Historically, sleep classification algorithms have been trained on manually
annotated records from selected cohorts with monophasic, night-time sleep data. Cultural
preferences and shift work mean standard approaches might fail to reveal unbiased insights
over 24-hour free-living conditions. In this chapter, we leverage the heart rate signal recorded
by most state-of-the-art wearables and evaluated our device- and annotation-agnostic labeling
approach across four separate study populations against gold- standard PSG or sleep diaries.
Results show that heart rate-derived labels preserve the accuracy demanded in clinical sleep
studies without the need for effort-intensive human annotations. This has potential applications
in longitudinal studies and personalized medicine.
Actigraphy is a well-established and widely used method to objectively detect sleep non-
obtrusively and longitudinally. This method, as well as its modern counterpart, accelerometry,
are often integrated into wrist-worn wearable devices, offering a scalable and affordable
alternative to PSG [379, 380]. Actigraphy has its precedent in early telemetric measurements
of motor activity in the 1970s which were used to assess sleep quality [381]. Since then,
a vast number of studies have assessed the use of actigraphy for sleep monitoring against
PSG [379, 267, 382].
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Over the past 30 years, a number of actigraphy-based algorithms have been derived with
nocturnal sleep-wake scoring, showing strong validity and reliability against PSG [255, 383–
387]. These algorithms have been readily used ever since and were recently benchmarked
against both each other and newer machine learning and deep learning methods, highlighting
the strengths and limitations of each method [223]. Across multiple studies that evaluated the
performance of actigraphy against PSG, it was shown that actigraphy struggled to classify wake
events during the sleep period, yielding poor specificity [223, 380, 386, 388, 389]. Similarly,
these actigraphy-based algorithms were only optimised for nocturnal sleep-wake scoring, thus,
they face a major challenge when applied to 24 hour recording. In order to work, they require
additional information from expert sleep scorers or reliable sleep diaries [390, 112]. This
requirement is also observed in most proprietary commercial brand algorithms, requiring the
user to report habitual sleep times when they first set up a profile. Further, these algorithms do
not allow the assessment of daytime sleep, severely limiting their relevance in cultures where
multiple sleep episodes are common or amongst shift workers.
Wearable devices for both research and consumer applications have increasingly adopted
multimodal sensing capabilities, combining movement and cardiac sensing, usually through
actigraphy or accelerometry and photoplethysmography (PPG), respectively. These devices
exploit recent advances in microelectromechanical systems (MEMS) and the associated im-
provements in cost, battery capacity, and increased memory. Thus, they are attractive not only
for personal health monitoring, with large technological companies investing heavily in the
space, but also in large epidemiological studies, as exemplified by the “All of US” research
program [391]. Given the widespread adoption of consumer-grade wearable devices and their
potential in large scale cohorts, the need for validation against gold-standard sleep measures
has become imperative. Indeed, recent studies have shown that consumer and research-grade
multimodal devices can be used to predict not only sleep-wake but also sleep stages during
the night period [392, 393]. Furthermore, these multimodal approaches have been shown to
improve the performance of models that only employ movement data in large populations,
likely due to their ability to measure changes in autonomic nervous system activity reflected in
heart rate (HR) and heart rate variability (HRV) [394]
Whilst these approaches are valuable, they have limited applicability in other large, free-
living cohort studies for three main reasons. First, they rely on machine learning and deep
learning methods which were derived specifically for those data sets, hence necessitating
domain adaptation to be appropriately used in a different population or device. Second, in
common with all previous well-established and widely used algorithms, they are only derived
for the night period, limiting their ability to infer sleep in less regular sleepers, including shift
workers [87]. Finally, these approaches rely on self-reported habitual sleep data, either through
questionnaires (i.e., how much sleep you get on a typical weekday), or sleep diaries, which
typically record times of getting into and out of bed. Both self-report measures are prone to
recall bias, with survey data not providing sufficiently reliable labels [85, 395]. Of note, when
using sleep diaries, it can often take in excess of 6 recorded days to achieve an agreement with
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objective labels, even amongst those with more regular sleep patterns [86]. At present, the
typical recording time for large-scale studies is about one week, contingent on device battery
life. Thus, annotation and device/cohort-independent algorithms have the potential to infer
sleep from objective 24-hour sensor data in a hitherto unprecedented manner.
In this work, we leverage heart rate data which can be obtained from most commercial and
research grade wearable devices to develop a universal set of statistical attributes and an
algorithm. We use these to infer both sleep periods and awakenings. In contrast to machine
learning methods that require data to be sent to the cloud and large computational resources, our
method is does not require this process or training before deployment, making it an attractive
candidate to run directly on devices. This also limits the privacy issues associated with the
transfer of personally generated data that are of paramount concern due to the nature of this
data. The approach is also independent of device-type and make and was evaluated in four
separate settings. First, the approach was developed in a large population (n=193) with multiple
nights of recording accompanied by detailed sleep diaries. This cohort wore a combined heart
rate and movement sensor, in addition to a variety of accelerometers (both wrist and hip),
facilitating the comparison of the performance of our method against both the diaries and
postural changes in multiple anatomical locations. We chose to develop the algorithm in this
population because we were able to evaluate ≈ 8 nights of sleep per participant, enabling testing
of both inter and intra-individual variability. We then assessed the performance of our method
in a large, diverse, open-source dataset with PSG data (n=1,743). Moreover, to showcase the
performance of our method in a readily available commercial device, we validated the approach
in a cohort that wore an Apple Watch and concurrent PSG (n=31). Finally, the performance
of our method in free-living conditions was further validated in a separate population against
detailed, non-habitual sleep diaries that also wore a triaxial accelerometer and heart rate sensor
(n=22).
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4.3 Methods
Here we used four different datasets using a variety of devices and populations to showcase
the performance of our proposed method.
4.3.0.1 The UK Biobank Validation Study (BBVS)
Participants of the BBVS study were recruited from the Fenland study [396]. In brief, 193
participants were recruited between the ages of 40 and 70, with a BMI between 20 and
50·kg · m−2. Recruitment aimed to balance age, sex, and BMI distributions. Participants
were invited to attend an assessment centre on two separate occasions, separated by a free-
living period of 9 to 14 days during which they wore three waveform triaxial accelerometers
(dominant and non-dominant wrists and thigh) as well as a combined movement and heart
rate sensor. During the free-living period, participants were asked to keep a detailed log
of their sleep, by recording the time they fell asleep and woke up on a daily basis. Ethical
approval for the study was obtained from Cambridge University Human Biology Research
Ethics Committee (Ref: HBREC/2015.16). All participants provided written informed consent.
Full details of the BBVS study are described elsewhere [397].
4.3.0.2 Multi-Ethnic Study of Atherosclerosis (MESA)
The Multi-Ethnic Study of Atherosclerosis (MESA) is a multi-site prospective study that
includes 6,814 men and women who identify as White, Black/African American, Hispanic, or
Chinese, and are between the ages of 45-84 [333, 334]. Participants in this study were followed
prospectively to evaluate risk factors for cardiovascular disease. 2,237 MESA participants are
enrolled in a sleep exam (MESA Sleep Ancillary Study [398]), which includes seven days of
wrist-worn actigraphy, one full overnight unattended polysomnography (wrist-worn actigraphy
collected concurrently), and a sleep questionnaire. MESA participants who reported regular
nighttime use of nocturnal oxygen or positive airway pressure devices were excluded from
participation.
All data used from the MESA Sleep Ancillary study used in this work is publicly available
from the National Sleep Research Resource repository1. Institutional Review Board approval
was obtained at each MESA study site (Wake Forest University School of Medicine, North-
western University, University of Minnesota, Columbia University, University of California





A number of common sleep disorders were identified and logged for the MESA sleep study,
representing numbers that are close to their real prevalence in similar populations. A breakdown
of those diseases is presented in Table 4.6.
4.3.0.3 PhysioNet Apple Watch Polysomnography Study
Data for this study was collected at the University of Michigan between 2017 and 2019.
The study consisted of 39 healthy subjects with no prior diagnosis of sleep-related breathing
disorders, parasomnias, restless leg syndrome, central disorders of hypersomnolence, peripheral
vascular disease, cardiovascular disease, vision impairments not correctable by glasses or
contact lenses or other disorders that could cause neurological or psychiatric impairment. The
study also excluded on the basis of shift work and recent transmeridian travel. Furthermore,
participants were ruled out on the basis of excessive daytime sleepiness according to the
Epworth Sleepiness Scale, and after the PSG visit, participants which showed symptoms of
either obstructive sleep apnoea or REM sleep behaviours were also excluded. A total of 31
subjects met the required criteria. Data for the study can be obtained through Physionet [399]
and a detailed description of this data set is available elsewhere [392].
Participants in this study wore an Apple Watch to collect their activity patterns for 7 to 14 days
before spending one night in a sleep lab. During the final night, participants underwent a PSG
study while wearing the Apple Watch device (which collected HR and triaxial acceleration).
The study was approved by the University of Michigan Review Board and all participants
provided written informed consent.
4.3.0.4 The Multilevel Monitoring of Activity and Sleep in Healthy people (MMASH)
Data for the MMASH study was collected by BioBeats in collaboration with researchers from
the University of Pisa and was obtained through Physionet [399, 400]. The study collected data
from 22 healthy young adult male participants comprising continuous heart rate and triaxial
accelerometry monitoring as well as variety of questionnaires to assess their physical activity,
psychological and sleep characteristics as well as a detailed sleep diary. Participants also
recorded their perceived mood (Positive and negative Affect Schedule-PANAS), Daily Stress
Inventory (DSI) during the free-living protocol and completed a Morningness-Eveningness
Questionnaire (MEQ), State-Trait Anxiety Inventory (STAI-Y), Pittsburgh Sleep Quality
Questionnaire Index (PSQI) and Behavioural avoidance/inhibition (BIS/BAS) during their
clinic visit. Further, anthropomorphic characteristics were recorded. All data was processed
and recorded by sport and health scientists with the objective of assessing psychophysiological
response to stress stimuli and sleep.
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All participants provided written informed consent. Information was provided to them regard-
ing the research protocol in accordance with General Data Protection Regulation: Regulation -
EU 2016/679 of the European Parliament and of the Council 27/04/2016. Further, all exper-
iments conducted were in accordance with the Helsinki Declaration as revised in 2013, the
study was approved by the Ethical Committee of the University of Pisa (#0077455/2018).




Participants were fitted with a combined heart rate and movement sensor (Actiheart, CamNtech,
Cambridgeshire, UK), measuring heart rate and uniaxial acceleration of the trunk every 15
seconds [401]. In addition, participants were fitted with three waterproof triaxial accelerometers
(AX3, Axivity, Newcastle upon Tyne, UK); one device was attached to each wrist with a
standard wristband, and one to the anterior midline of the right thigh using a medical-grade
adhesive dressing. These devices were set up to record raw, triaxial acceleration at 100Hz with
a dynamic range of ±8g. BBVS participants were asked to wear all four devices continuously
for the following 8 days and nights while continuing with their usual activities. In addition,
they were asked to complete a diary of their sleep onset and wake times daily. This ensured
that any small changes in onset and offset of sleep were captured during the recording period.
Following the download of the devices, the combined sensor heart rate data was cleaned and
non-wear periods identified by the combination of non-physiological heart rate and prolonged
periods of no movement [402]. All signals from the triaxial accelerometers were re-sampled to
a uniform 100Hz signal by linear interpolation, and then calibrated to local gravity using a well-
established technique [403, 404]. Periods of non-wear were classified on the basis of windows
comprising an hour or more wherein the device was inferred to be completely stationary,
where stationary is defined as standard deviation in each axis not exceeding the approximate
baseline noise of the device itself (13·milli-g). All non-wear periods were removed from
the analysis. Additionally, pitch, roll and z-angles for all three accelerometry devices were
calculated enabling postural assessments and direct comparisons to previously established
approaches which only rely on acceleration data [113, 390]. The residual acceleration signal
can be interpreted as a measurement of the rotated gravitational field vector which can then
be used to determine the accelerometer’s orientation angles (the conventional pitch and roll
and z-angle, defined as the dorsal-ventral direction [113, 390]). Angles for each device were






























The accelerometry and heart rate signals were summarized to a common time resolution of
one observation per 30 seconds and the time-series were aligned. Participants were excluded
from the final analysis if they had less than 72 hours of concurrent wear data (three full days of
recording from all four devices). Participants with less than 3 nights of concurrent wear and
diary data were excluded from the final analysis. After these pre-processing steps the resulting
analytical sample was of 158 participants. Three of these participants were on cardioreactive
medication and two were taking betablockers.
4.3.1.2 MESA
The MESA Sleep Study was conducted using a Compumedics Somte System for PSG, which
includes the ECG signals here used to derive HR and HRV and their associated features,
alongside an Actiwatch Spectrum from Philips Respironics (Pennsylvania, USA) to record
actigraphy data. This device captures measurements of movement defined as “activity counts”2
and aggregates them into 30 second epochs. The Actiwatch was securely fastened to partic-
ipant’s non-dominant wrist. These actigraphy signals and their associated features can be
derived in most research-grade wearable devices. The sensors for the Compumedics PSG com-
prised: cortical EEG, bilateral EOG, chin EMG, abdominal and thoracic respiratory inductance
plethysmography, airflow, ECG, leg movement sensor and finger pulse oximetry. These sensors
collected three types of signals: bioelectrical potentials (EEG, EOG, EMG, ECG), waveforms
received from transducers (thermistors on the airflow devices, inductance respiratory bands,
piezo leg sensors and position sensors from the leg device) and auxiliary devices (oximetry
measures of oxyhemoglobin saturation and nasal pressure records). Full details of the setup,
protocol and sampling rates are available3,4. All participants included in our study had at least
one full night of PSG recording with concurrent actigraphy and ECG. All nocturnal recordings
were transmitted to a centralized reading center at the Brigham and Women’s Hospital (Boston,
MA, USA) and data was scored by trained technicians using AASM guidelines.
For this study, we synchronized PSG, ECG and actigraphy records into 30-second sleep epochs
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participants were excluded on the basis of: (1) lack of concurrent PSG, ECG and actigraphy
data; (2) lack of sufficient quality standard data (< 3 h of usable data from the concurrent three
sensing methods); or (3) lack of data integrity or misalignment of data, removing the resulting
actigraphy outlier epochs based on human expert annotations. These outliers resulted from
either non-wearing periods or equipment failure periods. For actigraphy epochs labeled as
outliers, their corresponding HR/HRV epochs were also removed [405]. Further, to ensure that
our evaluation was fair, we only included participants who had at least 30 minutes of wake
time prior to sleep onset and a maximum of 240 minutes after sleep offset, resulting in a total
of 1,183 participants.
To obtain HR information, we used the QRS complexes (R-points) detected using Com-
pumedics Somte (Abbotsford, VIC, Australia) software Version 2.10 (Builds 99 to 101). The
R-points were classified as normal sinus, supraventricular premature complex or ventricular
premature complex. For the data cleaning, filtering and noise removal, we used the Python
package HRV-analysis5. First, RR interval outlier data was filtered using a threshold method,
with a range between 300 to 2000 ms, based on the approach previously described by Tanaka
et al. [351], then ectopic beats were removed by through the methods described in Malik et
al. [352]. After this step was completed, we linearly interpolated the removed R-points and we
grouped the RR intervals into 30 seconds epochs.
4.3.1.3 PhysioNet Apple Watch
For the PhysioNet Apple Watch study, Apple Watch raw triaxial acceleration data (x,y,z axis
measured in g) at a 50Hz resolution was converted into postural based metrics like the ones
described on BBVS.
The Apple Watch measures HR in beats per minute, sampling every several seconds through
its PPG sensor. For our analysis, we down-sampled HR to 15-second resolution. For the
PhysioNet Apple Watch study, the laboratory technicians started a "recording" period for the
watch before the PSG recording started. For our final analysis, we only included participants
whose sleep onset and offset were greater than 10 minutes from the start and end of the
recording period, respectively. Through this process we intended to introduce a more realistic
setting for our model. Details on the laboratory PSG settings can be found elsewhere [392].
The final cohort consisted of 22 partipants.
4.3.1.4 MMASH
The 22 MMASH participants were fitted with two devices for continuous recording during 2




beat-to-beat intervals and was used to obtain HR data and a triaxial accelerometer (ActiGraph
wGT3X-BT - ActiGraph LLC, Pensacola, FL, USA) was worn on the wrist. Participants were
asked to wear the devices continuously during the duration of the protocol and to complete a
diary of their sleep onset and wake up times during the recording period. For MMASH we
followed the same pre-processing, data quality and noise removal protocols that we described
in BBVS for both the triaxial accelerometry signal and the HR signal. Two participants were
removed from analysis on the basis of missing diary entries.
A description of the cohorts we analysed and the wearable devices used to record data in each
study is available in Table 4.1.
Table 4.1 Summary of population size and devices used in the different datasets.
Study # Participants Sensor type Wearable device make PSG Sleep Diary











Actiwatch Spectrum, Philips Respironics (PA,USA) ✓ ✓
PhysioNet Apple Watch 22
Triaxial accelerometer
Heart rate sensor (PPG)
Apple Watch (Series 2,3), Apple (CA, USA) ✓
Multilevel Monitoring of Ac-





ActiGraph wGT3X-BT, ActiGraph LLC (FL,USA)
Polar H7, Polar Electro Inc (NY,USA)
✓
4.3.2 Algorithm to estimate the sleep window using heart rate
Several challenges must be accounted for when developing a method for the detection of
sleep in free-living conditions. First and foremost, most methods derived for sleep-wake
classification using wearable devices have been derived on and for use during the night period
[385, 384, 223, 255, 392]. These approaches were mostly conducted in small studies using
concurrent PSG and as such, their application during the full day period greatly compromises
the quality of the results. They also tend to be optimized in small, non-diverse populations,
comprising their generalizability to other cohorts. Moreover, they tend to be device and
make specific, often requiring conversions into arbitrary activity intensity measures or counts.
Finally, most algorithms that can be applied during the 24 hour period require sleep diaries or
questionnaires for guidance, which are often biased and burdensome to obtain [406].
Here we introduce a simple approach to estimate sleep window leveraging the HR sensing
capabilities that most modern wearables have. One of the major challenges presented by large
cohort studies is inter-individual differences. For instance, individuals who are fitter, tend
to have lower resting heart rates than those who are not as fit [99]. Hence, an approach that
relies on HR signals should not follow a one size fits all, but rather adapt to each individuals’
own heart rate profiles. To account for these considerations, we use the empirical cumulative
distribution function (ECDF) of each individual’s daily heart rate profile. This function, F (x),
is the probability that for each individual their heart rate takes a value x such that:
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F (x) = P (Xi ≤ x0), (4.4)
for every sequence i = 1, ..., n. Namely, F (xo) is the probability of the event {Xi ≤ x0}. In
this case, x0 is a threshold heart rate value (in beats per minute). To estimate the probability of
a given event, we turn to the ratio of such an event given an individual’s daily sample of heart
rates. This results in:
F̂n(x0) =
number of Xi ≤ x0
total number of observations
=
∑n






I(Xi ≤ x0) (4.5)
as the estimator of F (xo), that is the ratio of HR less than x0, where I() is the indicator
function.
Thus, for every x0, we can use such quantity as an estimator, so the estimator of the cumu-
lative distribution function, F (x) is F̂ (x), which is referred to as the empirical cumulative
distribution function.
By using the HR cumulative distribution function for each participant and each day of recording,
our method accounts for inter- and intra-individual variation. It can adjust to different levels of
fitness which often result in different resting HR during sleep [99]. Further, an elevated resting
heart rate (RHR) accompanied by a fever is a well-known response to infection [407], alcohol
consumption [408], stress [409] and can even be used to monitor influenza-like illness [410],
something that our approach would account for. The method contains no in-built assumption
of absolute time for the sleep window, and can therefore be used in night shift-workers and
non-monophasic sleepers (those whose have more than one principal sleep windows in a 24-
hour period) where the circadian HR rhythm is shifted so that most of the lower HR values still
occur during sleep independent of the absolute time window when their sleep takes place. An
example of our method applied to a shift worker can be observed in Supplementary Figure 4.9.
The first step of our heart rate sleep algorithm involves pre-processing the time series by
assigning binary wake/sleep labels whenever the participant’s heart rate dips above/below a
specific quantile threshold (Q). The threshold value is calculated from the ECDF over 24-hour
windows arbitrarily starting at 15:00 each day. Figure 4.3 showcases this cutoff for the full
BBVS population based on two intervals (full day and from 21:00 to 11:00, a conventional
night).
Wake/Sleep labels are then smoothed with a 5-minute rolling median and the length of their
sequences is calculated. Sequences of sleep labels that are longer than a minimum length (L)
are extracted and merged with other sleep sequences if their gap is smaller than a pre-defined
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length (G). These Q, L and G parameters where optimized for each dataset with the goal of
finding the best possible combination.
To be eligible as part of the final sleep window, the sleep sequence must not be preceded by
more than 90 minutes of wake in the previous 4 hours of recording. The limits of the merged
sleep sequences then guide a search (in a window starting 240 minutes before and 60 minutes
after) for epochs with high HR volatility. This HR volatility threshold is defined as a rolling
10-epoch standard deviation of the HR signal of 6 beats per minute. Defining the final sleep
window limits as the last, and first high volatility epochs for sleep onset and offset, respectively,
is meant to increase the algorithm’s sensitivity at discriminating sedentary time just before or
after sleep (e.g. reading in bed) from the sleep window itself.
Finally, the algorithm also labels naps and awakenings, but these were not used in the analysis
of the present datasets. Naps are the initial sleep sequences that lie outside a buffer 180-minute
window either side of the main sleep window. For awakenings, the algorithm labels all the
epochs when the HR rises above a quantile threshold AV extracted from the daytime (8am -
10pm) HR ECDF. From these only the sequences longer than 5 minutes are kept and then the
sequences separated by less than 5 minutes of sleep are merged and then labeled as the final
awakenings.
Figure 4.1 Heart rate sleep algorithm description. The approach can be broken down into
three distinct steps. The first step, involves obtaining the wearable sensor HR data, pre-
processing that data and setting initial sleep blocks through ECDF quantile thresholds Q.
Blocks longer than L minutes are kept and merged with other blocks if their gap is smaller
than G minutes. We extract the limits of the resulting blocks as sleep candidate for sleep
onset and offset. Next, rolling heart rate volatility is used to refine these candidate times by
finding nearby periods where this volatility is high. Finally, nap and awakenings are labeled,
the former coming from the candidate sleep blocks not included in the largest sleep window,
while the latter are short periods (<60 minutes) within the sleep window when the heart rate
exceeds the daytime threshold. A detailed description of this algorithm and parameters used
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Pseudocode for the approach is provided in the Supplementary of this Chapter. A visual
overview of the algorithm is provided in Figure 4.1 and Figure 4.2 showcases the application
of the algorithm to a random participant trace.
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Figure 4.2 Heart rate sleep algorithm in action for a participant chosen at random. The
first step involves setting initial sleep blocks through ECDF quantile thresholds (in this experi-
ment, Q = .35). Blocks longer than L = 40 are kept and merged if the gap between blocks is
smaller than G = 60 minutes. We extract the limits of the resulting blocks as candidate state
changes. The bottom panel highlights the use of rolling heart rate volatility to refine these
candidate times by finding nearby periods where this volatility is high. The resulting candidate
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Figure 4.3 Cumulative distribution function for BBVS heart rates. (A) shows the HR
ECDF for the full day across all participants and all days, (B) shows the HR ECDF for the
periods of 21:00 to 11:00. The yellow dotted line shows the 0.35 cutoff for full-day and 0.55
for night-only and how for both time periods the HR profiles within those cutoffs are similar.
Each individual line represents one participant for one day of recording.
Quantile cutoffs for HR sleep algorithm






4.3.4 Validation of the proposed approach
We used the four previously described cohorts to validate our method against gold-standard
measures of sleep using PSG (MESA, Apple Watch PhysioNet) and detailed silver-standard
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measures through sleep logs, as opposed to habitual sleep diaries which could be subject to
recall bias (BBVS, MMASH). Although an ideal experimental protocol would have multiple
days of PSG and free-living wearable sensor data, detailed sleep logs allowed us to evaluate
the algorithm across more than one or two nights, showcasing the strength of our method at
discerning both inter- and intra-individual variability.
We performed epoch by epoch evaluation on all four cohorts and derived comparisons regarding
the performance of our method with regards to total sleep time (TST), sleep onset and sleep
offset time.
4.3.4.1 Evaluation metrics
The following performance metrics were used to evaluate against the ground truth in each
study: differences in onset, waking time, total sleep block duration (minutes), mean square
error (MSE) and Cohen’s kappa. We evaluated our algorithm systematically for individual HR
CDF quantiles 0.25-0.9, window lengths of 25-50 minutes and time merge parameters between
0.5-6 hours, optimizing for MSE.
We defined MSE as:
MSEalgo,diary =








where algo and diary are the binary labels for that epoch (1 for sleep, 0 for wake) out of n
minutes in each subject’s heart rate time series. Epoch length is specified by the different study
cohorts (1 minute in BBVS, 30 seconds in MESA and 15 seconds in both PhysioNet Apple
Watch and 5 seconds in MMASH). Thus, if the sleep windows found by the HR algorithm
match the ground truth labels exactly, MSE = 0. If the algorithm labels all epochs as wake,
then MSE is the proportion of sleep in the time series according to ground truth, while if
the algorithm and ground truth labels diverge entirely, MSE will be the sum of their sleep
proportions out of the total time series. For all four cohorts we performed systematic parameter
optimization for best MSE on the basis of quantile, window length and window merge values.
We also computed cohen’s kappa, which is used to determine the classifier agreement with
ground truth (PSG or sleep diary), relative to chance [411]. Cohen’s kappa is calculated
through (po − pe)/(1 − pe), where po stands for the percentage of observed classifications
with agreement, and pe is the percentage of classifications from hypothetical chance agreement.
Finally, tests of statistical significance were conducted using a two-tailed t-test [412].
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4.3.4.2 Evaluation with sleep diary and postural change: BBVS
In the BBVS study, participants wore a variety of wearable devices and recorded the time
they went to bed and woke up on a daily basis, providing detailed sleep diaries. As such, we
conducted two types of evaluations on this cohort.
Evaluation with sleep diary. First, we compared the performance of our method against those
sleep diaries. For our evaluation, we only included participants who had filled out those diaries
and had more than three days of concurrent sensing and diary data. We evaluated our model
against the diaries in terms of total sleep time, sleep onset and offset.
Evaluation with angle change algorithm. We assessed the performance of our approach
versus an angular change algorithm inspired by previous work [390, 113]. The angular change
approach started with calculating the pitch and roll using triaxial acceleration for the device
being evaluated. To isolate the gravitational acceleration for each axis, we applied a low-pass
filter (0.2 Hertz) to each of the three axes (X, Y and Z) of every recording being evaluated.
Pitch, roll and z-angles were then calculated and the difference between successive epoch
values was then smoothed using a 5 minute median rolling window. A threshold method (<
10th percentile of values in that given day · 15) was applied to both columns, dividing the time
series into initial sleep and wake blocks.
Of these blocks, only those larger than 30 minutes were kept. Blocks separated by less than 60
minutes were then merged and the largest block was deemed as the main sleep block within
the day.
Two different angular change evaluations were performed, first, the intersection of the epochs
when both pitch and roll calculations agreed on a sleep label created a voting system for a
more reliable final sleep window. Alternatively, z-angle only measures were used to generate
those sleep metrics. All the previous steps were done separately for each limb (dominant and
non-dominant wrists, and thigh) on which BBVS participants wore a device.
In BBVS, HR is recorded continuously across the 24-hr period. Thus, the threshold quantile is
expected to be lower the longer the sampling interval for the ECDF given that sleep occupies a
smaller proportion of the total interval being evaluated. To evaluate the effect of the chosen
ECDF, we analyzed the optimal thresholds and parameters for both full-day and night-only
(9PM to 11AM) and their associated results to better understand how experimental design may
affect the performance of our approach.
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4.3.4.3 Evaluation with polysomnography and sleep diary: MESA.
Evaluation with polysomnography. The recording time for PSG started when the subject’s
setup was complete, yielding a period of sedentary wakefulness prior to sleep onset. While in
an ideal scenario the participant would have been subject to ground truth recording also during
the day, this is not a possibility given the nature of PSG. However, this limitation was addressed
by evaluating PSG against sleep diary on the same dataset and evaluating our approach against
both PSG and diary data. For this evaluation we compared the resulting sleep blocks from
PSG, defined as epochs where the participant was in either NREM (N1, N2, N3) or REM sleep,
to the sleeping window obtained through our HR algorithm.
Further, in MESA, we explored how our algorithm performed in healthy participants versus
participants with sleep disorders. To do so, we first evaluated in the full cohort (n=1,210) and
then on the subset of participants with (n=199) and without (n=1011) any sleep disorders. The
goal of this analysis was to caution and inform about potential limitations that our method may
have when evaluating in diseased participants.
Evaluation with sleep diary. PSG derived sleeping windows were compared to sleep diary
records in the MESA cohort. This comparison allowed us to further understand the deviations
of habitual self-reported sleep to objectively monitored, ground-truth through PSG. For the
evaluation we use the same metrics as previously explored in the evaluation against PSG.
4.3.4.4 Evaluation with polysomnography and postural change: PhysioNet Apple Watch
Polysomnography Study.
Evaluation with polysomnography. The PhysioNet Apple Watch study provided a unique
opportunity to test our method in a commercial-grade wrist-worn wearable sensor that was
concurrently worn during PSG. For this study, we used the same evaluation method explored
in MESA, exploring our method based on the night-time concurrent recordings of wearable
HR and PSG.
Evaluation with angle change algorithm. Given the multimodal nature of the study, we
evaluated both the HR based algorithm and the angular change based algorithm on this
population. For this evaluation we followed the same procedure as previously described on
BBVS.
4.3.4.5 Evaluation with sleep diary and postural change: MMASH.
In the MMASH study, participants wore an HR strap and triaxial wrist accelerometer and
recorded detailed sleep diaries including the time they fell asleep and woke up, which was
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filled on a daily basis. For this cohort, we also conducted two types of evaluation following the
procedures used during the BBVS evaluation.
Evaluation with sleep diary. First, we compared the performance of our method against the
sleep diaries of each participant. We evaluated our approach against the sleep diaries in terms
of total sleep time, sleep onset and offset.
Evaluation with angle change algorithm. Similar to our second evaluation in BBVS, we





Full descriptions of the population samples and devices included in our analyses are provided
in Table 4.1.
4.4.1 Evaluation of the algorithm in the BBVS
The results of the evaluation on the BBVS study are summarized in Table 4.2. Our HR
algorithm estimated TST on average 0.60 minutes less than those reported through sleep diary.
For the full-day protocol the optimal quantile was 0.35 yielding an MSE of 0.06. On the other
hand, the night-only HR analysis had an optimal quantile of 0.55 also resulting in an MSE
of 0.06. The angular change approach had an underestimation of 125.37 minutes on the best
performing wrist-worn device (non-dominant wrist). The results across all three accelerometers
for this approach were comparable as summarized in Supplementary Table 4.7, each yielding
an MSE of 0.10.
Our HR model estimated sleep onset on average 24.86 minutes later than sleep diary while the
angular change approach resulted in an average of 85.4 minutes earlier. For sleep offset, our
HR algorithm the estimation was on average 5.18 minutes earlier while for the angular change
approach that estimation was 64.01 minutes for the device that yielded the best results (thigh).
We also examined how night-only versus full-day evaluation influenced our results and resulted
in different optimal parameters, particularly ECDF thresholds. These results are summarized in
the Supplementary Table 4.8 and figures summarizing the results of this search for the BBVS
cohort (both full-day and night-only) can be found in the Supplementary (Figures 4.7 and 4.8).
Finally, modified Bland-Altman plots for the HR and angle approaches against sleep diary for
the BBVS cohort are presented in Figure 4.4.
Table 4.2 Comparison of HR and angle change algorithm performance for the BBVS
dataset. In this table, the angle change algorithm presented was applied on data from the
device worn on the non-dominant wrist (ndw). Results for devices worn on other limbs are
available in the Appendix.
Sleep parameter Metric HR Algorithm Angle change algorithm (ndw) p-value
Value (mean ± 95% CI) Value (mean ± 95% CI)
Total sleep time
Time difference (minutes) -0.60 ± 0.21 125.37 ± 0.26 < 0.00
MSE 0.06 ± 0.00 0.10 ± 0.00 < 0.00
Cohen’s kappa 0.86 ± 0.00 0.76 ± 0.00 < 0.00
Sleep onset Time difference (minutes) 1.14 ± 0.20 -60.17 ± 0.21 < 0.00
Sleep offset (Wake Up) Time difference (minutes) 0.54 ± 0.16 65.20 ± 0.20 < 0.00
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Figure 4.4 Modified Bland-Altman plot for BBVS. Modified Bland-Altman plot on the left
shows the TST differences (delta) between the HR algorithm and diary in the y-axis and the
x-axis shows the TST average for every participant. The figure to the right shows the same
comparison for the angle algorithm and diaries in BBVS. TST: total sleep time
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Bland-Altman plot comparing the HR algorithm and Diary.
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Bland-Altman plot comparing Angle Alg. (ndw) and Diary.
Figure 4.5 Example participant (chosen at random), showcasing estimated sleep through
the heart rate sleep window algorithm, sleep diary sleep onset and offset and angle
changes for both wrists and the thigh accelerometers. The algorithm picks up subtle
sleep regularity differences at a participant level. This approach overlaps more closely to
the sleep diary than any of the accelerometer-based approaches. Notice for the angle change
approach the algorithm is more effective on the non-dominant wrist accelerometer than on the
dominant wrist or thigh accelerometer for most nights. TST: total sleep time
Angle algo sleepHR algo sleepDiary sleepHR pitch roll
4.4.2 Evaluation of the algorithm in the MESA study
In MESA, we evaluated our algorithm against polysomnography for the full population, the
subset of the population that were deemed healthy sleepers and those that were diagnosed with
sleep disorders, a full breakdown of the results is presented in Table 4.3. Further, we evaluated
the performance of sleep diaries against polysomnography in this study as well. Modified
Bland-Altman plots for both the evaluation of our method against PSG and the diaries are
presented in Figure 4.6.
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Table 4.3 Results for the MESA dataset. Both HR algorithm and sleep diaries are evaluated
against PSG. Results are also shown for the subset of healthy participants and participants with
sleep disorders.
Sleep parameter Metric HR algorithm Sleep Diary p-value
Value (mean ± 95% CI) Value (mean ± 95% CI)
Full cohort (n = 1154)
Total sleep time
Time difference (min.) -33.15 ± 0.12 -34.04 ± 0.18 0.756
MSE 0.10 ± 0.00 0.13 ± 0.00 < 0.00
Cohen’s kappa 0.66 ± 0.00 0.62 ± 0.00 < 0.00
Sleep onset Time difference (min.) 23.39± 0.10 6.25 ± 0.11 < 0.00
Sleep offset (Wake Up) Time difference (min.) -9.76 ± 0.08 -27.79 ± 0.16 < 0.00
Healthy participants (n = 965)
Total Sleep Time
Time difference (min.) -27.46 ± 0.28 -23.75 ± 0.42 0.605
MSE 0.10 ± 0.00 0.13 ± 0.00 0.004
Cohen’s kappa 0.65 ± 0.00 0.60 ± 0.00 0.073
Sleep onset Time difference (min.) 21.68 ± 0.23 6.92 ± 0.25 0.002
Sleep offset (Wake Up) Time difference (min.) -5.78 ± 0.20 -16.84 ± 0.37 0.084
Participants with sleep disorders (n = 189)
Total Sleep Time
Time difference (min.) -34.27 ± 0.13 -36.05 ± 0.19 0.565
MSE 0.10 ± 0.00 0.13 ± 0.00 < 0.00
Cohen’s kappa 0.66 ± 0.00 0.62 ± 0.00 < 0.00
Sleep onset Time difference (min.) 23.73 ± 0.11 6.12 ± 0.12 < 0.00
Sleep offset (Wake Up) Time difference (min.) -10.54 ± 0.09 -29.93 ± 0.17 < 0.00
Figure 4.6 Modified Bland-Altman plot for MESA. Modified Bland-Altman plot on the left
shows the TST differences (delta) between the HR algorithm and PSG in the y-axis and the
x-axis shows the TST average for every participant. The figure to the right shows the same
comparison for the sleep diaries and PSG in MESA. Further, healthy participants are color
coded in blue for both plots and participants that were diagnosed with sleep disorders are
shown in orange.
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The results in MESA reflect that our HR algorithm yields better performance to that of sleep
diaries in terms of MSE for the full population (0.10 vs 0.13 MSE) as well as for the subset of
the population with sleep disorders and healthy participants (0.10 vs 0.13 MSE). For all three
analysis the best quantile was 0.85, likely due to the short amount of wake and active time
in the recordings. The time differences in total sleep time are slightly less for the sleep diary
(-34.04 versus -33.15 in the full population). Interestingly, while the time difference for sleep
onset was around 20 minutes for the algorithm, it was only around 6 minutes for the sleep
diary. In contrast, the algorithm approach fared much better at inferring sleep offset (between
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-5 and -10 minutes of time deviation) whereas the diary underestimated sleep offset by almost
30 minutes. Finally, the algorithm approach yielded a stronger Cohen’s kappa for all three
sub-analysis than the sleep diary.
4.4.3 Evaluation of the algorithm in the PhysioNet Apple Watch Polysomnog-
raphy study
Our algorithm was applied to data obtained from a commercial, readily available wrist-worn
wearable and evaluated against gold-standard measures of sleep obtained with PSG. In this
cohort, we evaluated both the HR algorithm and the angle change approach given the presence
of triaxial accelerometry. The HR algorithm resulted in an MSE of 0.06 while the wrist-based
angular change approach yielded an MSE of 0.12. Similar to MESA, the best performing
quantile threshold was 0.8. This high quantile is likely due to the nature of the evaluation
protocol consisting of concurrent PSG and wearable without much out of bed activity. Total
sleep time deviation was of -23.23 minutes for the HR approach and 44.39 for the angle change
approach. Sleep onset time deviation was of 15.12 minutes for the HR approach and of -21.77
for the angle change approach, while the difference was of -8.10 and 22.61 for sleep offset.
However, Cohen’s kappa was slightly lower for the HR approach (0.67) than for the angle
change algorithm (0.71). These results are summarized in Table 4.4.
Table 4.4 Results for the PhysioNet Apple Watch dataset. The table presents results for
both the HR and angle change algorithm for total sleep time, sleep onset and sleep offset in the
PhysioNet Apple Watch dataset. ndw: Non-dominant Wrist
Sleep parameter Metric HR Algorithm Angle change algorithm (ndw) p-value
Value (mean ± 95% CI) Value (mean ± 95% CI)
Total sleep time
Time difference (min.) -23.23 ± 0.42 44.39 ± 1.30 0.003
MSE 0.06 ± 0.00 0.12 ± 0.00 0.191
Cohen’s kappa 0.67 ± 0.00 0.71 ± 0.00 0.656
Sleep onset Time difference (min.) 15.12 ± 0.16 -21.77 ± 0.96 0.021
Sleep offset (Wake Up) Time difference (min.) -8.10 ± 0.39 22.61 ± 1.00 0.058
4.4.4 Evaluation of the algorithm in the MMASH study
Our final set of evaluations took place in the MMASH cohort, which included both HR and
triaxial accelerometer data recorded continuously for full-day periods. As in BBVS, we
evaluated both the proposed HR approach and the angle change approach against detailed
sleep diaries. We found that the results validated the findings from BBVS, resulting in the
same optimal quantile (0.35) yielding an MSE of 0.07 and total sleep time difference of -14.08
minutes, with a cohen kappa of 0.85 for the HR approach. On the other hand, the angle change
approach resulted in an MSE of 0.08 and cohen kappa of 0.83, but the total time deviation was
substantially worse, yielding a total sleep time difference of -60.17 minutes. Full results for
the MMASH cohort are presented in Table 4.5.
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Table 4.5 Results for the MMASH dataset. The table presents results for both the HR and
angle change algorithm for total sleep time, sleep onset and sleep offset in the MMASH dataset.
ndw: Non-dominant Wrist
Sleep parameter Metric HR Algorithm Angle change algorithm (ndw) p-value
Value (mean ± 95% CI) Value (mean ± 95% CI)
Total sleep time
Time difference (min.) -14.08 ± 1.26 -60.17 ± 1.18 0.002
MSE 0.07 ± 0.00 0.08 ± 0.00 0.344
Cohen’s kappa 0.85 ± 0.00 0.83 ± 0.00 0.366
Sleep onset Time difference (min.) -15.75 ± 0.68 15.13 ± 0.62 0.013
Sleep offset (Wake Up) Time difference (min.) -29.83 ± 0.97 -45.04 ± 1.08 0.022
4.5 Discussion
Objective and unobtrusive measurement of sleep in large, free-living populations at scale will
help facilitate epidemiological investigations powered to explore the relationships between
sleep, physical behaviours and disease. Concurrently, the rapid growth and adoption of
commercial grade wearable devices offers a unique opportunity for the objective monitoring
of sleep at scale. However, most commercial devices use algorithms that are not open-source
or do not report thorough validation against gold-standard measures. Similarly, conventional
algorithms tend to rely on device specific metrics, such as counts, requiring extensive adaptation
for each device and cohort tested, as well as a predefined search window through expert
annotations or sleep diaries. This often renders evaluation across devices and without sleep
diaries futile.
Here we introduced a device agnostic algorithm that exploits the HR sensing capabilities
present in most modern wearable devices. We presented an algorithm based on a personalized
HR feature that allows detection of sleeping windows under free-living conditions. The
proposed method relies on the well-established changes in HR that occur when individuals
transition from wake to sleep [413]. Hence, it is able to infer sleep on individuals regardless
of fitness level or illness and can be used amongst shift workers who exhibit sleep episodes
outside of the night period. These qualities may be particularly relevant when evaluating
sleep in populations with fragmented sleep, in countries where sleep timing changes due to
seasonality or where cross-cultural sleep differences are observed [414]. The value of this
approach lies in the fact that it is device-agnostic, does not require sleep diary or questionnaire
data and adapts to inter- and intra-individual (day-to-day) variability, allowing for accurate and
reliable sleep window labeling.
We evaluated our HR-based algorithm in four cohorts: BBVS, MMASH, PhysioNet and MESA.
Both BBVS and MMASH include free-living HR, movement and sleep diary data for multiple
days. By contrast, PhysioNet and MESA provide lab-based HR data and gold-standard PSG.
Our aim was to evaluate the algorithm’s performance in free-living conditions in the first two
cohorts and compare it to existing measures that could be leveraged in these cohorts, whilst
using the last two cohorts to evaluate its validity against gold-standard measures. Further,
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through this process, we aimed to identify the range of parameters (Q, L, G) that produce the
best results in free-living conditions, allowing for application and deployment in the absence
of any ground truth.
For the first evaluation in the BBVS study, we found that the proposed method performed
strongly in free-living conditions, with an average time deviation for total sleep time compared
to non-habitual sleep diaries of -0.6 minutes. In this study, we performed optimal parameter
search using both full day measures of HR as well as night-only measures to analyze how the
availability of sensor data or the design of the experiment affect the choice of best parameters.
The parameter search for the optimal MSE was performed based on quantile, window merge
and window length values and are presented in Figure 4.7. We found that the optimal parameters
for this cohort were 0.35 for the quantile (Q) and 30 minutes for the window length (L) and
time merge block of 120 minutes (G). This resulting optimal quantile also makes intuitive
sense as it represents about 8h, which is around the expected time spent sleeping for most
individuals.
The algorithm performed better at detecting sleep offset (wake up), than sleep onset, yielding
a time difference of 0.54 and 1.14 minutes respectively. This may be due to the fact that the
sleep logs for validation of sleep onset and offset, while more detailed than traditional sleep
diaries, rely on self-report and may not be wholly accurate. While sleep offset is relatively
straightforward to annotate as most people wake up with alarm clocks, the exact time of sleep
onset cannot be recorded, and is prone to measurement bias, if attempted at the time, or recall
bias, if filled in the next day. Thus, the quality of self-reported sleep may vary based on the
sleep onset latency of each participant for each given night. Nevertheless, the performance of
the method across a diverse population and multiple nights of recording showcases its potential
for free-living applications.
Finally, in the BBVS cohort, we evaluated the performance of an angle change-based algorithm
inspired by previous work [390, 113] leveraging the multiple accelerometers available to
evaluate postural changes. We found that this approach is valuable, but the results were more
modest than those of our proposed method, yielding a total sleep time MSE of 0.10 and a time
deviation of 125.37 minutes for the non-dominant wrist device. We also found that using the
combined pitch and roll approach versus only the z-angle did not significantly alter the results.
In sum, while valuable, the angle change approach performed significantly worse than our
HR-based algorithm in the BBVS cohort. These results suggest that when HR is available,
it should be used in preference, but triaxial accelerometry is a valuable second option in the
absence of HR.
The algorithm was also evaluated in the MESA cohort, a large, diverse population where
gold-standard PSG sleep measures through PSG were available, alongside self-reported sleep
(through sleep diaries). In MESA we optimized the method to minimize MSE and additionally
evaluated it in subsets of population with and without sleep disorders, yielding the results
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reported in Table 4.3. In MESA, the deviation of total sleep time versus gold-standard
measures of sleep was -33.15 minutes and MSE of 0.10 for the full population, whereas the
same comparison between PSG and sleep diaries yielded a total sleep time deviation of -34.04
minutes and MSE of 0.13. This shows that our HR-based method can reliably and objectively
monitor sleep in the absence of PSG and performs better than sleep diaries. It is also worth
noting that the HR approach was significantly better at detecting sleep offset (wake up) with
a time difference versus PSG of -9.76 minutes compared to the -27.79 of the diaries. These
results further highlight that our algorithm can be used in the absence of sleep diaries and also
shows superior performance in terms of MSE to conventional, habitual sleep diaries in this
large cohort. Furthermore, the comparable results for the analysis carried out in the subset
of the cohort with formally diagnosed sleep disorders point to the fact that our method may
also be valuable when monitoring sleep in people suffering from these conditions. To the best
of our knowledge, this is the first study that conducts these types of sensitivity analyses on
a subset of disease subjects to show the validity of the proposed method in individuals who
suffer from sleep disorders. Future work should carry more through validation on a larger
population sample with sleep disorders to confirm these findings.
For the MESA cohort, recording in laboratory conditions and for less than 24 hours produces an
HR ECDF that is different in shape from free-living conditions. The scarcity of non-sedentary
activities means that the optimum quantile (Q) threshold needs to be higher to preserve its
sensitivity at detecting sleep versus sedentary periods (optimum quantile of 0.85). This could
have potentially constrained the performance of our method in this population. Future studies
should explore continuous recording of HR during the day paired with full-PSG to test the
validity of our method in a similar setting to that of BBVS or MMASH.
We further examined the performance of the HR algorithm in the PhysioNet Apple Watch
cohort that recorded concurrent Apple Watch data and a night of PSG. This study followed
a similar experimental protocol to that of the MESA study. In this cohort, the HR algorithm
yielded an MSE of 0.06 and a time-deviation of -23.23 minutes when compared to gold-
standard measures of sleep through PSG. Similar to MESA, the optimal quantile (Q) was
quite high (0.8, with 0.85 producing the same results), which is likely due to the nature of the
experimental setting where the Apple Watch recording period only started when the PSG was
setup. Nevertheless, these results showcase the potential of the method in commercial-grade
wearable devices that obtain HR through PPG. We also examined the angle change approach
in this cohort, with this method performing less well than it did in BBVS, yielding an MSE of
0.12 and a total sleep time deviation of 44.39 minutes.
Finally, we validated our method in the MMASH cohort, where free-living HR, movement and
sleep diary data was available. In this cohort, our algorithm’s performance was optimal using a
0.35 quantile (Q) and window length (L) of which is the same result obtained for BBVS. Our
HR approach yielded an MSE of 0.07 and a total sleep time deviation of -14.08. The angle
change approach resulted in an MSE of 0.08 and total time deviation of -60.17. Our results in
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MMASH confirm the strong validation performance we observed in BBVS when using our
algorithm in free-living conditions across multiple days of recording. Based on the results
obtained in BBVS which were then validated in MMASH, in free-living conditions a quantile
(Q) of 0.35 lead to the best MSE results. Similarly, we recommend using a window length
(L) in the range of 30-45 minutes and a merge block (G) in the range of 60-240 minutes as
summarized in the pseudocode 1 formulation of our approach. These values can be used as
priors for our algorithm an can be further fined tuned in the presence of ground truth.
One important limitation of the BBVS and MMASH studies is that they did not include
PSG-derived ground truth sleep annotations. Although an ideal experimental protocol would
have multiple days of PSG and free-living wearable sensor data, detailed sleep logs allowed us
to evaluate the algorithm across more than one or two nights, showcasing the strength of our
method in discerning both inter- and intra-individual variability. Similarly, the accelerometers
included in these studies offer an important perspective on postural changes and how they
compare to our proposed approach. Moreover, in ideal circumstances, HR for the full day
would have been available in both the MESA and PhysioNet cohorts, optimizing the results of
our approach by having exposure to non-sedentary wake behaviors. However, the results in
these two datasets showcase the validity of our approach even under constrained laboratory
conditions.
Future work should explore the robustness of the HR-based algorithm in cohorts such as
inpatients. As the algorithm relies on HR signals already monitored continuously for other
medical purposes, no additional accelerometer sensor would be required. Accurately labeling
sleep in inpatients is challenging due to other factors that influence the HR ECDF, such as
limited mobility, fever, medication, physiological and psychological stress, drug and alcohol
use and cardiovascular conditions. However, objectively monitoring sleep without additional
obtrusion could help improve sleep quality during hospital stays, which is a challenge for most
patients [415], and hence promote both healing and patient satisfaction. Moreover, optimization
of the angle change approach should be explored such that it can be used more reliably in the
absence of HR sensor data, in this investigation we limited our evaluation of this method to the
original parameters reported [390]. Parameter optimization could yield more generalizable
and stronger outcomes for this approach. Finally, our method could be used in collaboration
with some of the well-established activity-based approaches where multimodal settings are
present. For instance, using conditional programming traditional methods could complement
our approach in the detection of awakenings and assist in the derivation of conventional and
novel sleep metrics.
Remark: Overall, our work highlights the potential of HR to detect the sleeping window not
only in research and clinical contexts, but also in ecologically valid free-living conditions,
enabling the objective monitoring of sleep in large-scale populations without PSG labels or
sleep diary guidance. The low effort involved in collecting and analysing objectively inferred
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sleep data coupled with low exclusion rate due to technical issues, missed diary entries or
dropout would likely result in larger and more diverse study cohorts, as well as facilitating
long-term objective data collection. For instance, few studies have been able to properly test
the longitudinal, and likely synergistic, association between sleep quality and disease. Where
this has taken place, sleep data is often collected through questionnaires [416] or with short,
arbitrary follow-up periods. These studies could have missed long-term trends that significantly
influence health status over months or years.
In sum, our proposed method was shown to accurately infer sleep in both free-living and
laboratory conditions without the need for sleep diaries. As highlighted by Depner and
colleagues [417], our analysis and evaluation will help enable the translation of findings from
laboratory-based sleep studies into large-scale cohort studies and clinical trials, by providing
an objective, device agnostic method to monitor sleep without the need for sleep diaries.
Chapter 4: Supplementary
Table 4.6 Sleep Disorder Population details for the MESA study. The MESA study allowed
us to evaluate our method in a population which included sleep disorders with roughly the
same prevalence as that of in the general population.
Total subjects Healthy Sleep apnea Insomnia Restless Legs Syndrome
1743 1469 (84.3%) 132 (7.6%) 109 (6.2%) 78 (4.5%)
Table 4.7 Comparison of angle algorithm performance for the BBVS dataset by the limb
on which the device was worn. All participants wore devices on their dominant (dw) and
non-dominant (ndw) wrist as well as on their thigh. The best performance metrics were
obtained for the non-dominant wrist device, but thigh wearables gave the least time differences
overall in terms of total sleep time (TST), sleep onset and offset.
Sleep parameter Metric Angle change algorithm (ndw) Angle change algorithm (dw) p-value Thigh p-value
Value (mean ± 95% CI) Value (mean ± 95% CI) ndw-dw Value (mean ± 95% CI) ndw-thigh
Total sleep time
Time difference (min.) 125.37 ± 0.26 124.50 ± 0.26 0.814 118.68 ± 0.27 0.126
MSE 0.10 ± 0.00 0.10 ± 0.00 0.032 0.10 ± 0.00 0.002
Cohen’s kappa 0.76 ± 0.00 0.76 ± 0.00 0.039 0.75 ± 0.00 0.007
Sleep onset Time difference (min.) -60.17 ± 0.21 -58.19 ± 0.20 0.562 -54.66 ± 0.24 0.175
Sleep offset (Wake Up) Time difference (min.) 65.20 ± 0.20 66.32 ± 0.20 0.710 64.01 ± 0.23 0.756
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Algorithm 1 Method to estimate sleep periods based on Heart Rate.
Input: W - Wearable Data with Heart Rate Data
Q - Quantile Value (Default: 0.40)
L - Minimal window length (Default: 45)
G - Maximal gap interval in minutes to merge sleep windows (Default: 60)
Output: Sleep window inferences
Function HR_Algorithm:
/* Split data into “experiment days” from 3pm-to-3pm. */
WD = split_days(W, time=15)
for d ∈ D do
/* Extract HR data from wearable device */
HR = get_HR(Wd)
/* Calculate quantiles for day */
HRQ = calculate_quantile(HR, Q)
/* Get sequences that HR < HRQ */
SleepArrays = get_sleep_sequences(HR, HRQ)
/* Keep only sequences larger than W. */
for sleepArray ∈ len(SleepArrays) do




/* Merge Sequences if gap between them is smaller than G */
for i ∈ len(SleepArrays) do




/* Select Limits of merged Sleep Window */
for limit ∈ (onset; offset) do
Select searchWindow = (limit − 240epochs; limit + 60epochs)
HR Vol = get_rolling_std_dev(searchWindow, window = 10 epochs)
From searchWindow select epochs where HRV ol ≥ 6 beats per min and add to
highVolatilityList
end
/* Define final Sleep Window */
if onset select last epoch from highVolatilityList then
Overwrite limit as last epoch
end
if offset select first epoch from highVolatilityList then






Figure 4.7 Mean Square Error (MSE) results for Biobank Validation Study (BBVS) us-
ing the full-day Empirical Distribution Function method to detect sleep windows. The
MSE was calculated through evaluation against sleep diary. The Y axis represents the quantiles
tested for the analysis while the X axis are the window lengths. The optimal combination found
through this search was a quantile of 0.35, time merge block of 120 minutes and a window
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Table 4.8 Results of applying the HR algorithm on the BBVS dataset for both full-day
and night-only data.
Sleep parameter Metric HR algorithm (Full day) HR algorithm (Night only) p-value
Value (mean, 95% CI) Value (mean, 95% CI)
Total sleep time
Time difference (minutes) -0.60 ± 0.21 -8.47 ± 0.20 0.050
MSE 0.06 ± 0.00 0.06 ± 0.00 < 0.00
Cohen’s kappa 0.86 ± 0.00 0.87 ± 0.00 < 0.00
Sleep onset Time difference (minutes) 1.14 ± 0.20 0.48 ± 0.16 0.832
Sleep offset (Wake Up) Time difference (minutes) 0.54 ± 0.16 -7.98 ± 0.15 0.004
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Figure 4.8 Mean Square Error (MSE) results for Biobank Validation Study (BBVS) us-
ing the night-only Empirical Distribution Function method to detect sleep windows. The
MSE was calculated through evaluation against sleep diary. The Y axis represents the quantiles
tested for the analysis while the X axis are the window lengths. The optimal combination found
through this search was a quantile of 0.55, time merge block of 360 minutes and a window
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Figure 4.9 Applying the HR sleep algorithm on a shift worker. The free-living trace shows
the subtle changes for day of the week picked up by the algorithm, with 2 sleep windows
detected on Saturday, when they were not at work during the night. HR: Heart Rate; Sed:
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Wrist movement and postures
5.1 Summary
Background
Wrist-worn accelerometry is the commonest objective method for measuring physical activity
in large-scale epidemiological studies. Research-grade devices capture raw triaxial acceleration
which, in addition to quantifying movement, facilitates assessment of orientation relative to
gravity. No population-based study has yet described the interrelationship and variation of
these features by time and personal characteristics.
Methods
2043 UK adults (35-65years) wore an accelerometer on the non-dominant wrist and a chest-
mounted combined heart-rate-and-movement sensor for 7 days free-living. From raw (60Hz)
wrist acceleration, we derived movement (non-gravity acceleration) and pitch and roll (forearm)
angles relative to gravity. We inferred physical activity energy expenditure (PAEE) from
combined sensing and sedentary time from approximate horizontal arm-angle coupled with
low movement.
Results
Movement differences by time-of-day and day-of-week were associated with forearm-angles;
more movement in downward forearm-positions. Mean(SD) movement was similar between
sexes ∼31(42)mg, despite higher PAEE in men. Women spent longer with the forearm pitched
>0◦, above horizontal, (53% vs 36%) and less time at <0◦ (37% vs 53%). Diurnal pitch was 2.5-
5◦ above and 0-7.5◦ below horizontal during night and daytime, respectively; corresponding
roll angles were ∼0◦ (hand flat) and ∼20◦ (thumb-up). Differences were more pronounced in
younger participants. All diurnal profiles indicated later wake-times on weekends. Daytime
pitch was closer to horizontal on weekdays; roll was similar. Sedentary time was higher (17 vs
15 hours/day) in obese vs normal-weight individuals.
Conclusions
More movement occurred in forearm positions below horizontal, commensurate with activities
including walking. Findings suggest time-specific population differences in behaviours by age,
sex, and BMI. The findings of this work also inspired the approaches used to evaluate postural




Wrist-worn accelerometry has become a feasible option for the objective measurement of
physical activity in large-scale epidemiological studies, such as Pelotas birth cohorts, the UK
Biobank and Whitehall II [418, 3, 419]. Additionally, public adoption of consumer-grade
wearable devices that include accelerometry has been increasing steadily in recent years
[420, 421], with potential utility for public health research [39].
Accelerometers record a continuous time-series of data and recent advances in the technology
and battery life allow for ubiquitous capture of raw accelerometer signals which have the
potential to provide insights to interventional and epidemiological studies. Several features
can be easily extracted from the acceleration signal, including the magnitude of movement and
the orientation of the accelerometer with respect to gravity.
Chapter Significance: This chapter introduces the derivation of postural wrist measures using
accelerometer data. The implications of this work relate to the possibilities associated to the
use of these biomechanical inferences alongside traditional intensity based metrics like vector
magnitude.
Previous research using wrist accelerometry has described variation in population physical
activity expressed predominantly as the activity-related acceleration magnitude as explored in
Chapter 1. For example, da Silva et al noted age and sex differences in three Brazilian birth
cohorts from Pelotas assessed at the ages 6, 18, and 30 years of age [418], and Doherty et al
described the unique diurnal patterns of physical activity by age group, documenting that the
lower activity levels generally observed in older adults are particularly pronounced in the later
hours in the day [3]. Magnitude-based measures of activity have also been related to health
outcomes, such as body composition and fitness [422, 39].
Less attention has been given to the description of orientation-related measures of human
behaviour using wrist-worn acceleromery, although they have been used in thigh-worn activity
monitoring [423]. Pitch and roll angles are examples of well-defined, biomechanically relevant
and easy-to-interpret signal features that describe device orientation. In Figure 5.1, we illustrate
pitch and roll for an individual with an accelerometer placed on the left wrist, and axes aligned
as shown. Body posture is by definition a description of angles of all segments of the body and
is determined by their relationship with gravity, which can in theory all be measured but in
practice usually are not in studies of free-living behaviour. However, as body segments are
connected, and therefore range of motion is restricted, measurements and the variables that
can be mathematically derived from them tend to be highly correlated [397]. This allows
inferences from the measurement of one body site to be made on whole-body posture. For
example, previous work has shown strong correlations between time spent sedentary inferred
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from wrist accelerometry (by combining information on acceleration magnitude and pitch
angle) and thigh accelerometry (r∼0.93) [424].
Figure 5.1 Schematic of forearm Pitch and Roll on participant with accelerometer on
the left wrist, including axes alignment. Roll is defined by rotation around the y-axis,
while Pitch is defined by rotation around the x-axis. (Note that axis labeling depends on
study protocol and device specifications)
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5.2 Background
Sedentary behaviour can be defined as any waking behaviour that is characterized by an
energy expenditure ≤ 1.5 METs while the subject is engaging in either sitting, lying or
reclining postures [425]. People spend the majority of their time in sedentary behaviours,
and the proportion of time spent sedentary increases as people age [426]. High volumes of
sedentary behaviour have been associated with increased mortality and risk of developing
chronic conditions [43, 427, 426, 428, 425]. This only seems to be eliminated by very high
levels of moderate intensity physical activity (60-75 min per day, i.e. equivalent to double the
amount currently recommended for adults [427]). However, most of this evidence base is based
on self-reported sedentary and activity estimates which come with important methodological
limitations and bias [429].
Consequently, objectively assessing sedentary behaviours, as well as characterizing different
activities performed during daily living may be critical to inform public health recommenda-
tions. Traditionally, sedentary and active behaviours were characterized using such intensity
derived measures from the accelerometer signal. Figure 5.8 provides a visual representation
of triaxial wrist acceleration (top panels) during four common activities of lying, walking,
sitting, and cycling, alongside derived pitch and roll angles (bottom panels), demonstrating
clear differences between activity types. When assessing activity patterns, diurnal profiles of
pitch and roll combined with movement intensity metrics may allow us to further understand
how different postures relate to different activities and activity intensities.
In this chapter, we describe the distribution of forearm postures, acceleration, derived sedentary
time and PAEE in a large cohort of UK adults (n=2043 participants). These analyses allow us
to further understand the distribution of sedentary and active behaviours in the population and
how this distribution may differ based on time of the day, sex, age, body mass index (BMI) and
overall activity levels. Ultimately, the methodology developed for the work presented aims to
help inform how changes in sedentary and active behaviours may impact energy expenditure.
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5.3 Methods
5.3.1 Study population
The Fenland Study is an ongoing prospective cohort study of 12,435 men and women aged
35-65 years, designed to identify the behavioural, environmental and genetic causes of obesity
and type-2 diabetes. As previously described in detail, participants attended one of three
clinical research facilities in the region surrounding Cambridge, UK, and completed a series
of physical assessments and questionnaires [396]. Exclusion criteria for participation in the
study were: clinically diagnosed diabetes mellitus, inability to walk unaided, terminal illness,
clinically diagnosed psychotic disorder, pregnancy or lactation. Following the baseline clinic
visit, all participants were asked to wear a combined heart rate and movement sensor (Acti-
heart, CamNtech, Cambridgeshire, UK) for 6 consecutive days and nights, and a subsample
of 2100 participants were asked to simultaneously wear a wrist accelerometer (GeneActiv,
ActivInsights, Cambridgeshire, UK) on the non-dominant wrist. This subsample constitutes
the sampling frame for the current analyses. Participants were excluded from this analysis if
they had insufficient individual calibration (treadmill test-based) data, or had less than 72h of
concurrent wear data (equivalent of 3 full days of recording). Given only very few participants
were very severely underweight (BMI ≤ 15) in this subset of the Fenland study, they were
also excluded, resulting in a total of 2043 subjects. All participants provided written informed
consent and the study was approved by the University of Cambridge research ethics committee
and performed in accordance with the Declaration of Helsinki.
5.3.2 Data Collection
5.3.2.1 Physical Activity Measures
The combined heart rate and movement sensor attached to the participant’s chest, measured
heart rate and uniaxial acceleration of the trunk in 15-second intervals [401]. The wrist
accelerometer worn on the non-dominant wrist recorded triaxial acceleration at 60 Hertz.
Participants were instructed to wear both waterproof monitors continuously for 6 full days and
nights during free-living conditions, including during showering and while they were sleeping.
During the baseline clinic visit, participants performed a ramped treadmill test to establish their
individual heart rate response to a submaximal exercise test . These measurements produced
calibration parameters that were used in a branched equation model of PAEE [430]. Heart
rate data collected during free-living was pre-processed to eliminate potential noise [402],
following which the branched equation model was applied to calculate instantaneous PAEE
(J· min1 · kg1). This inference has been validated against intensity from indirect calorimetry
[431, 432] and volume from doubly-labelled water in several populations [433], including
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a sample of UK men and women in whom the technique was shown to explain 41% of the
variance in free-living PAEE as well as no mean bias [434]. The wrist accelerometer data
was processed using pampro, an open-source software package. The triaxial acceleration was
auto-calibrated to local gravitational acceleration using a method described elsewhere [403].
Non-wear time was defined as time periods where the standard deviation of the acceleration
in each of the three axes fell below 13mg for over an hour, inferring that the device was
completely stationary [435]. When a non-wear period was detected, it was removed from
the analyses. The magnitude of acceleration was calculated using Vector Magnitude (VM)
(expressed in milli-g/mg) per sample:
V M(X, Y, Z) =
√
(X2 + Y 2 + Z2) (5.1)
VM, or Euclidean Norm, can be interpreted as the magnitude of acceleration the device was
subjected to at each measurement, which includes gravitational acceleration. Any potential
noise component in the high-frequency domain was filtered out by a 20 Hertz low-pass filter. To
isolate the movement-related acceleration, we also applied a high-pass Butterworth filter to the
VM signal at 0.2 Hertz (therefore treating gravity as a low-frequency component) naming the
resulting metric Vector Magnitude High-Pass Filtered (VM HPF, expressed in mg) [435, 39].
VM HPF is commonly used as a proxy of acceleration resulting from human movement,
has high validity [37], and was the primary description of wrist movement in the following
analyses. To isolate the gravitational acceleration for each axis, we applied a low-pass filter
(0.2 Hertz) to each of the three axes (X, Y and Z). The residual acceleration signal can be
interpreted as a measurement of the rotated gravitational field vector which can then be used to
determine the accelerometer’s pitch and roll orientation angles. Pitch and roll of the device



















As the monitor was mounted in such a way that the X-axis was aligned in anatomically opposite
directions for left- and right-handed participants, we multiplied it by -1 for all left-handed
participants who wore the monitor on their right wrists to align with the anatomical coordinate
system defined above (examples of untransformed data shown in Figure 5.9). Consequently,
positive pitch indicates upwards position of the arm (hand above elbow), while positive roll
indicates the lateral (radial, thumb) side of the arm being higher than the medial (ulnar, pinky)
side of the arm. Figure 5.1 illustrates these concepts. All derived signals were summarized to a
common time resolution of one observation per hour. This window length was chosen since
we were mostly interested in observing changes at a diurnal level, rather than variations within
the hour. Using the combined-sensing measurements, participants were stratified by average
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activity energy expenditure into three equal tertiles: lower active (≤ 39 J · min−1 · kg−1),
medium (40-56 J · min−1 · kg−1) and upper (≥ 57 J · min−1 · kg−1). These activity estimates
were calculated for each participant for each day of the week and then averaged, allowing us
to generate a activity-level stratification based on the individual weekly average. picture of
changes in behaviour over the course of the week. Similarly, we calculated estimates of time
spent in sedentary (i.e. sitting or reclining) by detecting bouts where wrist pitch (i.e. fore arm
elevation) is ≥ 15 ◦ below the horizontal, while wrist acceleration is minimal (VM HPF ≤
47.61 mg)). This is based on principles from previously developed methodology which derives
sedentary time estimates from wrist accelerometry data (i.e. sedentary sphere methodology
[424]), as well as estimations of physical activity energy expenditure in free-living using
wrist accelerometry [397]. The latter defined the acceleration threshold (VM HPF =47.61
mg) equivalent to 1.5 gross METs (PAEE=35.5 J· min−1 · kg−1) as the cut-off for sedentary
behaviour [39]. Data in lower latitudes, that is, less than -15◦ from the horizontal, suggest
hanging of the arm, associated to standing behaviours and are hence not classified as sedentary
time. Equally, if the mean levels (VM HPF) over a minute fell into the light, moderate or
vigorous category, they were not classified as sedentary behaviour. Using the diurnal profiles
derived from the cohort, we studied differences based on sex, age, activity levels, BMI and
time of the day.
5.3.3 Statistical analyses
We computed descriptive statistics (mean, median, standard deviation, minimum, maximum
and variance) for the participants in this analysis. We examined wear-time distributions using
the Friedman test for time-of-day (00:00-05:59, 06:00-11:59, and so on in six-hour periods)
and tested the differences in weekdays versus weekend days using Wilcoxon signed ranks.
These tests were performed in men and women separately. Mean acceleration differences (VM
HPF) were examined using ANOVA for time of the day and day of the week. Differences
between men and women are shown by using box plots, providing information about the
median, inter-quartile range, minimum and maximum. We analysed the differences between
different BMI groups (underweight ≤ 18.5 kg/m2, normal weight 18.5-24.9 kg/m2, overweight
25-29.9 kg/m2, obese 30-34.9 kg/m2 and severely obese ≥ 35 kg/m2) in both sexes based
on pitch, roll, VM HPF and PAEE. Similarly, we conducted the analysis based on age group
and PAEE levels. These summary statistics were computed at an hourly level after collapsing
information derived on a fifteen-second time window. Furthermore, we tested for differences
in time spent in sedentary time across the different BMI populations using 3-way ANOVA and





Among the 2043 participants, a total of 286,020 person-hours were included in our analysis, or
an average of 5.8 days per participant. As shown in Table 1, PAEE was higher in men although
both groups had large standard deviations. However, wrist movement was similar between
genders but mean BMI was larger in men than in women for this cohort.




Age (years) 50.9 (7.3) 50.5 (7.1)
Height (m) 1.78 (0.07) 1.64 (0.06)
Weight (kg) 86.2 (14.1) 70.8 (14.3)
BMI (kg · m2) 27.2 (4.2) 26.4 (5.3)
PAEE (J · min−1 · kg−1) 53.1 (21.9) 47.7 (19.1)
Wrist movement, VM HPF (mg) 31.7 (44.9) 31.1 (40.8)
Figure 5.2A shows pitch and roll distributions for men and women. There is higher occurrence
of pitch and roll positions around 0° and the roll distribution is distinctly bimodal with an
additional peak around 35°. Less common are extreme anatomical forearm positions e.g., arms
up in the air, reflected by a pitch >60°, or the radial (thumb) side of the arm turned inwards
and downwards as indicated by less roll data below -45°. Figure 5.2B and 5.2C shows the
differences among different age groups for average sedentary time and PAEE respectively.
PAEE declines with age in both men and women, and there is a tendency for the wrist measure
of sedentary time to increase with age, showing a close inverse relationship between these two
measures.
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Figure 5.2 Pitch and roll (A) distribution among participants, and box plots for time
spent sedentary (B) and PAEE (C) by age group and sex (n=2,043).
5.3.4.1 Relation between wrist movement and forearm postures, and physical activity
energy expenditure
Figure 5.3 shows differences in wrist measures by tertile of physical activity energy expenditure;
more active individuals spend more time in low-pitch (below horizontal) postures; less active
participants tend to be spending more time in postures that suggest sedentary behaviours, such
as sitting or reclining. Whilst roll angles differ by activity level in women, there is almost no




Figure 5.3 Pitch (top panels), Roll (middle panels), and Vector Magnitude High-Pass
Filtered (VM HPF) by physical activity energy expenditure level (lower, medium, or
upper) and gender (A), and diurnal profiles (hourly averages) by time of day in women
and men (B).
Some of the most visually striking results regarding the role of posture on physical activity
behaviours can be seen in the 3-dimensional time-lapse plots that appear on the online supple-
mentary online material of this paper (see video) published on the Journal of the Measurement
of Physical Behaviour (2019) [113]. A schematic representation of these time-lapses is
presented in Figure 5.4 at four times of the day.
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Figure 5.4 Schematic representation of time-lapse diurnal change in Pitch and Roll an-
gular profiles and their associated acceleration signal (Vector Magnitude High-Pass Fil-
tered, in mg). All plots have been normalized. (Figure derived from the male population
of this analysis n=953).
5.3.4.2 Diurnal Profile Differences by sex and age
Figure 5.5 shows the distribution of pitch, roll, and movement intensity across the day, stratified
by sex and age group. We observe differences between age groups within sex, but also
differences between men and women within age groups. Most differences between men and
women occur during the working hours (8 AM to 6 PM) of the day, with little differences at
night although women generally keep their arms at slightly higher pitch throughout the 24
hours. Some of the biggest differences between age groups in both sexes happen during the
early hours of the morning and late hours of the evening. Forearm angles differ more between
age groups in men (lower pitch in older during working hours), and gender differences in pitch
and roll profiles are most apparent among the 35-40 age group.
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Figure 5.5 Pitch (top panels), Roll (mid panels), and Vector Magnitude High-Pass Fil-
tered (bottom panels) profiles (hourly averages) by time of the day and age group (from
35–40 to 60–65 years old) in women (middle column) and men (right column). Left
column (A) shows participant-level summary data.
5.3.4.3 Pitch and Roll Profiles Differ on Weekends versus Weekdays
Figure 5.6 shows average pitch, roll and movement intensity across the day, separately for each
day of the week, and stratified by sex. The variation between weekdays at a population level is
minimal, but they differ from the diurnal profiles at the weekend and particularly among sexes.
A visible shift on weekend days towards later hours of the morning suggests a “later start” to
the day, and later bed times on Friday and Saturday nights. The most extreme postural contrast
are seen for pitch angles in men which reach the lowest level at the weekend (around -10°) in
parallel to highest level of movement; pitch in women is also lower in the weekend but only to
the weekday level of the men (around -5°) but with a similar level of movement as men.
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Figure 5.6 Differences in Pitch, Roll, and Vector Magnitude High-Pass Filtered (hourly
averages) based on day of the week (solid lines indicate weekdays , dashed lines indicate
weekends ) and time of the day in women and men.
5.3.4.4 Wrist Accelerometry Profiles by Gender and BMI
The differences in mean VM HPF between the different BMI groups are striking with obese
individuals moving considerably less than normal-weight but equally notable are differences
in pitch and roll profiles (Figure 5.7). Differences among groups were more apparent in men
than in women when considering the diurnal profile. Somewhat surprisingly, given higher
movement is generally occurring at the lower pitch angles (Figure 5.3), overweight and obese
individuals spend more time with their arms in this space but they just do not seem to move
as much. The underweight women’s pitch and roll profile are very different to that observed
in the severely obese men, suggesting that the higher level of mean physical activity in this
group is also related to a very different set of activities. These observations are supported by
stark differences on the average time spent in sedentary behaviours stratified by sex and BMI
category, where non-obese participants spent considerably less time in sedentary behaviours
than obese participants, particularly women. Also, the profiles observed in obese men closely
resemble that observed in the oldest age group as presented in Figure 5.5. We confirmed
differences across different BMI groups for average time spent in sedentary behaviours,
following adjustment for age and sex. We found that moderately obese participants spent
significantly more time in sedentary behaviours than normal-weight participants (p<0.001),
and so did severely obese (p<0.001) and even overweight participants (p<0.001). We also
found a strong significant difference between overweight and moderately obese participants
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(p=0.0001); however, differences between normal-weight and underweight participants were
not statistically significant (p=0.57).
Figure 5.7 Pitch (top panels), Roll (second row panels), Vector Magnitude High-Pass
Filtered (third row panels), and sedentary time (bottom row panels) profiles (hourly
averages) by time of the day in women and men, stratified by BMI categories (ranging
from underweight [BMI: 16–18.5] to severely obese [BMI ≥35]).
5.4 Discussion
In this paper, we have explored the physical space in which physical activity occurs and
described population differences in wrist movement and posture between men and women,
age groups, BMI categories, and physical activity levels in a population sample of UK adults.
Although higher activity was associated with lower pitch profiles, we observed the apparent
paradox that older and more obese individuals who as groups are generally less active also
spend more time at these postures, indicating that these groups either perform different types of
activities or perform them at slower pace. Vector magnitude of movement intensity and pitch-
roll angular features can all be considered direct measures of human behaviour, rather than
estimates, as there is very little inference involved in deriving them; they have biomechanical
meaning in their own right as also illustrated in Figure 5.8. The estimate of sedentary time, on
the other hand, is not a direct measure but an estimate resulting from an inference but we have
included it here to demonstrate the utility of combining directly measured features.
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Remark: Including movement as well as pitch, roll (both indicating posture), and sedentary
time estimates in our analysis allowed us to more comprehensively examine differences
in human behaviour between time-of-day and weekdays and weekends, and illustrates the
importance of taking all these features into consideration for large-population studies.
Non-surprisingly, our results suggest different wake-up times between weekdays and weekends;
participants seem to wake up later during the weekends than weekdays. This information is
of interest particularly given recent research suggesting that sleep irregularity may be a risk
factor for cardio-metabolic disease [436]. The large differences in movement and postural
measures between weekdays and weekends suggest differences in the type of activities that
participants partake in between weekdays and weekends. These differences are particularly
striking when comparing women and men. We found that women spend more time with
their forearm elevated above horizontal than men do (53 % of their time vs. 36 % for men).
Similarly, the pitch and roll profiles coincide with increases in movement around noon of the
weekend days, pointing towards a behavioural pattern that could be suggestive of “weekend
warrior” lifestyle, where participants tend to do most of their physical activity during the
weekend. Further inspection of the data through visualization techniques (Figure 5.4) suggests
that the activities participants engaged in strongly depended on time-of-day; it is apparent that
the relative occupation of different physical spaces and the relationship between postures and
movement changes drastically depending on the time of the day, indicative of engagement in
different activity types.
We observed differences between men and women across most other substrata for both move-
ment (vector magnitude) and posture (pitch and roll) measures, suggesting that men spent more
time in postures that may be suggestive of sedentary behaviour than their female counterparts
(sitting down, lying down). The inferred time estimate for sedentary behaviours (from vector
magnitude and pitch), largely based on the methodology previously described by Rowlands
et al [424], indicated that this was by far the most dominant behaviour across the whole
population (∼ 17 hours/day). However, younger individuals tended to spend less time than
their older counterparts in these sedentary behaviours (suggesting more active lifestyles), and
even starker differences were observed between different BMI groups; individuals with higher
BMI spent the most time in sedentary behaviours, and we statistically confirmed that this was
independent of age and sex. Movement and PAEE were both lower in the older age groups,
a similar result to that observed in other population studies [437, 112, 162](2,33,34). We
observed that older participants (60-65 age group) spend a large proportion of their time in
postures that are similar to those with high BMIs, particularly in men. What was slightly
paradoxical was that older and obese individuals spend more time at pitch angles generally
associated with higher activity, ie with the arm below horizontal. As both movement and
pitch are direct measurements of what the arm is physically doing, these results indicate
true differences in activities, either as type or intensity or both. Using the sedentary time
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estimation methodology, it was suggested that older and heavier individuals spent more time in
sedentary behaviours. Future inference work on raw non-dominant wrist acceleration signals
may further elucidate other differences, for example in the specific type of activity performed,
including the separation of awake sedentary behaviour and sleep. Strengths of our study
includes its standardised placement and 24-hour wear protocol which ensured greater certainty
in the orientation of the accelerometer on each participant; that said, it is possible that some
participants may have removed and replaced their device during the monitoring period. Still
our results may provide guidance on probable axis orientation to other studies such as UK
Biobank which do not have strict device orientation protocols. Another strength was that
both wrist acceleration and PAEE was assessed simultaneously, thus providing more accurate
stratification by PAEE levels; however a limitation of our work is that we only measured
physical activity during one week of monitoring, and this may not be representative of habitual
behaviour in this population. Another potential limitation is the separation between static and
dynamic wrist acceleration; as has been previously addressed, the high- and low-pass filter
parameters does not perfectly discriminate between static and dynamic and a small proportion
of real movement will be missed during rapid rotations [438]. Nonetheless, this is likely to
only bias the movement differences we observe towards the null, since younger and slimmer
individuals are more able to produce more rapid movements, and it will likely not impact
much on the postural measures, as the gravitational acceleration component is several orders
of magnitude larger than residual movement in the low-pass filtered signal, thus still returning
a valid estimate of the relative distribution of gravity in the three axes. Finally, in this work
we describe hourly averages of behaviour and movement; however, there are alternatives to
describing the underlying variability of these hourly-periods based on distributional statistics
that were not explored in this paper.
5.4.1 Conclusions
In conclusion, we found that direct measures of accelerometry-derived forearm angles provide
biomechanically relevant information alongside the more well-established movement intensity
metrics such as vector magnitude to better characterize objectively measured physical activity
in free-living conditions. Movement is more likely to occur, on average, at forearm angles
below horizontal but despite older and heavier individuals moving less, these individuals
still spend more time at lower forearm angles, suggesting population differences in style of
movement which may be important for other health outcomes. These findings suggest that
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these postural assessment methods for wrist accelerometers are valuable complements to
traditional intensity based measures as explored in Chapter 1.
Figure 5.8 Raw triaxial wrist Acceleration, forearm Pitch and Roll Profiles (postures)
for typical daily activities. From top to bottom: lying, walking, sitting and cycling.
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Figure 5.9 Untransformed Pitch and Roll distributions (full population), stratified by
left versus right-hand accelerometer wear (top panel). The two plots underneath show
examples of pitch-roll distributions from two participants wearing the accelerometer on
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Self-supervised transfer learning of physiological representations from wearables
6.1 Summary
Background
Wearable devices such as smartwatches are becoming increasingly popular with consumers as
well as a standard tool for large-scale public health studies. However, continuous and accurate
monitoring of heart rate (HR) with these devices remains expensive and noisy in free-living
conditions. Most wrist-worn wearable sensors are equipped with cheap accelerometers, which
have proven to be reliable tools for physical activity monitoring. Further, current single modal-
ity sensors can tell us when and how much one particular behaviour, like exercise takes place
as showcased in Chapter 5. State-of-the-art multimodal sensors coupled with deep learning
could inform the effects that these behaviours have in the user’s physiology, helping inform
better decisions about our bodies and lifestyles.
Methods
In this work, we exploit the underlying physiological relationship between human activity and
HR responses to forecast HR from accelerometry data. This approach offers an affordable,
scalable and reliable way to monitor heart rate in free-living conditions without the need of an
additional sensor. Similarly, labelling continuous accelerometer signals for use in supervised
machine learning tasks can be prohibitively expensive and laborious. Therefore, we developed
a self-supervised model that exploits HR data as a supervisory signal for activity data obtained
from the accelerometer sensor. Through a deep neural network, we are able to forecast users’
HR profiles using solely activity data as input. In addition, we propose a custom quantile loss
function that accounts for the long-tailed HR distribution present on the general population
given the variable fitness levels of individuals. Moreover, we conduct ablation studies to
evaluate the impact of model components and input modalities across our experiments.
Results
We evaluate our model in the largest available free-living combined-sensing dataset (com-
prising >120k records of wrist accelerometer & wearable ECG). Our findings show that our
model outperforms feature-based models and other baselines, for the personalized forecasting
of heart rate. Additionally, we leverage the information captured through this self-supervised
task by proposing a simple way to aggregate the learnt latent representations (embeddings)
from the window-level to user-level. In doing so, we hypothesized that these embeddings
would capture physiologically meaningful and personalized information given the nature of
the self-supervised task. Notably, we show that the embeddings can generalize in various
downstream tasks through transfer learning with linear classifiers. For example, they can be
used to predict variables associated with individuals’ health, fitness and demographic factors,
outperforming simple bio-markers.
Conclusions
Overall, we propose the first multimodal self-supervised method for behavioral and physiologi-
cal data. This method has implications for large-scale health and lifestyle monitoring and can




The advent of wearable technologies has given individuals and researchers the opportunity
to ubiquitously and unobtrusively track everyday behavior. Thanks to the growth of internet-
enabled wearable devices, sensor time series comprise a considerable amount of user-generated
data [439]. However, extracting meaning from this data can be challenging, since sensors
measure low-level signals (e.g., acceleration) as opposed to the more high-level events that
are usually of interest (e.g., arrhythmia or obesity onset). Most wearable devices, particularly
those that are wrist-worn, incorporate accelerometry sensors, which are valuable and very
affordable tools to study physical activity patterns [397]. Indeed, the relationship between
activity signals arising from wrist-worn accelerometers and physical activity has been studied
in large population cohorts and is well established [112, 42, 419]. Physical behaviours are
characterized by both movement and the associated cardiovascular response to movement
(e.g. heart rate increases after exercise and the dynamics of this increase are dictated by
fitness levels [440]) 1. Heart Rate (HR) is a valuable marker not only for the study of specific
physical behaviours, but also for the characterization and understanding of one’s health and
fitness level. In healthy individuals, HR responses to activity are defined by an increase
in HR that is concurrent to the increasing intensity of the activity [441]. This relationship
is conceptualized in Figure 6.1. HR responses to exercise have been shown to be strongly
predictive of cardiovascular disease (CVD), coronary heart disease (CHD) and all-cause
mortality [442]. However, due to limitations of sensing technologies, the relationship between
continuous HR and health has not been thoroughly studied in free-living conditions.
A one-off measurement of resting HR (RHR) can be obtained using just one’s fingers, either
at the wrist or the side of the neck, or by using simple mobile applications requiring less
than 4 minutes. By contrast, measuring continuous HR is expensive, often burdensome and
noisy when engaging in higher levels of physical activity [443]. Photoplethysmograph (PPG)
sensors, that infer HR from blood pulse waves, have been incorporated in smartwatches.
However, signals obtained from PPG are corrupted by motion induced noise, which can impair
their performance particularly under non-resting conditions [80]. Moreover, these sensors are
still expensive, limiting their scalability and application in large-population studies.
In this work, we set to infer ECG-level quality HR signals by only utilizing accelerometry.
Thereby, we provide an approach that compresses low-level sensor information while dealing
with the idiosyncrasies inherent to this data, such as noise [444], the lack of annotations
and labels associated to the raw signals [445], and long-tail distributions [446]. We present
Step2Heart, a model that maps movement patterns from wrist accelerometery to HR responses,
introducing the possibility of large scale, affordable and accurate inference of HR response in
populations. We employ deep learning techniques that capture both the temporal dynamics
1Please note that throughout this work, we refer to activity, movement and acceleration interchangeably as
signals obtained from wearable accelerometers.
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Figure 6.1 Heart rate and acceleration temporal dynamics. Illustrative visualization of
the relationship between movement and heart rate responses (randomly selected participant).
Shaded areas show this lagging relationship.































of sequential wearable sensor data and exploit the latent representations inherently present in
this data. Recurrent and Convolutional neural networks have shown great promise in time-
series modeling as they are able to flexibly capture non-linear relationships within sequential
data [227], [447], [448], [449]. Importantly, these deep learning techniques do not require
handcrafted feature engineering and are able to deal with noisy raw signals with diverse
resolution such as those obtained from wearable sensors. These approaches have shown great
promise in human activity recognition tasks using wearable sensor data [450–452].
Chapter Significance: In this chapter we devised a self-supervised framework that exploits
the multimodal nature of modern wearable device data to generate personalized embeddings.
In this work, we forecast heart rate resposes to movement as an auxiliary or pre-training
tasks based on the hypothesis that through this task our model will learn valuable infomation
regarding how each individual responds to movement or exercise. We then use the resulting
embeddings in a number of downstream classification tasks to showcase the potential that these
embeddings have when predicting health-related outcomes.
We also explore the latent information captured as a byproduct of the optimization of our
architecture. Drawing parallels from the fields of natural language processing (NLP) and
computer vision (CV), pioneers in representation learning [453], we posit that the behavioral
and physiological signals captured by wearable sensors are appropriate and suitable for neural
embeddings. In NLP and CV, researchers share pre-trained networks that can then be used
to solve various downstream tasks. Inspired by the terminology used in [454], physiological
signals display similar levels of complexity (it is not trivial to generate hand-crafted features)
and consistency (movement is reflected as an increase in acceleration across all people) to
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Figure 6.2 Schematic of model architecture and tasks.
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NLP and CV. We believe that this could motivate a similar paradigm shift in the area of mobile
health data especially given the privacy constraints associated with sharing such data. Instead,
sharing models and embeddings would not directly expose participants’ information and could
accelerate research in a privacy-conscious way. Therefore, we position our model as a transfer
learning model trained with self-supervision. Self-supervised learning is a training paradigm
that exploits the intrinsic structure present in the data inputs, as explored in the introduction of
this thesis. These models make use of large unlabelled data by learning objectives so as to get
supervision from the data itself, using supervised loss functions [455]. Most importantly, the
valuable intermediate representations capture intrinsic semantic meaning that can then be used
for a variety of downstream tasks. A noteworthy multimodal application of this approach was
learning to predict the audio of images and then using these representations to solve image
recognition tasks [456]. In this work, we propose the first multimodal self-supervised model
for behavioral and physiological data.
Remark: This chapter puts forward four key technical contributions:
• We propose a novel self-supervised approach to forecast HR responses from movement
data using wrist-worn accelerometers. Through this architecture, our model learns
physiologically meaningful user-level representations that can then be used for a variety
of practical downstream tasks that are personalized to the users’ unique physiology.
• We evaluate this model in what, to the best of our knowledge, is the largest dataset
of its kind, including over 1,700 participants with combined wearable ECG and wrist
accelerometry for a week. Our model outperforms a set of benchmarks and we perform
ablation tests to show the performance of different input modalities to the architecture.
The best HR forecasting models achieve an average error of ∼9 beats per minute in free
living conditions.
• We introduce a joint loss function that acts as a regularizer to traditional MSE by using
several quantiles of the predictive density of the model in order to capture the long-tails
of HR data observed in the real world.
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• We perform a set of downstream, transfer learning tasks by aggregating the window-level
features to user-level ones and showcasing the value captured by the learned embeddings
through strong performance at inferring physiologically meaningful variables. For
example, our models achieve an AUC of 70 for BMI prediction and an AUC of 80 for
Physical Activity Energy Expenditure.
We envision our work having applications in facilitating the comprehensive monitoring of
cardiovascular health and fitness at scale. Further, our models could be used to correct faulty HR
readings of noisy sensors such as PPGs and broadly to characterize the objectively measured
physical behaviours in large population cohorts. Some of the downstream classification tasks
highlight the potential of these techniques for the monitoring of important health information,
which is usually costly or burdensome to obtain (such as fitness or obesity levels). The proposed
model is summarized in Figure 6.2 and our code will be made publicly available.
6.3 Related work
Objective monitoring of physical behaviors. Large scale studies of physical activity lever-
aging mobile devices’ built-in accelerometers have shown promise as global physical activity
surveillance tools, demonstrating inequality across different countries and world regions [457].
Mobile and wearable sensors allow for continuous and ubiquitous monitoring of an individ-
ual’s physical activity profiles, which combined with cardio-respiratory information, provides
valuable insights into that individuals’ health and fitness status [458]. Hence, the possibility
of measuring individuals’ physiological characteristics in free-living conditions is of great
interest for research, clinical and commercial applications.
Machine learning for wearable sensing. Recently, advances in deep learning architectures
for sequential modeling based upon wearable and mobile sensing have been used for health
and fitness predictions and recommendations. For example, FitRec, an LSTM-based approach
to modelling HR and activity data for personalized fitness recommendations was able to learn
activity-specific contextual and personalized dynamics of individual user HR profiles during
exercise segments [459]. This approach is helpful but requires prior segmentation of activities,
which can be a constraint when applying these techniques in free-living, unconstrained condi-
tions. Additionally, previous work has explored forecasting heart rate from movement data,
however this was done on a much smaller scale (3 users) and used PPG sensors instead of the
more accurate ECG as ground-truth [460].
Self-supervised pre-training. Recent work using self-supervised learning has shown state-
of-the-art results in computer vision [65, 461], signal processing and natural language pro-
cessing [455]. Use cases in wearable and mobile sensing have been limited to human activity
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recognition using mobile devices [69] and emotion recognition using ECG data [462]. Our
work is also inspired by the cardiovascular signature network introduced by Hallgrimmson and
colleagues [463]. However, this is an auto-encoder based approach requiring a historical input
of 1-month of data for its prediction which renders the whole setup not feasible for real time
applications. Furthermore, the data used is much more aggregated than the data presented here.
Overall, the generalizability of the learned embeddings is an under-explored area with some
recent promising results in hospital operation room data [454], while attributes like gender and
age have been proved to be predictable with wearable embeddings [464].
6.4 Methods
In this section, we provide with a brief introduction to the problem formulation and notation
used and then explore the model architecture and the associated methods proposed in this
chapter.
6.4.1 Problem formulation and notation
For this work, we assume N samples, an input sequence X = (x1,...,xN ) ∈ RN×T ×F and a
target heart rate response y = (y1,...,yN ) ∈ RN . Additionally, we also consider contextual
metadata like the hour of the day M = (m1,...,mN ) ∈ RN×F . We use the same length T for all
sequences in our model. However, this sequence length is not a requirement and can be adapted
based on the requirements of the task at hand or the granularity of the data. The intermediate
representations of the model after training are E = (e1,...,eN ) ∈ RN×D where D is the latent




U is the number of users, in order to predict relevant outcome variables ỹ = (ỹ1,...,ỹN ) ∈ RN .
Our full notation is summarized in Table 6.1. We employ two representation learning tasks:
self-supervised pre-training and a downstream transfer learning task.
Pre-text task: self-supervised pre-training and HR forecasting. Given the accelerometer
input sensor sequence X and associated metadata M, predict the target HR y in the future. The
input and target data shouldn’t share temporal overlap in order to leverage the self-supervised
paradigm and learn to predict the future. Motivated by population differences in heart rates,
here we propose a custom quantile regression loss to account for the tails of the distribution.
This task by itself can be used for a reliable and real-time estimation of HR based on activity
data.
Downstream task: transfer learning of learned physiological representations. Given the
internal representations E –usually at the penultimate layer of the aforementioned neural
network [465]–, predict relevant variables ỹ regarding the users’ fitness and health using
traditional classifiers (e.g. Logistic Regression). Inspired by the associations between word and
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Notation Description




M, ∈ RN×F input user metadata
y, ∈ RN target heart rate response
N number of data points (samples)
T length of input sequence
F number of features (attributes)
U number of users
D̃train, D̃test training and testing set for the transfer learning task
θ parameters (weights) of a trained neural network
D dimension of latent space embedding




×D embeddings matrix learned like E (aggregated at the user level)
ỹ, ∈ R
N
U target variable for transfer learning (user level)
Table 6.1 Notation.
document vectors in NLP [466], we develop a simple aggregation method of sensor windows
to the user level. This is a common issue in the literature [467].
6.4.2 Model architecture
As shown in Figure 6.2 we propose Step2Heart, a deep neural network for HR forecasting
and transfer learning. Its layers receive high-dimensional activity inputs along with associated
metadata and learn spatio-temporal dynamics in order to accurately predict HR responses. It
uses stacked convolutional (CNN) and recurrent (RNN) layers building upon architectures
like DeepSense [468], which have been proven state of art in mobile sensing. Here we present
each component of the model. An overview of the overall method is given as a pseudocode in
Algorithm 1.
6.4.2.1 CNNs to learn spatial features
Given an input sequence X = (x1,...,xN ), it passes through a stack of CNN layers that scan
over the sequences with 1D windows and learn filters f : {0, ..., k − 1} ∈ R. The convolution
operation F of a sequence element s is defined as
F (s) = (x ∗ f)(s) =
k−1∑
i=0
f(i) · xs−i (6.1)
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where k is the filter size, s − i records the convolution step and ∗ denotes the convolution
operator. Please note that the 1D window learns patterns across all the parallel features of the
3D input tensor X.
6.4.2.2 RNNs to learn temporal features
The learned filters of the CNNs are then fed into stacked RNNs. Specifically we employ a fast
variant of RNNs known as Gated Recurrent Units (GRU) [447]. The GRU has a reset gate r
and an update gate z which change the hidden state h at each time step. The update functions
are as follows:
rt = σ(Wrxt + Urht−1 + br)
zt = σ(Wzxt + Uzht−1 + bz)
h̃t = tanh(Wxt + U(rt ⊙ ht−1) + b)
ht = (1 − zt) ⊙ ht−1 + zt ⊙ h̃t
(6.2)
where matrices W , U and b are model parameters and biases respectively, σ is a sigmoid
function, and ⊙ element-wise multiplication. The stacked GRUs output sequences which
correspond to latent temporal features.
Algorithm 1: Step2Heart model pseudocode
Input :X (sensors), M (metadata), y (target HR)
Output : Ẽ (user-level embedding), ỹ (target variable)
while neural network θ not converged do
pass X through CNN/RNN layers (eq. 6.1 & 6.2);
pass M through reLU layers;
concatenate outputs in E;
forecast & backpropagate with joint loss L (eq. 6.5);
end
use trained network θ to extract embeddings E;
aggregate E to the user-level Ẽ with average pooling;
train a linear model to predict target variables ỹ;
6.4.2.3 Pooling and prediction
Then, the GRU output ht passes through a pooling layer that performs global element-wise
averaging in order to summarize all the timesteps of the 3D tensor to a 2D matrix. If needed, the
representation after the pooling operation can be concatenated with other features or metadata
after passing through feed forward ReLu layers. We also refer to this representation at the
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Figure 6.3 Quantile vs MSE loss. Illustration of the relationship between the prediction and
the loss with respect to the shapes of the MSE and various levels α of quantiles. Simulated
data, the true value is yi = 0.
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penultimate layer, E, or embeddings matrix. Lastly, the final layer is a feed forward neural
network with a linear activation which is appropriate for regression tasks.
6.4.2.4 Custom loss function
Heart rates vary across large populations. As such, some individuals may reach very low (<50
bpm, at rest/sleeping) or high (>180 bpm during vigorous exercise) [469] generating very
long tails on the heart rate distribution. In traditional regression, the aim is to minimize the
squared-error loss function or MSE LMSE(y, f) = 1N
∑N
i=1 L(yi −f(xi))2 to predict a single
point estimate, similarly, quantile regressions aim to minimize the quantile loss in predicting a
certain quantile. As such, the higher the quantile, the more the quantile loss function penalizes
underestimates and the less it penalizes over estimates.
The loss for an individual data point in quantile regression is defined by:
L(ξi|α) =
{
αξi if ξi ≥ 0,
(α − 1)ξi if ξi < 0.
(6.3)
where α is the required quantile (between 0 and 1) and
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ξi = yi − f(xi), where f(x) is the predicted (quantile) model and y is defined by the
observed value for input x. A more compact version of Eq. (6.3) can be formulated as
L(ξi|α) = max(αξi, (α − 1)ξi) where ξ ∈ R is the residual. As such, the average quantile
loss over the whole dataset is:





L(yi − f(xi)|α) (6.4)
The quantile loss (or tilted/pinball loss in the literature) can be seen as tilted version of the l1
loss which estimates the unconditional median. Instead, if a prediction falls below a given
quantile (e.g. α = 0.10), the residual is scaled (or tilted) by its probability α. Thus, we
can obtain the conditional quantile by minimizing the empirical LQ loss. This formulation
is inspired by similar loss functions applied to transportation problems [470] as well as
reinforcement learning [471].
In practice, we are interested in different quantile levels for the predicted probability distribu-
tion, not only one. Let {a}Jj=1 be a set of J quantiles (e.g. 0.05, 0.10, ..) we propose a joint















which can be seen as a sum of the MSE and the respective quantile losses, represented in one
scalar. This scalar is used as the new backpropagation objective.
In Figure 6.3 we use a toy example to illustrate the differences between the MSE and Quantile
loss: the former increases very fast in case of outliers, whereas the latter is more robust. For the
individual quantiles, we observe that for very extreme values (e.g. 0.01 or 0.99) the loss skews
significantly assigning high penalties to underestimation and overestimation, respectively. In
our context, very athletic or sedentary people can be considered as long-tail outliers and we
want our models to account for it. Intuitively, the proposed loss can be seen as a combination
of multiple objective functions where the second term acts as a regularizer for the MSE. During
our experiments in next sections we apply different ablations of these terms to evaluate their
impact.
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Feature Seq. Inp. Unit
Sensor
Acceleration ✓ ✓ m/s2
Heart Rate ✓ ✗ Beats per Minute (BPM)
Timestamp ✓ ✓ N/A
Metadata
UserID ✗ ✗ N/A
Height ✗ ✗ Meters
Weight ✗ ✗ Kilograms
Sex ✗ ✗ Male–Female
Resting HR ✗ ✗ BPM
VO2max ✗ ✗ mL/min · kg
Derived
Triaxial Acceleration ✓ ✓ m/s2
ENMO ✓ ✓ milli-g
VM-HPF ✓ ✓ milli-g
PAEE ✗ ✗ J/min· kg
Body Mass Index (BMI) ✗ ✗ kg/m2
Month, Hour ✓ ✓ [-1,1] cos/sin transform
Table 6.2 Data description. Seq. denotes sequential measurements (timeseries), while Inp.
the inputs to the forecasting model. Triaxial Acceleration: mean, std of x, y, z axes, ENMO:
mean of Euclidean Norm Minus One. VM-HPF: mean, min, and max of Vector Magnitude





Participants were recruited from general practice lists in and around Cambridgeshire in the East
of England to the Fenland Study, a population-based study designed to investigate interactions
between environmental and genetic factors in determining obesity, type 2 diabetes, and related
metabolic disorders in younger and middle-aged adults between the ages of 35-65 [396].
Exclusion criteria included prevalent diabetes, pregnancy or lactation, inability to walk unaided,
psychosis or terminal illness (life expectancy of ≤ 1 year at the time of recruitment).
After a baseline clinic visit, a subsample of 2,100 participants were asked to wear a combined
heart rate and movement chest sensor (Actiheart, CamNtech, Cambridgeshire, UK) and a wrist
accelerometer (GeneActiv, ActivInsights, Cambridgeshire, UK) on their non-dominant wrist.
Before the free-living monitoring period, participants performed a treadmill test to establish
their individual heart rate response to a submaximal test. These measurements were used to
produced calibration parameters to inform a branched equation model of PAEE, which has
been validated against instantaneous PAEE (intensity) from indirect calorimetry. Weight was
measured to the nearest 100g using a calibrated scale (TANITA model BC-418MA; Tanita,
Tokyo, Japan) and height was measured to the nearest 0.1cm using a calibrated wall-mounted
stadiometer (SECA 240; Seca, Birmingham, UK). Body Mass Index (BMI) was calculated in
kg/m2
All participants provided written informed consent and the study was approved by the Univer-
sity of Cambridge, NRES Committee - East of England Cambridge Central). All experiments
and data collected were done in accordance with the declaration of Helsinki.
6.5.1.1 Study protocol
The mobile ECG measured heart rate and uniaxial acceleration in 15-second intervals while the
wrist device recorded 60 Hz triaxial acceleration. Participants were told to wear both monitors
continuously for 6 complete days and were advised that both monitors were waterproof and
could be worn during showering, sleeping or exercising. During a lab visit, all participants
performed a treadmill test that was used to establish their individual response to a submaximal
test, informing their V O2max (maximum rate of oxygen consumption measured during
incremental exercise). RHR was measured with the participant in a supine position using the
mobile ECG. HR was recorded for 15 minutes and RHR was calculated as the mean heart
rate measured during the last 3 minutes. These measurements were then used to calculate the
Physical Activity Energy Expenditure (PAEE) [472].
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MSE RMSE MAE
Step2Heart (A) 144.61 (0.62) 12.02 (0.02) 9.23 (0.03)
Step2Heart (A/T) 143.65 (0.28) 11.98 (0.01) 9.21 (0.03)
Step2Heart (A/R) 91.76 (0.12) 9.57 (0.00) 6.92 (0.03)
Step2Heart (A/R/T) 91.11 (0.37) 9.54 (0.01) 6.88 (0.02)
Baselines
Global mean 250.99 15.84 12.46
User mean 186.05 13.64 10.40
XGBoost (A) 162.92 (0.20) 12.76 (0.00) 9.83 (0.00)
Table 6.3 Forecasting task results. Ablation test to compare the HR forecasting error using
different input modalities and baselines. To make for a fair comparison please note that only the
MSE loss (LMSE) is used as an objective for our models here. (A=acceleration, T=temporal
features, R=Resting Heart Rate)
6.5.1.2 Pre-processing
All participant heart rate data collected during free-living conditions underwent pre-processing
for noise removal. Similarly, all accelerometer data was auto-calibrated to local gravity,
non-wear time was inferred and participants with less than 72 hours of wear were removed.
Magnitude of acceleration was calculated through high-passed filtered vector magnitude (VM
HPF) (expressed in milli-g/mg per sample). Both the accelerometry and ECG signals were
summarized to a common time resolution of one observation per 15 seconds and no further
processing to the original signals was applied.
Since what time it is can have a big impact on physical activity be it sleeping, commuting or
even the season of the year, we encoded the sensor timestamps using cyclical temporal features
Tf [473]. Here we encoded the month of the year and the hour of the day as (x, y) coordinates
on a circle:
Tf 1 = sin
(2 ∗ π ∗ t
max(t)
)
(6.6) Tf 2 = cos




where t is the relevant temporal feature (hour or month). The intuition behind this encoding
is that the model will "see" that e.g. 23:59 and 00:01 are 2 minutes apart (not 24 hours). We
perform ablation tests with and without these features during our experiments to evaluate their
impact.
6.5.2 Training procedure
To create appropriate training batches for deep learning, we segmented the signals into fixed
non-overlapping windows of 512 timesteps, each one comprising 15-seconds and therefore
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yielding a window size of approximately 2 hours. We divided our dataset into training and test
sets randomly using an 80-20% split with the training set then being further split into training
and validation sets (90-10%). We ensured that the test and train set had disjoint user groups.
Further, we normalized the data by performing min-max scaling on all features described on
Table 6.2 (sequence-wise for timeseries and column-wise for tabular ones) on the training set
and applying it to the test set. During training, the target data (HR bpm) is not scaled and the
forecast is 15" in the future after the last activity input.
The neural network was built through a stack of 2 CNN layers of 128 filters each, followed
by 2 Bidirectional GRU stacked layers of 128 units each (resulting in 256 features due to
bidirectional passes). When using extra inputs (RHR or timestamp derived features), a ReLu
MLP of dimensionality 128 was employed for each one and its outputs were concatenated
with the GRU output. We trained using the Adam [474] optimizer for 300 epochs or until the
validation loss stopped improving for 5 consecutive epochs 2. The quantiles we used were
[0.01, 0.05, 0.5, 0.95, 0.99] so that they equally cover extreme and central tendencies of the
heart rate distribution. The XGBoost baseline’s hyperparameters were found through 5-fold
cross validation and were then applied to the test set. Likewise, in the transfer learning task,
we followed the same procedure for Logistic Regression.
For the transfer learning task, we studied if the learned embeddings E can predict user variables
ranging from demographics to fitness and health. Since a slightly lower number of users (1506)
had sufficient fitness data obtained from the lab test visit, we report only their results (the users
remained in the same train/test splits D̃train / D̃test as earlier). To create binary labels we
calculated the 50% percentile in each variable’s distribution for the training set and assigned
equally sized positive-negative classes. The window-level embeddings were averaged with an
element-wise mean pooling to produce user-level embeddings3. Then, to reduce overfitting,
Principal Component Analysis (PCA) was performed on the training embeddings after standard
scaling and the resulting projection was applied to the test set. We examined various cutoffs of
explained variance for PCA, ranging from 90% to 99.9%. Intuitively, lower explained variance
retained fewer components; in practice the number of components ranged from 10 to 160.
6.5.3 Baselines and metrics
For our baselines, we used naive lower bounds that require no models as well as modern ML
regressors:
2hyper-parameter search was conducted with different layer numbers, unit sizes, learning rates and optimizers
and we evaluated their impact on the validation set.
3we experimented with min, max and median pooling over embeddings but yielded consistently worse results
across all variables.
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MSE RMSE MAE
Step2Heart (A/R/T)
LMSE 91.11 (0.37) 9.54 (0.01) 6.88 (0.02)
LMSE+Q 90.94 (1.12) 9.53 (0.05) 6.90 (0.10)
L0.5∗MSE+Q 90.27 (0.53) 9.50 (0.02) 6.81 (0.05)
LQ 92.0 (0.16) 9.59 (0.00) 6.75 (0.02)
Table 6.4 Loss function results. Ablation test to compare the best performing model in terms
of modalities (Step2Heart (A/R/T)) in regards to different loss functions.
Figure 6.4 Forecasting predictions (a-b). Prediction distributions (test set) using Step2Heart,
showing the impact of including the (static) resting heart rate as input.
(a) A/T model





























• Global mean: Predicts yi at each time step as the global HR mean of the training set.
This is a naive baseline that assumes all users have the same HR anytime but provides a
good lower bound for this longitudinal dataset.
• User mean: Personalized baseline obtained by predicting yi at each time step as the
mean value for all the user’s X in the training set. This is similar to the previous baseline
but considers the entire heart rate range of each user over the study week.
• Autoencoder: A convolutional autoencoder which compresses the input data X with
a reconstruction loss. This baseline uses movement data only and the intuition behind
this is to assess whether Step2Heart learns better representations due to learning to map
movement to heart rate X → y. To make a fair comparison, it has similar number
of parameters to the self-supervised models and we use the bottleneck layer to extract
embeddings (128 dimensions). This baseline is used only for the transfer learning
experiments.
• Gradient Boosting (XGboost) (A): gradient boosting machines are among the best
performing ML methods [475]. We use it as a comparison to demonstrate that the
temporal modeling capabilities of our architecture through CNN/GRUs outperform the
best ML baselines. Since XGboost cannot work directly on timeseries, we extracted the
following statistical features from the sensor windows: mean, std, max, min, percentiles






PCA* 90% 95% 99% 99.9% 90% 95% 99% 99.9% 90% 95% 99% 99.9%
VO2max 52.6 52.6 59.6 61.8 58.6 60 63.9 64.5 68.3 67.8 68 68.2
PAEE 69.6 70.0 70.2 71.8 74.7 74.7 77.5 76.8 78.2 79.2 80.6 79.7
Height 60.8 60.3 75.9 79.4 66 67.4 77.4 82.1 70.3 74 80.5 81.3
Weight 56.5 56.2 70.3 72.1 65.7 67.6 75 77.2 69.9 70.7 77.4 76.9
Sex 66.7 67.0 86.5 89.7 72.3 72.9 87.1 93.2 76.2 81.5 91.1 93.4
Age 46.2 46.3 53.9 59.5 55.0 61.7 66.2 66.9 61.1 63.8 67.3 67.6
BMI 51.6 51.5 60.1 61.2 62.8 63 68.2 67.6 64.7 66.1 67.8 69.4
Resting HR 49.1 49.4 55.8 55.4 56.7 56.6 62.7 61.7 N/A
Table 6.5 Transfer learning results. Performance of embeddings in predicting variables
related to health, fitness and demographic factors. A random baseline yields an AUC of 50.
(*percentage of explained variance by compressing the dimensionality of embeddings with
PCA)
Given the sequential nature of the regression forecasting task, we use standard metrics such as
the Root Mean Squared Error (RMSE), Mean Squared Error (MSE) and Mean Absolute Error
(MAE) for our evaluation. While MSE–RMSE put importance on the biggest errors, MAE
gives the same importance to each error and is more robust to outliers. For the transfer learning























|yt − ŷt| (6.10)
6.6 Results
6.6.1 Forecasting
We consider different ablation tests for Step2Heart as well as several baselines and report the
average and standard deviation of 3 runs. All results are evaluated on the test set. For our
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ablation tests we consider the same model with different inputs: acceleration features only (A),
with temporal features (A/T), with resting heart rate (A/R) and with both temporal features and
resting heart rates (A/R/T).
Impact of the Resting Heart Rate. All results are summarized in Table 6.3. Step2Heart
outperforms all baselines for this forecasting task and, when including temporal features and
resting heart rate (Step2Heart(A/R/T)), all performance metrics improve, resulting in an RMSE
of 9.54. We note that the RMSE is probably the most interpretable metric since it directly
translates to the error in HR beats per minute. Figures 6.3a and 6.3b depict the improvement in
performance when including the resting heart rate and temporal features. Namely, while the
(A/T) model seems to struggle with the prediction of HR which is below 60 BPM (presumably
fit individuals or during sleep time) the (A/R/T) model manages to capture this tail and as
well approximate better the long tail of the high BPM. Therefore, given the acceleration
input, the addition of the RHR appears to be the most significant input, improving the RMSE
by ∼ 2.5 and validating previous research that highlights RHR as a powerful bio-marker
[476]. Regarding the temporal features, their contribution is marginal when combined with
an acceleration model (A/T), but they achieve the lowest error in combination with the RHR
(A/R/T), showcasing the impact of the seasonality and circadian rhythms.
Implicit personalization. Interestingly, the baselines also serve to reinforce the importance
of personalized approaches for this type of tasks as the user mean baseline vastly outperforms
the global mean. Also our models implicitly learn personalized patterns outperforming both
the XGboost model and model-free baselines. Given the strong results of the embeddings in
demographic prediction we present in the next section, we postulate that these models learn
personalized features that would not be possible with other methods that –for example– require
user-specific layers and might not scale in large-scale datasets [477].
Impact of the joint loss. When comparing different loss functions with the best performing
model Step2Heart(A/R/T), we see (Table 6.4) that the proposed loss function better captures
the long tails of HR. The lowest error, 9.5 RMSE, is achieved when weighting the MSE loss
with the rest of the quantiles (L0.5∗MSE+Q). Notably the pure quantile model achieves the
best MAE of 6.75. We understand that a model optimized with the MSE loss would achieve
better MSE score and a model including the 50% quantile would optimize the MAE score.
Thus, for this experiment we evaluate the impact of the losses across all 3 metrics. In this
case, the joint losses achieve the best results; the LQ model may achieve the best MAE but
predicably falls short in the other metrics. Given the overlapping standard deviations of the
joint models (L0.5∗MSE+Q and LMSE+Q) we consider both to be our best models, however
we pick the former as the one with the lowest average error.
Practical applications. This approach may be employed to estimate HR in consumer devices
and large population studies that collected accelerometry data. Moreover, it could be used for
the systematic minimization of motion-induced HR measurement error in wearable devices that
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integrate optical heart rate through PPG [80] and movement sensing or for more energy-efficient
wearable sensing deployments [460].
6.6.2 Transfer learning
For this set of results, we used the model with the best performance as shown above (L0.5∗MSE+Q),
extracted the embeddings as described in sec. 6.5.2 and trained linear classifiers (logistic re-
gression) for different outcomes using the same embeddings.
Generalizing in downstream tasks. Quantitatively, the embeddings achieved strong results
in predicting variables like user’s sex, height, PAEE and weight (93, 82, 80 and 77 AUC
respectively). Also, BMI, V O2max and age are moderately predictable (70 AUC). The
pure acceleration model (A/T) moderately predicts Resting HR (62 AUC), but this does not
apply to the (A/R/T) since it already includes the RHR as input. Generally, the A/R/T model
outperforms the A/T model showing that using the RHR as input is helpful, as discussed in the
previous sections.
Our results validate previous studies like [463] with different data, which reported achieving
70 AUC in BMI and age prediction by auto-encoding wearable data. As a simple baseline,
we followed their idea of using the RHR as a single predictor and we could not surpass an
AUC of 55 for BMI and age. Also, the autoencoder baseline, which learns to compress the
activity data, under-performs when compared to Step2HeartA/T , illustrating that the proposed
task of mapping activity to HR captures the physiological state of the user, which translates
to more generalizable embeddings. We note that both approaches operate only on activity
data on inference time. This shows that the embeddings carry richer information than single
biomarkers or modalities by leveraging the relationship between physical activity and heart
rate responses. Obtaining these variables in large populations can be valuable for downstream
health-related inferences which would normally be costly and burdensome (for example a
V O2max test requires expensive laboratory treadmill equipment and respiration instruments).
Additionally, PAEE has been strongly associated with lower risk of mortality in healthy older
adults [478]. Similarly, V O2max is prospectively associated with the incidence of type 2
diabetes [88].
Implicit personalization. Interestingly, the baselines also reinforce the importance of person-
alized approaches as the user mean baseline vastly outperforms the global mean. Our models
implicitly learn personalized patterns outperforming all baselines. Given the strong results of
the embeddings in demographic prediction we present in the next section, we postulate that
these models learn personalized features which would not be possible with other methods that
–for example– require user-specific layers and might not scale in large-scale datasets [477].
Impact of the latent dimensionality size. From the representation learning perspective, we
observe considerable gain in accuracy in some variables when retaining more dimensions
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Figure 6.5 Model embeddings for transfer learning visualized with t-SNE. 2D representa-
tion of the embeddings for PAEE prediction. Color coding shows the extreme expenditures,


















(PCA components). More specifically, Sex and Height improve in absolute around +20 in
AUC. However, this behavior is not evident in other variables such as PAEE and V O2max,
which seem robust to any dimensionality reduction. This means that the demographic variables
leverage a bigger dimensional spectrum of latent features than the fitness variables which can be
predicted with a subsample of the features. These findings could have great implications when
deploying these models in mobile devices and deciding on model compression or distillation
approaches [479].
Visualizing the latent space. Qualitatively, we visualized the resulting latent space in 2D
with t-Distributed Stochastic Neighbor Embedding (t-SNE) [480] as shown in Figure 6.5. In
this setup, we used both the embeddings of the train and the test sets together since we want to
illustrate the structure of the entire dataset. We found that many of the inferred variables, like
the depicted PAEE cluster in their own specific regions. We decided to color code and focus
on the extreme PAEE users in order to illustrate the fact that most normal users are spread in
the middle but high/low PAEEs are diametrically opposed. This structure and separability is
hypothesized to be due to the nature of the embeddings learned through the self-supervision
process. These visualizations can help us understand common behaviours (similar users
are neighbors in the latent space), would allow for risk stratification and potentially suggest





Our results showcase the generalizability of the proposed models to solve different tasks
relevant to physiological and behavioral data. Our models achieve competitive performance in
real-time HR forecasting as well as in more abstract tasks such as cardio-respiratory fitness
prediction and demographics inference.
With regards to the HR forecasting, we consider the error acceptable for real-world deploy-
ments, especially in cases of energy-constraint environments where the heart rate sensors could
be prohibiting (an accelerometer consumes substantially less power). In our future work, we
will assess the feasibility of the deployment of such model and examine its performance in
different conditions (e.g. HR is generally steadier during sleep and that may affect the average
error).
Perhaps more interestingly, are the transfer learning results, as they showcase the potential
that this method holds for the generation of participant-specific representations. Through self-
supervised learning, we can leverage this unlabelled data to learn meaningful representations
that can generalize in situations where ground truth is inadequate or simply infeasible to collect
due to high costs. Such scenarios are of great importance in population health where we
may be able to achieve clinical-grade health inferences with widely-adopted devices such as
wearables and smartphones. Our work makes contributions in the area of transfer learning
and subject-specific representations, one of utmost importance in machine learning for health.
Further, the proposed approach allows us to move beyond traditional intensity based metrics to
truly capture inter-individual differences that would have otherwise been missed.
Remark: Our proposed methodology yields valuable user-level embeddings than can then be
used in downstream classification tasks. Future work will explore how these individualized
signatures may be used to better characterize large population cohorts, beyond what traditional,
intensity based-metrics currently offer.
Finally, some interesting extensions to the transfer learning experiments would be to quantify
the optimal number of hours or days we need for each user in order to accurately predict these
health-related variables. Our current approach assumes that all temporal windows over the
observation week for each user are aggregated resulting in a user-level embedding. This could
have cost saving implications as well, given that large population studies like the UK Biobank
[112] or the All of Us [391] procure wearable devices for large cohorts over long periods of
time and therefore the shortest monitoring period would be beneficial. This shall be addressed
in future work.
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6.7 Conclusion
In this chapter, we proposed a novel self-supervised deep learning model to forecast HR
responses from movement data using wrist-worn accelerometers. Through this architecture,
our model learns user-level representations that can then be used for a variety of practical
downstream tasks that are personalized to the users’ unique physiology.
We evaluated this model in what, to the best of our knowledge, is the largest dataset of its kind,
including over 1,700 participants with combined wearable ECG and wrist accelerometry for a
week. Our model outperforms a set of benchmarks and we perform ablation tests to show the
performance of different input modalities to the architecture.
In the forecasting task we found that including a single measure of RHR had significant impact
on the error, indicating that an individual’s continuous HR is greatly influenced by this marker.
Moreover, we show that cyclical modeling of the hour and the month contributed to achieving
the lowest error of ∼9 beats per minute in free living conditions. Nevertheless, even the model
relying purely on acceleration (A/T) achieved competitive results (∼12 beats per minute)
outperforming other ML baselines.
We also introduced a joint loss function that acts as a regularizer to traditional MSE by using
several quantiles of the predictive density of the model in order to capture the long-tails of
HR observed in the real world. These joint losses outperformed single losses across all error
metrics.
Lastly, we performed a set of health-related downstream, transfer learning tasks by aggregating
the window-level features to user-level ones and showcasing the value captured by the learned
embeddings through strong performance at inferring physiologically meaningful variables. For
example, our models achieve an AUC of 70 for BMI prediction and an AUC of 80 for Physical
Activity Energy Expenditure. By inspecting the embeddings we also noticed most outcomes
improve in performance with higher latent dimensionality while some are invariant to its size,




PREDICTIONS FROM FREE-LIVING WEARABLE
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Publications
Part of this work is under review for publication in Heart.
Contributions
I planned this project and devised the analysis plan in collaboration with my colleague Dimitris
Spathis and our supervisors. Dimitris and I have worked on the analysis collaboratively and I
have written this chapter and the associated manuscript (work in progress at the time of thesis
submission) which plan to submit for publication following its completion. The first part of
this chapter also introduces association results in the same cohort from a study led by Tomas
Gonzalez which I have also worked on as part of a team and is currently under review for
publication.
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7.1 Summary
Background: Low cardiorespiratory fitness (CRF) is a well-established predictor of cardio-
vascular and metabolic disease as well as all-cause mortality. An individual’s CRF is usually
determined through a VO2max test. However, the setup of these tests is costly and burdensome
making CRF assessments impractical in healthcare or large population studies. Due to the need
for proxy measures, non-exercise, self-reported methods to estimate VO2max have gained
popularity in recent years, but their reliability is limited.
Methods: CRF (expressed as VO2max) was estimated from a submaximal treadmill test. First,
we examined the association of RHR (in beats per minute) and CRF from 11,059 participants
that took part in the Fenland Study. Further, we exploited movement and cardiac signals
extracted from wearable sensors in free-living conditions from these participants to derive a
non-exercise model. Building on the findings from Chapter 6, we developed a deep neural
network approach that leverages time-series sensor information extracted from multimodal
wearable sensors to forecast individual’s VO2max in free-living conditions. Finally, we inter-
rogated the ability of our deep learning models to adapt to change in CRF by evaluating it in a
subsample of the Fenland population (n = 2140) that repeated the protocol after a median of 6
years (inter-quartile range: 5-8 years) from the original visit.
Results: The age- and sex-adjusted RHR (seated, supine, sleeping) association with CRF
were: -0.26 (95%CI -0.27; -0.24), -0.31 (95%CI -0.33; -0.29), and -0.31 (95%CI -0.34; -0.29)
ml O2·kg−1 · beat−1, respectively. In the longitudinal analyses (Fenland I vs Fenland II),
each 1-bpm increase in supine RHR was associated with 0.23 (95%CI 0.20; 0.25) ml O2·kg−1
· beat−1 decrease in CRF. Our wearable sensing non-exercise model yielded an R2= 0.89
and RMSE = 1.61 (calibrated) and R2= 0.67 and RMSE = 2.84 (non-calibrated). Further,
preliminary results showed that our adaptive approach is able to forecast VO2max in the
Fenland II population with an R2= 0.543, RMSE = 3.509 and correlation = 0.739.
Conclusion: Our findings show that RHR is a valuable biomarker of CRF and provides an
adaptable non-exercise model for CRF predictions given the growing adoption of multimodal
wearable sensors. The proposed model outperforms state-of-the-art non-exercise CRF models
and regression based models using objectively measured physical activity, showcasing the
value of habitual monitoring of physiological signals in free-living condition for these types
of inferences. Additionally, we show that our deep learning models are adaptable to change
and that the predictive performance improves when new sensor data is fed to the model. Our
model could potentially be used in large population studies and health care settings, as well as




Cardiorespiratory fitness (CRF) is an important modifiable marker of cardiovascular health
exhibiting a strong inverse relationship to the incidence of cardiovascular disease (CVD), type
2 diabetes, cancer, mortality and other adverse health outcomes across a number of published
studies [481–484, 90, 485–487, 458]. Vast epidemiological and clinical evidence demonstrates
that CRF is not only potentially a stronger predictor of mortality than well-established risk
factors like hypertension, type 2 diabetes, high cholesterol or smoking, but that using CRF to
complement these traditional risk factors significantly improves the precision of risk predictions
for adverse CVD health outcomes [488, 483, 489, 490].
Beyond its implications in medicine, VO2max is frequently used in athletics as an indicator
of the endurance capacity of athletes, having strong predictive value for other sport-related
variables [488]. The gold-standard measure of CRF is maximal oxygen uptake (VO2max)
which measures the maximal rate at which an individual can consume oxygen during exercise.
Usually, VO2max is measured through a maximal exertion incremental treadmill or ergometer
test which require trained staff and expensive laboratory settings with specialized equipment
[491, 492]. These tests require participants to reach volitional exhaustion while performing
ventilatory gas analysis, which limits their scalability to large populations given the inherent
risk they introduce. Furthermore, even for elite athletes, incorporating maximal tests can be
inconvenient given strict training planning and the cumbersome nature of the tests.
Given these limitations, CRF assessments are not routinely performed in healthcare settings and
indirect methods to estimate VO2max through submaximal tests or non-exercise models have
been developed. Submaximal models aim to predict VO2max from continuous, incremental
exercise at submaximal intensities [493]. These models are based on the parallel increase of
heart rate (HR) and VO2 consumption during exercise and assume a linear relationship between
work rate and HR that holds at maximal intensities [494, 469]. Although these submaximal
tests are valuable alternatives to maximal exertion tests, particularly for older and non-athlete
populations, their scalability, cost, time consumption and potential risks associated to exertion
still limit their use in clinical settings and applicability in large-scale population studies [495].
Resting heart rate (RHR) has not previously been employed as a proxy for CRF due to
unresolved methodological challenges. RHR is known to be dependent on the physiological
state at the time of measurement [496]. In clinical practice, the most common states are
sitting upright during blood pressure measurement or lying supine during brief multi-lead ECG
measurement. In free-living conditions, however, wearable sensors conveniently measure RHR
in other states of rest, notably including sleep. It is unknown whether differences in RHR
measured in these ways alter the relationship with CRF. It is also unclear to what extent the
RHR-to-CRF relationship is affected by adiposity and physical activity, which have established
associations with CRF [497, 498]. Quantifying the influence these modifiable factors have on
the RHR-to-CRF relationship would strengthen researcher’s ability to accurately use RHR as a
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proxy measure of exercise capacity. Although some studies have described the longitudinal
relationship between RHR and CRF [94, 499], there is uncertainty regarding how individual
changes in RHR may reflect longer-term CRF changes in the general population.
Further, non-exercise models aim to provide an alternative for CRF assessment for widespread
use in many healthcare settings and amongst individuals who cannot safely exercise. These
models are usually regression-based and incorporate variables such as sex, age, body max
index (BMI), the aforementioned RHR (although not at the scale of the association work
presented on this chapter) and self-reported physical activity to infer VO2max [500, 501].
However, model performance and reliability of is limited [502]. Wearable devices, such as
activity trackers and smartwatches, provide a valuable opportunity for objective monitoring of
physical behaviours, facilitating the capture of valuable physiological signals in a non-obtrusive,
continuous manner. In particular, they enable continuous measurement of movement and
cardiac responses, providing a scalable way to investigate the relationship between objectively
measured physical activity, cardiac responses and CRF [503]. Although the use of these
devices continues to grow, most of the derived variables in commercial wearable devices
lack proper scientific validation and as such, their validity to make health-related inferences
has been questioned [75, 504–506]. Specifically, VO2max estimations using these devices
have been shown to be particularly complex and at times unreliable [505, 507]. Whilst some
commercial devices have shown stronger results than others, many rely on detailed activity
intensity measurements, speed monitoring through GPS and require users to reach HRs close
to their maximum capabilities monitored through chest straps, limiting the application to
self-selecting, fitter populations [508, 509].
The relationship between submaximal HR during a variety of physical activities and VO2max
has been studied in laboratory settings [510–512]. However, these types of studies have rarely
been conducted under free-living conditions and have mostly been limited to linear models
imputing activity counts and daily steps [500, 513, 503, 514].
Chapter Significance: This Chapter is divided into two parts. In the first part, we aimed
to assess the cross-sectional associations between different measures of RHR and CRF in a
large population-based study of UK adults, as well as how body composition and physical
activity may alter the association. Secondly, we examined whether longitudinal within-person
change in RHR are associated with within-person change in CRF. In the second part, we aimed
to substantially advance previous CRF non-exercise models by introducing a non-exercise
model approach that leverages the information captured by the wearable sensors worn in
free-living conditions. We used a deep neural network that utilises statistical features emerging
from the wearable sensor data and demonstrated that these models yield better performance
than traditional and state-of-the-art non-exercise models which do not use this free-living
wearable data. Further, we showed that these models can be used to predict VO2max using





The Fenland study is a population-based cohort study designed to investigate the independent
and interacting effects of environmental, lifestyle and genetic influences on the development of
obesity, type 2 diabetes and related metabolic disorders. Exclusion criteria included prevalent
diabetes, pregnancy or lactation, inability to walk unaided, psychosis or terminal illness (life
expectancy of ≤ 1 year at the time of recruitment) .
The Fenland study has two distinct phases. Phase I, during which baseline data was collected
from 12,435 participants, took place between 2005 and 2015. Phase II was launched in 2014
and involved repeating the measurements collected during Phase I, alongside the collection of
new measures. All participants who had consented to being re-contacted after their Phase I
assessment were invited to participate in Phase II. At least 4 years must have elapsed between
visits. As a result of this stipulation, recruitment to Phase II is ongoing.
After a baseline clinic visit, participants were asked to wear a combined HR and movement
chest sensor Actiheart, CamNtech, Cambridgeshire, UK) for 6 complete days. For the first part
of the study, data from 10,865 participants was included. These comprised all participants with
complete relevant covariates and all three RHR measurements. For the second study, 11,059
participants were included after exclusion of participants with insufficient or corrupt data or
missing covariates. A subset of 6,579 study participants (2,675 for the non-exercise model
part of our work) returned for the second phase of the study, after a median of 6 years (inter-
quartile range: 5-8 years). These participants underwent a similar set of tests and protocols,
including wearing the combined HR and movement sensor for 6 days. All participants provided
written informed consent and the study was approved by the University of Cambridge, NRES
Committee - East of England Cambridge Central committee. All experiments and data collected
were done in accordance with the Declaration of Helsinki.
7.3.2 Study procedure
Participants arrived at the testing facility after an overnight fast to complete baseline clinical
assessment and questionnaires. Resting pulse rate was measured in a seated position while
blood pressure was assessed three times at 1-minute intervals (Omron 705CP-II, OMRON
Healthcare Europe, Hoofddorp, Netherlands). Seated RHR was computed as the mean of
these three pulse rate values. At least one hour after arrival, RHR was measured with the
participant at rest in a supine position using a combined HR and movement sensor (Actiheart,
CamNtech, Papworth, UK) attached to the chest at the base of the sternum by two standard
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ECG electrodes.[19,20] HR was recorded for 6 minutes and RHR was calculated as the mean
HR measured during the last 3 minutes.
After their visit, participants wore the Actiheart wearable ECG which measured HR and
movement recording at 60-second intervals [401]. The Actiheart device was attached to the
chest at the base of the sternum by two standard ECG electrodes. Participants were told
to wear the monitor continuously for 6 complete days and were advised that these were
waterproof and could be worn during showering, sleeping or exercising. During a lab visit, all
participants performed a treadmill test that was used to establish their individual response to a
submaximal test, informing their V O2max (maximum rate of oxygen consumption measured
during incremental exercise) [430].
7.3.3 Cardiorespiratory fitness assessment
VO2max was predicted in study participants using a previously validated sub-maximal tread-
mill test [515]. Participants exercised whilst the treadmill grade and speed were progressively
increased across several stages of level walking, inclined walking, and level running. The test
was terminated if one of the following criteria were met: 1) the participant wanted to stop,
2) the participant reached 90% of age-predicted maximal HR (208-0.7*age) [469], 3) the
participant exercised at or above 80% of age-predicted maximal HR for 2 minutes.
7.3.4 Free-living wearable sensor data processing
Participants were excluded from this analysis if they had less than 72 hours of concurrent
wear data (three full days of recording) or insufficient individual calibration data (treadmill
test-based data). All participant HR data collected during free-living conditions underwent
pre-processing for noise removal [402]. Non-wear detection procedures were applied to the
Actiheart combined sensing data and non-wear periods were excluded from the analyses [516].
This algorithm detected extended periods of non-physiological HR concomitant with extended
(> 90 minutes) periods that also registered no movement through the device’s accelerometer.
This data was then modelled using a branched equation framework, resulting in physical
activity energy expenditure (PAEE) (kJ/kg per day) time series [472]. We converted these
intensities into standard metabolic equivalent units (METs), through the conversion 1 MET
= 71 J/min/kg ( 3.5 ml O2· min−1· kg−1). These conversions where then used to determine
intensity levels with ≤ 1.5METs classified as sedentary behaviour, activities between 3 and 6
METs classified as moderate to vigorous physical activity (MVPA) and activities > 6METs
classified as vigorous physical activity (VPA).
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Additionally, we derived a comprehensive set of features using the Python package tsfresh [517].
We performed ablation tests with and without these features during our experiments to evaluate
their impact.
7.3.5 Metadata
Participants arrived at the testing facility after an overnight fast to complete baseline clinical
assessment and to answer several questionnaires. For our analyses, we included ethnicity (bi-
nary: white, not-white), smoking status (never, former, current) and alcohol intake (units/week)
from those questionnaires. Additionally, weight was measured with a calibrated electronic
scale (TANITA model BC-418 MA; Tanita, Tokyo, Japan) and height was assessed with a
wall-mounted, calibrated stadiometer (SECA 240; Seca, Birmingham, United Kingdom). Body
composition was measured through dual-energy X-ray absorptiometry (DEXA) (GE Lunar
Prodigy Advanced fan beam scanner, GE Healthcare, Bedford, United Kingdom) deriving fat,
lean and bone mass measurements across all body regions [518].
7.3.6 Evaluation
To evaluate the performance of our deep learning regression models we computed root mean
squared error (RMSE), mean sequared error (MSE), mean absolute error, Pearson correlation
coefficient and the coefficient of determination (R2). Here y and ŷ are the measured and
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While MSE–RMSE put importance on the biggest errors, MAE gives the same importance to
each error and is more robust to outliers. For the evaluation of the directionality of change, the
evaluation metric is the Area under curve (AUC).
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7.3.7 Statistical Analyses
For the first part of our work, the interrelationships of RHR measures were examined through
linear regression. We used sex-stratified regression models to examine cross-sectional asso-
ciations between RHR and CRF while adjusting for potential confounding factors. Model 1
adjusted for age; Model 2 additionally adjusted for demographic and lifestyle factors (ethnicity,
smoking status, alcohol intake); Model 3 additionally adjusted for BMI. Subgroup analyses
were performed as follows: Analyses were stratified by age group (less than 50y; 50-59y; 60y
and above) and BMI (normal weight, BMI 18.5-25kg·m−2; overweight, BMI 25-30kg·m−2;
obese, BMI above 30kg·m−2). Descriptive statistics were reported as means and standard
deviations, unless otherwise specified. For the non-exercise model part of our work we used
the aforementioned evaluation metrics. For longitudinal analyses of the subsample with repeat
measures of RHR and CRF, associations between within-person change in RHR and CRF were
adjusted for baseline age, sex, RHR, CRF, and age at follow-up. Associations between RHR
and VO2max were visualised with binscatter plots (5% bins) as shown in Figures 7.2 and 7.3.
Statistical analyses were performed with STATA (Version 14.2; StataCorp, College Station,
TX); a p-value of <0.05 was considered statistically significant.
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Figure 7.1 Study and experimental design. (A) The Fenland study comprised of two as-
sessment phases: Fenland I (n=12,435) and Fenland II including a subset of the Fenland I
participants re-tested 6 years later. (B) During both phases participants underwent a variety of
tests during the baseline clinic visit, including anthropometric measurements, questionnaires,
DEXA scans and a submaximal VO2max test. Following this baseline visit, participants were
fitted with a combined activity and cardiac sensing device which they wore in free-living
conditions for 6 days. (C) In this work we derive associations between RHR and VO2max and
introduce three sets of experiments for our non-exercise models: First, CRF in Fenland I is
inferred leveraging free-living wearable data. Second, we demonstrate that even with scarce
new information regarding the participant’s future state, VO2max can be inferred reliably.
Finally, we show that our model is adaptable by re-training with the new wearable sensor
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7.4 Results
Baseline measurements were collected from 12,435 healthy adults from the United Kingdom
enrolled in the Fenland Study. A subset of these participants were assessed again after a
median of 6 years (interquartile range: 5-8 years). Descriptive characteristics of the cohort’s
two phases used for analysis by sex and category are presented in Table 7.1. The mean and
standard deviations (SDs) for each characteristic are presented in this table.
Table 7.1 Characteristics of the study analytical sample: The Fenland I and II studies
Fenland I Fenland II
Men (n= 5229) Women (n= 5830) Men (n=1448) Women (n=1593)
N or mean % or sd N or mean % or sd N or mean % or sd N or mean % or sd
Demographics
Age (years) 47.70 7.57 47.66 7.36 54.51 7.10 55.08 6.81
Anthropometrics
Height (m) 1.78 0.07 1.64 0.06 1.77 0.07 1.64 0.06
Body mass (kg) 85.85 13.83 70.54 13.92 85.88 14.23 70.22 14.54
BMI (kg/m2) 27.16 3.97 26.17 4.97 27.25 4.20 26.17 5.26
FMI (kg/m2) 44.32 12.21 45.67 10.84 N.A.
Alcohol consumption
<1/week 1328 25.4% 2262 38.8% N.A.
1-4/week 2823 54.0% 2746 35% N.A.
Almost daily 1009 19.3% 717 12.3% N.A.
Smoking status
Never 2740 52.4% 3288 56.4% N.A.
Former 1757 33.6% 1883 32.3% N.A.
Current 685 13.1% 618 10.6% N.A.
Physical activity
MVPA (min/day) 104.03 72.18 73.30 57.33 N.A.
VPA (min/day) 12.52 18.15 6.28 11.04 N.A.
RHR
Supine RHR (bpm) 61.48 8.68 64.46 8.28 N.A.
Cardiorespiratory fitness
VO2max per kg BM 41.95 4.61 37.44 4.73 44.04 10.33 36.40 8.02
VO2max per kg FFM 58.08 7.52 58.53 8.78 N.A.
Other
Beta-blocker 22 0.42 % 15 0.26 % 67 4.62 % 58 3.64%
Data are in mean (SD) or n (%) unless otherwise indicated
7.4.1 RHR as a biomarker of fitness
Mean (SD) baseline RHR in the seated position, supine position, and during sleep were:
67.6 (9.8), 63.5 (8.9), and 56.9 (6.9) bpm, respectively, and correlations (Pearson r) between
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modalities ranged between 0.65 to 0.81. On average, RHR was 3 bpm higher and VO2max
was 7.7 ml O2 · min−1 · kg−1 lower in women than men.
Table 7.2 Association between resting heart rate and maximal oxygen consumption ex-
pressed per kg of total-body mass: The Fenland Study. Reported values are beta coeffi-
cients (95% CI). Model 1: age-adjusted; Model 2: model 1 + ethnicity, smoking and alcohol
adjusted; Model 3: model 2 + body max index (BMI) adjusted.
Seated RHR Supine RHR Sleeping RHR
Men Women Men Women Men Women
Total sample
Model 1 -0.27 (-0.29, -0.24) -0.25 (-0.27, -0.22) -0.33 (-0.36, -0.30) -0.31 (-0.33, -0.28) -0.28 (-0.32, -0.24) -0.27 (-0.31, -0.24)
Model 2 -0.27 (-0.29, -0.24) -0.25 (-0.27, -0.22) -0.32 (-0.35, -0.29) -0.30 (-0.33, -0.28) -0.31 (-0.35, -0.28) -0.31 (-0.35, -0.28)
Model 3 -0.23 (-0.26, -0.21) -0.19 (-0.22, -0.17) -0.29 (-0.32, -0.26) -0.29 (-0.32, -0.26) -0.26 (-0.30, -0.23) -0.22 (-0.25, -0.19)
Age stratified
Model 2
<50 years -0.26 (-0.30, -0.22) -0.25 (-0.29, -0.21) -0.34 (-0.38, -0.29) -0.29 (-0.34, -0.25) -0.35 (-0.41, -0.29) -0.30 (-0.35, -0.24)
50-60 years -0.26 (-0.30, -0.23) -0.25 (-0.28, -0.21) -0.30 (-0.35, -0.26) -0.31 (-0.35, -0.27) -0.28 (-0.34, -0.22) -0.32 (-0.37, -0.27)
>60 years -0.28 (-0.33, -0.22) -0.24 (-0.30, -0.19) -0.33 (-0.39, -0.27) -0.32 (-0.38, -0.26) -0.31 (-0.40, -0.23) -0.33 (-0.41, -0.25)
Model 3
<50 years -0.22 (-0.26, -0.18) -0.20 (-0.23, -0.16) -0.30 (-0.34, -0.26) -0.25 (-0.29, -0.21) -0.29 (-0.35, -0.23) -0.21 (-0.26, -0.16)
50-60 years -0.23 (-0.27, -0.19) -0.19 (-0.22, -0.15) -0.27 (-0.31, -0.23) -0.25 (-0.29, -0.22) -0.23 (-0.29, -0.17) -0.22 (-0.27, -0.17)
>60 years -0.25 (-0.31, -0.19) -0.21 (-0.27, -0.16) -0.30 (-0.36, -0.24) -0.29 (-0.35, -0.23) -0.28 (-0.36, -0.20) -0.27 (-0.34, -0.19)
BMI stratified
Model 3
<25 kg/m2 -0.30 (-0.35, -0.26) -0.24 (-0.27, -0.20) -0.35 (-0.40, -0.30) -0.32 (-0.36, -0.28) -0.34 (-0.41, -0.27) -0.31 (-0.36, -0.26)
25-30 kg/m2 -0.21 (-0.24, -0.17) -0.18 (-0.22, -0.14 -0.27 (-0.31, -0.24) -0.22 (-0.26, -0.17) -0.24 (-0.30, -0.19) -0.17 (-0.22, -0.11)
>30 kg/m2 -0.18 (-0.23, -0.13) -0.11 (-0.15, -0.06) -0.22 (-0.28, -0.17) -0.17 (-0.21, -0.12) -0.19 (-0.26, -0.11) -0.13 (-0.19, -0.07)
We explored several sex-stratified regression models to study the associations between RHR
and VO2max per kg body mass (Table 7.2, Figure 7.2). In models with only age adjustment
(Model 1), RHR was significantly associated with VO2max in women and men, irrespective of
RHR modality. Associations were similar after adjustment for ethnicity, smoking, and alcohol
use (Model 2). Further adjustment by BMI (Model 3) attenuated associations by about 10%
for VO2max per kg body mass. Associations between RHR and VO2max were similar across
all RHR modalities, especially in maximally adjusted models, but BMI and physical activity
attenuated more of the relationship for sleeping HR in women (30% and 40%, respectively).
We also analysed the association between RHR and VO2max across age and BMI strata
separately. Associations in these subgroups were similar in strength to pooled associations and
remained statistically significant. Summary binscatter plots for these associations are presented
in Figure 7.2.
In the subsample of participants with 6-yr repeat measures of supine RHR and VO2max, mean
levels of RHR and CRF were relatively similar to baseline values but with diverse individual
change over time. The 5th to the 95th percentiles of change were -11.4 to 9.2 bpm and -10.1 to
10.8 ml O2· min−1· kg−1, respectively. Correlations between baseline and follow-up measures
were high for both RHR (r=0.70) and VO2max (r=0.64). In longitudinal association analyses,
each 1-bpm increase in supine RHR was associated with a 0.23 (95%CI 0.20; 0.25) ml O2·
min−1· kg−1 decline in VO2max. Sex-stratified coefficients were -0.21 (95%CI -0.24; -0.17)
and -0.25 (95%CI -0.28; -0.21) ml O2· min−1· kg−1 per 1-bpm increase in RHR in women
and men, respectively. These findings are summarized in Figure 7.3.
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Figure 7.2 Associations between RHR and VO2max. Associations between resting heart
rate and maximal oxygen consumption expressed per kg body mass, stratified by sex and
adjusted for age. Top: Seated resting heart rate. Middle: Supine resting heart rate. Bottom:
Sleeping resting heart rate. The Fenland Study (n=10,865). Each point represents 5% of data
in the binscatter plots
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Figure 7.3 Associations between RHR and VO2max over time. Association between 6-
year change in supine resting heart rate and change in fitness, stratified by sex. Models were
adjusted for follow-up time and baseline values of age, sex, RHR, and VO2max. Longitudinal
subsample, the Fenland Study (n=6,589). Each point represents 5% of the data in the binscatter
plot.
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Table 7.3 CRF inferences in the Fenland I cohort. Inferences of VO2max are presented in
a sequential level of complexity. All results reported are for three layer convolutional neural
network with regularization. Improvement upon linear regression was ≈ 2.5% (R2) across all
inferences.











Sensors + Anthropometrics + RHR
Acceleration/HR/HRV/age/sex/weight/BMI/height/RHR
0.649 0.806 2.999
Acceleration/HR/HRV/age/sex/weight/BMI/height/RHR\MVPA (non-cal.) 0.659 0.812 2.977
Acceleration/HR/HRV/age/sex/weight/BMI/height/RHR\MVPA (branch eq.) 0.931 0.964 1.341
7.4.2 A deep-learning framework for cardiorespiratory fitness inferences from
wearable sensor data
Based on the strong associations presented thus far in this chapter, we developed a more
complex non-exercise model that utilises the wearable sensors used during the free-living
protocol of the Fenland study.
To that end, we developed models (both regression and neural network based) that inputted
a set of statistical features produced using tsfresh on the time-series sensor data as well as
anthropometrics and RHR for each individual. We conducted ablation tests to study the
influence of each subset of features. The results for the deep learning models are presented
in Table 7.3 for the Fenland I population. These results were obtained using a simple neural
network model consisting of 3 layers and regularization.
Our results show that using this free-living sensor data greatly added to the predictive ca-
pabilities of our model, resulting in improvements in terms of R2, correlation and RMSE
with each set of feature additions. Adding individual calibrated MVPA summary statistics
yielded the best results (R2 = 0.933). However, given that these branch equation models
may not be available to use in any given cohort, we also report the non-calibrated results,
which still yielded state-of-the-art results with an R2 = 0.66. The calibrated result reflects the
relationship between habitual PA and fitness with PA being optimally estimated with treadmill
calibration, thus, if for completely protocol-free paradigms, it is more appropriate to look at
the non-calibrated result. The performance improvement when compared to linear regression
was of 0.2 points for all three metrics (R2, correlation and RMSE).
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7.4.3 Future cardiorespiratory predictions during the Fenland II assessment
Following our experiments in Fenland I, we evaluated our deep learning model on the subset
of participants who returned for Fenland II. To do this, we trained on the subset of participants
that returned for Fenland II (2140 training set, 535 test set) and performed transfer learning by
using the first 3 layers of the network trained on Fenland I and fine-tuned with 3 extra layers in
Fenland II. The results are presented in Table 7.4. Although still preliminary, the results are
encouraging, yielding an R2= 0.543, correlation= 0.739 and RMSE= 3.509.
Table 7.4 CRF inferences in the Fenland II cohort. Inferences of VO2max are presented
in a sequential level of complexity. All results reported are transfer learning results from
pre-trained network on Fenland I.








Sensors + Anthropometrics + RHR
Acceleration/HR/HRV/age/sex/weight/BMI/height/RHR
0.529 0.731 3.561
Acceleration/HR/HRV/age/sex/weight/BMI/height/RHR\MVPA (non-cal.) 0.543 0.739 3.509
Remark: This work demonstrates the promise held by wearable devices for the monitoring
of CRF in large populations. First, our association work showed that RHR alone is a strong
biomarker of CRF. RHR measures can be readily obtained from modern wearable devices
(usually through PPG) while the participant is at rest or sleeping. Our non-exercise model
shows that including time-series free-living data can greatly increase the forecasting abilities of
non-exercise models. These models could allow for the ubiquitous monitoring of CRF without
requiring laboratory visits or expensive testing equipment.
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7.5 Discussion
The first part of our study showed strong interrelationships between measures of RHR (when
seated, lying supine, and during sleep) and investigated their relationship with CRF (estimated
maximal oxygen consumption expressed as VO2max) in the Fenland study, a large population-
based study of UK adults. Cross-sectional analyses demonstrated inverse associations between
RHR and VO2max that persisted across different RHR measurement modalities. Part of the
association between RHR and VO2max was explained by physical activity. In longitudinal
analyses, within-person change in RHR was associated with within-person change in VO2max.
The magnitude of this association was similar to that observed cross-sectionally. RHR may
therefore represent a suitable biomarker of CRF, and changes in factors determining CRF are
paralleled by those that influence RHR.
Our association work is among the few existing studies to examine the influence of factors
underpinning the RHR-to-CRF relationship, reporting significant inverse associations between
RHR and CRF that are independent of age, sex or obesity. Together, these findings support
the notion that RHR and habitual physical activity levels are intrinsically linked to exercise
capacity. Thus, changes in CRF achieved through altered physical activity levels could be
feasibly monitored with periodic RHR measurements.
Building on our association work, for the second part of this chapter we developed a non-
exercise model that allowed for the inference of VO2max by leveraging the information
captured through the free-living sensor data recorded through the wearables that participants
wore for ≈ 5 days. Our results showed that this information greatly improved the predictive
capability of traditional non-exercise models and RHR alone, yielding an R2= 0.89 and RMSE
= 1.61 (calibrated) and R2= 0.67 and RMSE = 2.84 (non-calibrated). Through ablation tests, we
showed that the statistical features derived from the sensor data improved upon the performance
of traditional non-exercise models using anthropometrics and RHR data only. These findings
highlight the potential that capturing physiological signals from habitual PA has for fitness
inferences. Further, we showed that through transfer learning, our model could be used to infer
VO2max ≈ 6 years into the future without the need for updated anthropometric information.
The work reported in this chapter has some notable limitations. We used heart response to a
submaximal treadmill test to estimate VO2max, rather than a direct measurement. Even though
our group has validated this approach [515], associations between RHR and CRF reported here
may be influenced by residual error from the VO2max estimation process, which is largely
dependent on reaching a percentage of age-predicted maximal HR. Additionally, VO2max
estimated from HR response to submaximal exercise is unreliable in those taking medications
such as beta-blockers. We excluded participants on beta-blockers, as well as participants who
did not pass the medical screening for treadmill testing. Whilst this adds to the validity of our
results, it means that the findings cannot be generalised to these individuals. This warrants
future research to examine whether RHR could be used to clinically monitor CRF across the
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lifespan. Similarly, the results presented for our ML experiments are still largely preliminary.
Although the results are encouraging, deeper networks and other architectures should be tested
as well as thorough hyperparameter tuning.
Future work should explore the use of time-series data directly on our model, for instance
by replicating what commercial wearable devices seem to do when estimating VO2max.
These devices use 10-20 minutes of participant recorded activity (usually running) combined
with GPS to calculate VO2max based on how fast the user is running and the HR response
associated to that. Further, we should explore the role of HRV in recovery more thoroughly as
it has been shown to be an important biomarker of fitness as well. Finally, future work should
also explore the role of uncertainty in these inferences, particularly given the fact that not all
subjects will have the same amount of "valuable" data in these types of cohorts. For instance,
these last proposed approaches might work well if the participants happen to exercise during
the free-living period, but if the participant is mostly sedentary, the inferences might need to
be reinforced by data from similar or matched participants in terms of anthropometrics, RHR
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8.1 Summary
Mobile and wearable technologies, as explored throughout this thesis, have the potential to
transform healthcare by providing low-cost, objective measurements of digital phenotyping
data at unprecedented scale. However, there are significant ethical and data governance
considerations that must be addressed given the nature of the data collected and it’s ubiquitous
collection. In this final chapter we discuss the topic of data governance for digital phenotyping
technologies, drawing on parallels and lessons from genomics research and highlighting areas
which will require new governance frameworks.
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Mobile and wearable devices, such as smartwatches and fitness trackers, increasingly enable
the continuous collection of physiological and behavioural data that permit inferences about
users’ physical and mental health. Growing consumer adoption of these technologies has
reduced the cost of generating clinically meaningful data. This can help reduce medical costs
and aid large-scale research. However, the collection, processing, and storage of data comes
with significant ethical, security, and data governance considerations. A complex ecosystem is
developing, with the need for collaboration among researchers, healthcare providers, and a
broad range of commercial entities across public and private sectors, some of which are not
traditionally associated with healthcare. This has raised important questions in the literature
regarding the role of the individual as a patient, customer, research participant, researcher,
user and bystander when consenting to data processing in this ecosystem [519]. Here, we
use the emerging concept of “digital phenotyping” [520, 521] to highlight key lessons for data
governance which draw on parallels with the history of genomics research, while highlighting
areas where digital phenotyping will also require novel governance frameworks.
Chapter Significance: This Chapter concludes the thesis by examining whether and how
digital phenotype data ought to be regulated to ensure data privacy and security around user
data, without unnecessarily halting important scientific progress in this area. This work draws
from historical precedents in genetic research as well as providing with new frameworks and
considerations unique to digital phenotyping.
8.1.1 Ubiquitous personal health data
Phenotypic traits are broadly defined as the observable characteristics of an individual that
arise from the combined effects of their genotype and the environment. Analysis of phenotypes
yields important insights across many fields of scientific research, from anthropology, where
they have been used to improve our understanding of human life history, human evolution
or human ecology, to health sciences, yielding advances in the identification of the genetic
basis of disease and health-related traits, drug repurposing, and pharmacogenomics. Building
on developments made through the collection and analysis of other phenotypic data, digital
phenotyping can be defined as the “moment-by-moment quantification of the individual-level
human phenotype using data from personal digital devices” [521, 17]. This process is often
passive and allows for the quantification of the individual-level behavioural phenotype through
personal digital devices such as mobile phones and wearable technologies [17]. Advances
in these data collection tools have accelerated across both academia and industry, along with
diverse applications in clinical and public health settings. These tools enable, at unprecedented
scale, long-term phenotyping in free-living conditions with minimal subject attrition [521].
Further, while passive data collected and generated through mobile or wearable devices isn’t
without limitations, it overcomes some of the issues associated to traditional survey-based
methods, such as self-report bias. Early examples include large-scale involuntary hand tremor
189
Digital Phenotyping and Sensitive Health Data
analysis via mouse cursor movement [522] and the use of Microsoft Bing search queries to
detect neurodegenerative conditions [45].
While digital phenotyping offers many opportunities for researchers, clinicians and users such
as the ability to make more informed decisions, ubiquitous and unobtrusive monitoring or to
achieve better health outcomes, it also involves risks. Given the multidisciplinary nature of
the field and the different levels of sensitivity of the data being collected, digital phenotyping
interacts with a broad range of laws and governance regimes, ranging from medical and
research ethics to contract law and data protection regulation. Moreover, there is an added
layer of complexity associated to the alignment of regulatory frameworks that vary from
country to country and are ill-adapted to the international nature and adoption of smartphones
or wearables. As such, there is a risk that consumers will be insufficiently protected if they
are exposed to digital phenotyping technologies which do not fall neatly within any existing
consumer protection regime with an effective enforcement framework. Further, in consumer,
unregulated scenarios, an important dichotomy arises between the user’s motivation to use these
technologies and the technology provider’s incentives to collect, analyse, share or monetize
the data produced by these users, turning into a prosumer commodity [523]. Historically,
health-related data had been limited mostly to the academic and medical communities and
regulated accordingly. However, the widespread adoption and continuous advancement of
digital phenotyping tools and the types of inferences resulting from these technologies are
paradigm shifting. A broad range of potential harms has been highlighted in the academic and
policy literature, including unethical data collection [524], provision of inaccurate clinically
relevant data [525], and discriminatory use of sensitive data, such as exclusionary insurance,
employment discrimination, or unfair credit scoring [526, 527]. At the same time, a lack
of regulatory clarity can also fail to provide commercial providers and researchers with the
certainty required for ethical scientific research and innovation.
8.1.2 Digital phenotyping at scale
From a regulatory perspective, one difficulty posed by digital phenotyping is the use of data
collected outside of a traditional healthcare context to make health-related inferences. There
is already some scope for supervision by consumer protection agencies with relatively broad
remit, such as data protection authorities (DPAs), in Europe under the General Data Protection
Regulation (GDPR), and to an extent the Federal Trade Commission (FTC) in the US, for
misrepresentations regarding health data governance. However, given the scale of the field,
regulators continue to lack the cross-domain expertise and resources required to provide
comprehensive oversight. Greater regulatory clarity on the categorisation and treatment of
digital phenotyping data in different contexts, for example on the scope of EU GDPR definition
of personal data concerning health, would allow agencies such as the FTC and DPAs to
better allocate scarce resources. While governing digital phenotyping at scale may require new
models of resource allocation and oversight, initial steps could focus on developing enforceable
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industry standards, such as approved GDPR codes of conduct, to act as signals of consumer
rights.
A 2019 study found that numerous mobile health apps still regularly failed to disclose process-
ing of special category health data under the GDPR, instead providing only the more basic
protections required for less sensitive data [11]. Even among prominent apps more prone to
regulatory scrutiny, the complexity of terms and applicable regulations can prevent consumers
from understanding the nature of their data being processed. For example, the Fitbit Privacy
Policy treats the activity and fitness data that it directly collects as if it were non-health data,
while noting that for any health data obtained from other sources, or other special category
data under the GDPR, Fitbit will notify users and request separate explicit consent to process
that data 1. However, the same Privacy Policy separately notifies users of the possibility that a
broad range of collected data, including exercise, activity, sleep, biometric, geolocation, and
personally identifying information, may be collected. The result is that users may be unclear
when accepting the Privacy Policy what forms of data Fitbit classifies as “health data” at that
time and must trust that Fitbit will seek additional explicit consent to process this type of data.
Moreover, despite initially being developed as a consumer device, Fitbit and similar wearable
devices are increasingly used to generate health-related insights in research settings. However,
there are few agreed standards and minimal regulatory oversight on the necessary reliability
of outputs for research and clinical purposes. Although classification as a “medical device”
introduces requirements regarding validity of results, longitudinal reporting, notification to
users of serious health concerns, and improved reporting, only some device manufacturers
have elected to seek classification as a medical device (i.e.: Apple Watch’s electrocardiogram
(ECG) App obtained De Novo FDA clearance in the US, and is classified as a Class II medical
device), and often only for some device functions [528]. Moreover, these designations tend to
change across the globe and as a result, consumers may be under the impression that the device
has been subject to a greater degree of regulatory scrutiny than is necessarily the case. When
monitoring data important to their health, consumers in these circumstances may place undue
weight on potentially unreliable outputs, with the potential for misinformed self-diagnosis or
behavioural change.
Companies utilising digital phenotyping regularly make unilateral changes to their terms of
service, and privacy disclosures are frequently inadequate, underscoring a lack of protection
for personal data and user privacy [529]. Undisclosed sharing of digital phenotyping data,
including linkable identifiers, is prevalent [530]. Inconsistent regulatory oversight, unclear
terms and conditions, and failure to disclose data sharing and secondary use can limit the ability
for health care professionals to recommend otherwise beneficial apps in fields such as mental
health care [530]. In the research context, the GDPR adopts lower protections for data subjects
where the purpose of processing is solely for statistical or scientific research purposes. Despite
1Fitbit Legal Privacy Policy. Fitbit.com. (2020). Retrieved 20 March 2020, from
https://www.fitbit.com/us/legal/privacy-policy.
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submissions from some concerned groups, such as the BioMolecular Resources Research
Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC) regarding the
need to define “scientific research” to exclude some forms of commercial processing [531], the
GDPR was passed to also allow commercial providers to use this research exemption to process
sensitive personal data without consent (though still subject to EU Member State law, technical
safeguards, and research ethical standards). Clear policy guidance on data sharing practices in
these instances is critical to maintaining public trust in scientific digital phenotyping research
and enabling the use of these methods for clinical care.
8.1.3 The risks of digital phenotyping: lessons from genetics
When considering improvements to the framework for digital phenotyping governance, there
are valuable precedents from an earlier wave of health technology innovation. Advances in
genotyping techniques, particularly from the 1990s onwards, created an extraordinary op-
portunity to better understand human health. At the same time, the sharing of the sensitive
individual-level health data required for scientific advances created the need to develop new
standards, policies, and regulations for genetics and bioinformatics research. This allowed pol-
icymakers to enact measures such as obligatory genetic counselling, requirements for validity
of results, informed consent, and chain of custody procedures, which flowed from iterative
resources such as the Bermuda Principles, Oviedo Convention, genetic testing protocols, and
Council for International Organizations of Medical Sciences (CIOMS) guidelines.
To advance human health and infectious disease research, cross-border data sharing has become
essential in genomics, leading to the creation of a variety of genomic data resources. These
databases are mainly constructed by and for publicly funded scientific and medical researchers
and their institutions. They range from being completely open, like the BRCA exchange,
ClinVar, and Genome Aggregation database [532–534], to having regulated-access like the
European Genome-Phenome Archive, the database of Genotypes and Phenotypes (dbGaP), and
the Human Gene Mutation database [535–537]. Potentially instructive models to draw on for
digital phenotyping data include controlled/managed-access models, data access committees,
data safe havens, dynamic and tiered consent, differential access, explicit open-access consent,
and portable legal consent. In particular, dynamic and tiered consent models are readily
applicable to areas of digital phenotyping, where the sensors for data collection tend to be
associated with a consumer device, such as a mobile phone, which could more easily support a
user-friendly interface for dynamic consent models. Through collaboration across researchers,
commercial providers, and regulators it may be possible to leverage these technology platforms
to further improve the delivery and application of data management solutions developed in
genomics.
A series of studies has demonstrated the challenges for researchers of fully anonymising data
(including in controlled-access databases such as the dbGaP), observing data subjects’ bounded
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consent on collected data, and delivering clinically valid and meaningful data in a direct-to-
consumer (DTC) setting [538]. While the lessons learned from genomics in these areas can
assist with approaching digital phenotyping data governance, we must also be mindful of the
important differences between genotypic and phenotypic data. Whilst genotypic data solely
comprises genetic code, digital phenotypic data is extremely diverse. As a result, the data
collected under the umbrella of ‘digital phenotyping’ may give rise to a broader range of
possible harms.
Figure 8.1 Differences between genotyping data and digital phenotyping data. Digital
phenotyping can never be said to be “complete”, because new data is generated continuously to
reflect changing patterns of user behaviour. Although sophisticated data analysis often requires
considerable infrastructure and expertise, the cost of processing and analysing each additional
data point is usually negligible.
GENOTYPING DATA DIGITAL PHENOTYPING DATA
Single dataset Complex, multi-layered/modal datasets
Collected once Collection ongoing
Unchangeable/immutable Changeable/mutable
Often knowledge of collection Sometimes knowledge of collection
Non-negligible cost/expertise Negligible cost/expertise
Marginal benefits from triangulation Substantial benefits from triangulation
Though there are a number of differences between genotyping and digital phenotyping data,
the disparity is especially apparent in the manner of collection. The negligible costs of most
types of digital phenotyping data collection means that it is efficient to aggregate large digital
phenotyping datasets from different users who may be unaware of their inclusion in a dataset
where personal devices upload data by default to a centralised server. Even in cases where
explicit agreement is sought in terms of service for data collection, the terms may not reflect
the nature of consent for research or secondary use, and complex terms and conditions can
result in user fatigue and a “tick-box” approach, meaning that users are less likely to provide
fully informed consent [529]. Moreover, the vast majority of digital phenotyping data arises
from commercial products, where the role of this data and the associated research is at least
in part to support a business model. Most of this data is therefore not used to produce pure
public goods or knowledge and is not freely available under existing governance frameworks
for proprietary data.
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Figure 8.2 Building on developments in genetics to establish a path for digital phenotyp-
ing.
Precedents from Genetics
Data management and informed consent
Research methods
Supervision and guidance models
Ongoing challenges
● Creation of open, tiered, and managed access databases 
● Establishment of culture of research ethics and oversight
● Clear classification of consent to participation in secondary data use 
and explanation of the associated consequences
● Development of standards for the reliability of results in clinical and 
commercial settings
● Leveraging data-sharing practices for genome wide association 
studies
● Multi-stakeholder input into applicable guidelines and regulatory 
frameworks
● Scope for public-private collaboration and research exemptions 
constituted in the applicable laws
● Collaboration amongst clinicians, commercial providers and 
researchers
● Anonymization of individual-level data
● Management of disparities of historically marginalized groups
● Balancing of values and rights of participants while ensuring 
long-term sustainability of Biobanks
The current fragmented approach to regulatory oversight, classification of data for the purpose
of identifying the applicable laws, and varying data governance practices lowers user trust in
digital phenotyping and limits potential medical research. While the precedents of considered
regulation and multi-stakeholder collaboration in genomics should inform developments in
this field, it is also important to improve on these models where possible, and address aspects
of digital phenotyping which require novel solutions.
While genetics databases have generally tended towards releasing aggregate data, with an
inverse relationship between accessibility and individual-level data, the unique collection
and delivery platforms of digital phenotyping may offer new models for data management
and informed research participation. For instance, these technologies include the means to
reduce the current practice of centralised data consolidation for the purposes of extracting value.
Through privacy-preserving, decentralized methods like federated learning and zero-knowledge
proofs [539, 540], users could maintain sole custody of their data [541]. These methods also
enable model sharing, as opposed to data sharing, which could allow for more seamless
cooperation between corporations and academic or public sector institutions. Advances in
differential privacy techniques could also address this issue by collecting and aggregating
information about groups of users’ habits and behaviours while not sharing data from individual
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users, potentially compromising their privacy. Similarly, from a consumer-facing perspective,
digital phenotyping technologies could enable innovation in dynamic consent and through
modern user interfaces and devices.
Given the nature of the data collected, laying the foundations for responsible data governance
and providing reliable, well-validated and contextualized outputs will be critical to building
trust and enabling the development of the digital phenotyping field. Mobile and wearable
technologies have the potential to transform healthcare by providing low-cost, objective
measurements of physical, cognitive, emotional, and social behaviours at unprecedented
scale. By building on advances in genetics to promote good governance and user trust, digital
phenotyping techniques could be used to understand disorders, aid diagnosis, improve patient






Discussion, conclusion and implications
9.1 Summary of the aims and rationale of this thesis
The objective of this thesis was to advance understanding of multimodal sensing of physical
behaviours in free-living conditions by deriving new insights from this type of data. These
insights, in turn, provide a basis for better understanding human behaviour and its consequences
for health and wellbeing.
The studies that comprise this thesis addressed this central aim through 4 sub-aims, outlined in
detail in Chapter 1, relating to important gaps in the current literature. These comprise:
• Aim 1: To estimate sleep and sleep stages in free-living conditions through multi-modal
wearable sensing
• Aim 2: To explore the use of wearable sensors to better understand and characterise
physical activity
• Aim 3: To leverage multi-modal free-living sensing information to infer meaningful
physiological characteristics
• Aim 4: To summarise and provide recommendations for the future management of
mobile sensing data and digital phenotyping
The proliferation and growing adoption of wearable devices in both research and commercial
settings has enabled an outstanding opportunity to measure physical activity and sleep at scale.
While many heuristic models were developed during the 90s to classify sleep during the night
using actigraphy devices, these algorithms rely on brand-dependent activity counts and were
derived to be used during a given sleep window only, limiting their generalisability. These
algorithms were derived to be used only during the night-time period, severely limiting their
applicability to studies without sleep diaries or expert annotations and leaving an important
gap on methods to identify sleep in free-living conditions to be addressed. Similarly, although
commercial devices such as those produced by Garmin or Fitbit give sleep estimates, their work
has yet to be validated and their models are also proprietary. Aim 1, which looked at estimating
sleep and sleep stages in free-living conditions through multi-modal wearable sensing, was
addressed through the work in Chapters 2-4. Together, these studies aimed to provide more
accurate and scalable possibilities for sleep inference using multi-modal devices.
First, we explored how to leverage new multimodal sensing technologies to track sleep outside
of laboratory environments. We began by providing an in-depth overview of state-of-the-art
technologies and analysing their strengths and limitations (Chapter 2). We then provided a
holistic analysis of sleep and sleep stage classification using conventional heuristic models as
well as machine learning and deep learning techniques in the largest dataset available to-date
with multimodal sensing and ground truth for sleep and sleep stages. These experiments
highlighted, for the first time, the strengths and limitations of the generation of wearable
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sensors when predicting sleep stages at different levels of granularity and which sensor features
where most important in those inferences. We also showed how an ensemble model can be
used to improve upon conventional deep learning models (Chapter 3). Similar models could be
used to drive even stronger results in multi-class settings and may benefit from the inclusion of
domain knowledge regarding the transition probabilities across the different sleep stages. We
then developed a device and sampling rate agnostic algorithm to classify sleep periods based
on HR alone, showcasing its results in four datasets. These included two free-living datasets,
where the performance of the algorithm was evaluated across multiple nights on the same
participants showcasing it’s ability to capture intra and inter-individual variation, and in two
datasets where the evaluation was done against PSG, including a study where the evaluation
was carried using a commercial device (Apple Watch) (Chapter 4). The strength of this method
lies in the fact that it does not require expert annotations or a sleep diary and can effectively
track unconventional sleep schedules, such as shift work and naps, something that no prior
algorithm had been able to do.
Under Aim 2, in Chapter 5, we explored how pitch and roll can be used to describe physical
behaviours beyond what traditional intensity metrics from accelerometers offer. We found
that sedentary and physical behaviours are better characterised through these derivations than
when using intensity based-measures alone. For instance, our group has recently used pitch
and roll to showcase that these measures can be used to differentiate between lying, sitting,
standing, and moving in a study of hospitalized older patients [114]. Similarly, as explored in
Chapter 4, in the absence of HR data, pitch and roll signals from accelerometers can provide
valuable indications of when a participant is not changing posture frequently, which can help
infer sleep.
Under Aim 3, we used self-supervised learning to map movement to HR data, leveraging the
vast amounts of unlabelled time-series data that characterise large epidemiological studies
including objective monitoring through wearable sensors (Chapter 6). Through this architecture,
we obtained valuable embeddings which could then be used to infer physiologically meaningful
information at a participant level (BMI, age, sex, VO2max, etc). These findings were important
because they provide valuable evidence that the pre-training task generated embeddings that
learned personalized features for each participant fitted with these combined sensing devices.
These results showcase a transition from traditional summary metrics that capture when and
how much of a behaviour has taken place, such as exercise, and are a stepping stone towards
capturing something more meaningful, such as the consequences of that exercise. As such, this
method represents one of the first approaches that enables capturing individual characteristics
by leveraging contiguous multimodal wearable signals. Building on these findings, we devised
a deep learning approach that leveraged multimodal sensor data to infer an individual’s CRF
(VO2max) in the present, as well as to forecast individual’s fitness 6 years into the future
(Chapter 7). Our findings represent the first of their kind on the inference of CRF, given the
size of the cohort and the future prediction aspect of our work. In sum, these studies provide
an important step towards the development of scalable computational techniques to measure,
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characterise, understand, infer and enhance human behaviour and health through multimodal
wearable sensors.
Finally, under Aim 4, we outlined the implications for data governance that arise given the
advancements in digital phenotyping technologies such as those presented throughout this
thesis (Chapter 8). While harnessing the widespread adoption of mobile devices to generate
clinically meaningful data can help reduce medical costs and aid large-scale research, the
collection, processing, and storage of data require careful consideration of privacy, security, and
data governance. In this final chapter, we highlight the need for a new governance framework
with regards to digital phenotyping data, which draws on the history of genomics regulation to
provide clarity and protection for consumers, researchers, and commercial providers.
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9.2 Discussion and main contributions
Traditionally, healthcare has primarily taken the form of therapy and drug treatments given
once an individual presents with signs of ill-health. However, digital health, made possible by
wearable devices and a new era of the “quantified self”, is an emerging option that allows the
continuous, longitudinal monitoring of behaviour and physiological markers at scale. Not only
is this likely to be of research benefit in understanding the health causes and consequences
of physical behaviours but it could also ultimately facilitate health monitoring and the early
identification of disease, leading to better planning, earlier intervention and better outcomes.
For example, early behavioural markers of Alzheimer’s Disease can be identified through
changes picked up by wearable sensors before clinical symptoms become apparent [542].
Despite their potential utility, current wearable technologies have sizeable challenges to
overcome such that they can be reliably and usefully implemented in research and health
monitoring. These primarily relate to leveraging the multimodal nature of modern devices and
to the validation of inferences, generalizability and the development of an understanding of
how measurement errors may affect research conclusions or impact decision-making in clinical
settings.
Some of the most challenging problems surrounding wearable device technology in healthcare
and research settings relate to the reproducibilty, transparency and adaptability of algorithms
across datasets. Most commercial devices use proprietary algorithms which make reproducibil-
ity and validation challenging. In academic settings, algorithms are typically derived in small,
constrained populations often meaning that their performance is not sustained when deployed
in a more diverse set of users or settings. Another form of variability in wearable and mobile
sensor data is caused by the positioning of the sensors on different anatomical locations [543].
As such, some models fail to be robust when exposed to the real-world heterogeneity of
wearable and mobile sensor data. Further, while multimodal approaches have shown great
promise in laboratory-based HAR tasks [116, 46] the use of multimodal wearable devices
for health-related inferences is still at a nascent state. We believe that the impact of these
combined sensing approaches could amount to a revolution in the objective monitoring of
physical behaviours of similar magnitude to the one experienced through the introduction
of pedometers and actigraphy devices which enabled, for the first time, a move beyond self-
reported measures. For instance, they will allow a move beyond traditional intensity-based
summary measures and provide individual signatures which encompass much richer individual
physiological information and are truly personalized.
Throughout this work, we introduce a set of studies that shed light on how these multimodal sen-
sor approaches can augment single-modality inferences by capturing more complex phenotypes
and validate these inferences in large and diverse cohort studies.
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9.2.1 Main contributions
In this thesis, we have introduced a number of studies that demonstrate how multimodal
wearable sensors can be used to infer physical activity, sedentary behaviours and sleep in
free-living conditions by leveraging signal processing and machine learning methods. Further,
we have shown how deep learning and, in particular, self-supervision may enable vast amounts
of unlabelled data to be leveraged. This could then be used to make personalised inferences of
an individual’s health and fitness levels.
Chapters 2, 3 and 4 provided an overview of how new sensing technologies can be used to
effectively monitor sleep outside of laboratories, in free-living conditions. Through this work,
we showed that although wrist-worn wearable sensors can be used reliably to track total sleep
time and sleep onset and offset reliably, their performance when tracking sleep stages, even
when using multimodal cardiac and movement sensing is more limited. Further, we showcased
that HR sensing alone can be used to infer sleep windows in the absence of sleep diaries. These
findings are of particular importance given that HR sensors are now common in wearable
devices, many large cohort studies do not have sleep diaries and, even when these are available,
they are prone to recall bias [85]. Further, our method can be used in non-habitual sleepers,
such as shift workers, and to track naps, both valuable additions to the objective monitoring of
sleep in free-living conditions.
For our work on multimodal sleep sensing we found that whilst the performance of multistage
classification into Wake, NREM and REM was acceptable, as more granular sleep staging was
introduced, the models struggled to differentiate the most common NREM substage (N2) and
identify REM sleep for some participants. Hence, in future, commercial companies presenting
these types of more detailed inferences must caveat them and produce validation studies that
showcase their performance to avoid misleading customers. An alternative potential solution
might lie in focusing on the transition to bed, something which might be more actionable and
result in people getting a better night’s sleep and more regular sleep schedules, which also
have important implications for health and well-being. In parallel to the work described in this
thesis, we have developed a number of open-source multimodal wearable sensing processing
tools in Python that have been made available through Github.
Chapter 5 presented a descriptive epidemiological study showcasing the value added by in-
cluding postural features in physical activity studies that use triaxial accelerometers for better
characterisation of human behaviours. Inclusion of pitch and roll allowed for a more compre-
hensive understanding of human activity, beyond traditional intensity metrics derived from
these accelerometers. These metrics can be easily obtained from modern triaxial accelerome-
ters and have proven beneficial for the characterization of human behaviours. Leveraging these
insights, pitch and roll were then used to derive a modified version of the HDCZA method
to characterize limb immobility and inform sleep periods in Chapter 4. Similarly, pitch and
roll have recently also been used by our group to differentiate between lying, sitting, standing,
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and moving in a study comprising hospitalized older patients [114]. Together, the studies
contribute to the literature by advocating for the inclusion of pitch and roll in inferring physical
behaviours.
Chapter 6 introduced a self-supervised architecture that "mapped" activity obtained from a
triaxial accelerometer to HR. Through this auxiliary task we hypothesised that the model would
learn to capture useful, personalised representations that reflect individual characteristics. Thus,
we tested the information carried in those representations through a variety of downstream
transfer learning classification tasks that related to individual characteristics. Through these
tasks, we showed that the embeddings emerging from the self-supervised tasks could be
used to infer age, sex, BMI, height and VO2max (among other characteristics). To the best
of our knowledge, this is the first time a self-supervised architecture has been used used to
generate physiological signatures through these embeddings. information captured by modern
multimodal sensors could hold even greater promise. Current single modality sensors can
tell us when and how much one particular behaviour, like exercise takes place. Multimodal
sensors coupled with deep learning as we showed in this chapter could inform the effects
that these behaviours have in the user’s physiology, helping inform better decisions about
our bodies and lifestyles. This work inspired us to build a predictive model of CRF using
deep learning in Chapter 7. In this final analysis chapter, we found that resting and sleeping
HR have a strong inverse association with CRF and devised a model that leveraged sensor
information as well as some basic anthropometric information to infer current CRF (VO2max).
Further, we showed that our model could be used to infer VO2max 6 years into the future
using scarce new information (showing its performance with updated age and age, weight and
BMI) and that the performance improved further when retraining with new sensor information
collected 6 years in the future. This work has important implications for the role of wearable
devices to monitor CRF at scale. Indeed, the ability to ubiquitously and reliably infer CRF
using wearables could have important implications for preventative medicine, given its strong
associations with cardiovascular and metabolic health.
Finally, this thesis concluded with a chapter that explored data governance considerations for
the type of data generated throughout this thesis, termed digital phenotyping (Chapter 8). The
chapter used precedents from the field of genetics to highlight some valuable lessons from the
past and areas that are unique to this type of data. Mobile and wearable technologies have
the potential to transform healthcare by providing low-cost, objective measurements of digital
phenotyping data at unprecedented scale. Given the nature of the data collected, it is important
that the sequencing of the digital phenome follows data governance principles that guarantee
the rights of users, prevent misuse of data and promote trust in the rapidly evolving digital
health ecosystem.
Together, the studies that comprise this thesis demonstrate that multimodal digital phenotyping
technologies, in particular wearable sensors, can be used to accurately infer sleep, fitness
and other physical behaviours in large-scale populations, validating these results against gold-
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standard measures in diverse cohorts. Further, the results presented in this thesis point towards
several interesting future opportunities for research, some of which we shall outline here,
concluding the thesis.
9.3 Future directions
9.3.1 Domain adaptation for mobile and wearable sensing
One of the most interesting and important challenges that remains to be addressed in the field
of wearable sensing is transfer learning and domain adaptation. This concept was featured on
the introduction of this thesis and entails that a model trained on a particular device would
be seamlessly applied to other devices that may have a different sampling rate or be slightly
different in nature. This is particularly important when considering that currently, models
that are learned using particular devices or in particular populations may then be deployed in
completely different data distributions, halting the value of those inferences. For instance, a
machine learning model derived in a particular population (distribution) may not translate well
to a different population (different distribution) which could yield misleading results. This
is one of the reasons behind why we decided to build a device and population agnostic HR
approach (Chapter 4) as opposed to using one of the trained models for Chapter 3 and apply it
to any given population without appropriate domain adaptation.
Ideally, a model trained on a particular device would be seamlessly applied to other devices
that may have a different sampling rate or be slightly different in nature. To do so, we turn to
domain adaptation, a discipline that seeks to develop learning algorithms that can be easily
ported from one domain to another, from one device or brand to another [100]. Domain
adaptation techniques have shown strong results in natural language processing, image and
video classification tasks [101, 100, 102]. More recently, these techniques have been applied
to wearable and mobile devices in the context of human activity recognition tasks [103–
105]. Most existing approaches implement this philosophy of alignment by minimizing a
measurement of distributional discrepancy in the feature space, often some form of maximum
mean discrepancy (MMD) [106, 107], or a learned discriminator of the source and target as an
approximation to the total variation distance [108].
One potential approach for domain adaptation in wearable and mobile sensing data would be
to use self-supervised pre-training with the objective of aligning the source and target domains.
Most wearable device datasets, particularly those collected in free-living conditions, lack
proper labels as they are expensive and burdensome to achieve. Indeed, if the target domain
dataset had labels of the same nature as the source domain, a normal classification task would
suffice. However, due to the lack of labels in the vast majority of these datasets one could
introduce a set of self-supervisory auxiliary tasks which create their own labels for the data.
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By using multiple self-supervised tasks pertaining to different aspects of the wearable sensor’s
signals and training both domains together with the original task on the source domain, we
would anticipate producing robust, valuable and well-aligned representations that can then be
used for downstream classification or regression tasks on the target domain.
9.3.2 Improved human activity recognition through semi-supervised self-training
of wearable device data
Mobile and wearable computing’s key component in general, and for context awareness
in particular, is the automated assessment of what a user may be doing at any given time,
which is commonly referred to as Human Activity Recognition (HAR) [544]. The biggest
challenge in using artificial intelligence techniques for HAR scenarios is the absence of large
scale, labelled training datasets. Similarly, ground truth labelling is often of mixed quality or
ambiguous, which complicates training as well as validation of models built for HAR purposes.
New approaches like camera-based annotations and free-living GPS self-annotations have
been implemented to overcome the non-naturalistic environments of most conventional HAR
experiments. Sensors used for HAR purposes record temporal data, thus, HAR models need
to solve a dual problem: localise the contiguous portion of temporal data that is relevant
to the activity recognition problem (segmentation) and to classify those extracted segments
into particular classes. This represents an important challenge when compared to other fields
where deep learning techniques have been very successful, such as computer vision or natural
language processing. In these fields, massive amounts of labelled data (i.e.: Imagenet, CIFAR,
or the English Wikipedia) enable the generation and testing of new deep learning models.
Currently, there are very few datasets that would enable this type of work in HAR, and
those that are available are very limited given the important privacy issues that they raise and
annotation costs associated with these type of tasks at scale. Hence, most approaches to date
have been limited by the size and non-free living nature of these labelled datasets and there is a
lack of reference models that can be applied to natural, free-living conditions [450, 545, 546].
Semi-supervised learning approaches are a potential solution to the current limitations in
HAR as they could leverage unlabelled wearable data in free-living conditions present in
large population studies like the UK Biobank and combine them with the small amounts of
labelled data from smaller HAR studies [112]. Through unsupervised representation learning,
semi-supervised models take full advantage of the large diversity of activities and behaviours
present in large unlabelled data. Then, those learned representations can be fined tuned with a
smaller, labelled dataset through a supervised task that can then be used to label the full dataset.
In UK Biobank, the representations learned through unsupervised learning would not only be
rich with regards to the size of the population (100,000 participants), but also in their nature
(free-living, natural behaviours versus traditional constrained environments).
205
Discussion, conclusion and implications
Self-supervised learning is a training paradigm that leverages the intrinsic structure present
in the input signals [65]. These models make use of large scale unlabelled data by learning
objectives in order to get supervision from the data itself, using supervised loss functions.
Through this process, objectives are computed from the signals themselves by applying known
transformations to the input data. Most importantly, the intermediate representations capture
semantic and structural meaning that can then be exploited for a variety of downstream tasks.
While there might be conceptual overlaps with unsupervised learning, its goal is primarily
to learn a good geometrical structure of the data using the reconstruction loss (how well we
can compress and decompress the input) so that the result can be used mainly for clustering
purposes. On the other hand, self-supervised learning’s goal is to leverage relationships between
the input data using supervised losses (classification or regression). This new paradigm has
been successfully applied in filling the blanks for image datasets [66], next word prediction
[67], video frame order validation [68], and more recently to small-scale activity data [69]. In
BERT [67], for example, the task is to predict the next word given the past sequence. BERT
outperforms any other language modelling method by adding two auxiliary tasks within it’s
architecture, both of which are based on self-generated labels. On the other hand, the pre-
trained task of video frame order validation [68] improved the performance on the downstream
task of action recognition when used as first step. Similarly, in Chapter 6 of this thesis, we
used a pre-training framework that employed self-supervision to generate embeddings that
were then used in downstream classification tasks.
A possible solution lies on the use of self-supervised approaches that effectively utilise the
power of unlabelled data combined with the use of a semi-supervised teacher/student paradigm
which would use smaller, labelled datasets to fine-tune the model with true labels. We recently
submitted a piece of work that laid the foundations for future work in UK Biobank and other
large unlabelled datasets. The proposed approach, coined SelfHAR, is a self-supervised model
that effectively learns to leverage unlabelled mobile sensing datasets. Our approach combines
teacher-student self-training, which distil the knowledge of unlabelled datasets whilst allowing
for implicit data augmentation, and multi-task self-supervision, which learns robust signal-level
representations by predicting distorted versions of the input. Early results showed that this
architecture yields state-of-the-art performance over supervised and previous self-supervised
approaches, with up to 12% increase in F1 score using the same number of model parameters
at inference.
9.3.3 Robust methods and data science tools for large-scale observational stud-
ies
Throughout this thesis we have used multiple cohorts that included large-scale wearable data
to gain actionable insights on physical behaviours, health and fitness traits. In future, the
methods used to derive these measures could be leveraged in large population studies for
analyses exploring their associations to health and disease. Ultimately, this may be used to
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inform health guidelines and recommendations. However, given the observational nature of
most of these large cohort studies it is important to be able to rule out potential confounding
factors and other potential alternative explanations for any associations reported, including
inaccurate measures of the variables included in these studies to derive the variables of interest.
With regards to the accuracy of the measures, proper and systematic method evaluation and
validation against gold-standard measures, as was performed in the thesis chapters relating
to the inference of sleep, sleep stages and CRF, is required. With regards to confounding,
adjustment of models for potential confounding factors will be required. Further, longitudinal
studies and causal analyses leveraging genetic instruments could be used in future to ensure
the direction of association is correctly modelled. Further, deep learning models applied on
multimodal wearable sensor data could make use of Bayesian models. Bayesian models could
allow for data description in an interpretable way, something that could help overcome some
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